Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3048816	s-ca(7.4)	mmol/l (mmol/l)	27910	106510	0.48%
3048816	s-ca(7.4)	— (—)	8450	14969	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Hypothyroidism, drug reimbursement

784

1145

5.22

317.19

5.8

1.7

1.21

1.23

mmol/l

15.00

704

951

Used for control exclusion in common control thyroid runs

6106

17969

1.78

314.69

4.2

3.5

1.22

1.23

mmol/l

8.72

5414

15553

Contact with and exposure to communicable diseases

1895

7536

2.69

314.21

3.9

3.5

1.22

1.23

mmol/l

4.75

1593

6632

Hyperlipidaemia, other/unspecified

2856

12562

2.28

313.65

5.1

3.3

1.22

1.23

mmol/l

3.37

2580

10702

Pneumonia, organism unspecified

5533

22517

1.80

312.90

6.0

3.2

1.22

1.23

mmol/l

24.52

5044

19414

Sleep apnoea

5728

21678

1.79

312.04

4.0

3.8

1.22

1.23

mmol/l

6.44

4963

19050

Metabolic disorders

5924

20184

1.88

307.65

5.8

3.2

1.22

1.23

mmol/l

13.33

5404

17395

Abnormal spermatozoa

1111

3307

4.07

307.65

4.5

4.4

1.21

1.22

mmol/l

0.31

946

2950

Persons encountering health services for specific procedures and health care

6699

22246

1.89

307.65

6.6

2.8

1.22

1.23

mmol/l

16.99

6179

19023

Parasetamol

4328

11032

2.07

307.65

4.2

3.2

1.22

1.23

mmol/l

2.51

3837

9528

Liquid cancers, helper endpoint

2788

10098

2.65

307.65

7.8

3.0

1.23

mmol/l

1.03

2651

8499

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6993

23166

2.22

307.65

6.4

3.1

1.22

1.23

mmol/l

25.38

6394

19979

Other bacterial diseases

6075

22412

1.92

307.65

7.1

3.0

1.22

1.23

mmol/l

29.21

5630

19271

Provisional assignment of new diseases of uncertain etiology

3506

17699

2.11

307.65

5.0

3.6

1.22

1.23

mmol/l

2.08

3219

15331

Persons encountering health services in other circumstances, wide

8703

19490

2.46

307.65

4.6

3.4

1.23

mmol/l

1.97

7909

16602

Any reimbursement code in KELA

3197

5966

2.82

307.65

4.3

1.8

1.23

mmol/l

1.29

2842

4872

Hypertension, essential

4705

13342

2.10

307.65

5.0

3.0

1.22

1.23

mmol/l

4.47

4298

11484

Presence of other functional implants

5291

14016

2.93

307.65

4.2

3.5

1.23

mmol/l

4.43

4421

12224

Hypertension

4658

13581

2.03

307.65

5.2

3.0

1.23

mmol/l

3.27

4241

11690

Renal tubulo-interstitial diseases

6027

22357

2.14

307.65

7.7

2.9

1.22

1.23

mmol/l

34.43

5551

19223

Oral corticosteroids

7178

22167

2.03

307.65

4.6

3.5

1.22

1.23

mmol/l

1.62

6511

19075

First line medication for Crohn's disease

7200

20363

2.01

307.65

5.6

2.8

1.22

1.23

mmol/l

2.34

6609

17257

Fever of other and unknown origin

4097

15253

2.58

307.65

6.6

3.2

1.22

1.23

mmol/l

26.14

3812

12982

Persons encountering health services for other counselling and medical advice, not elsewhere classified

7791

19382

2.33

307.65

4.8

3.4

1.23

mmol/l

0.06

7281

16519

Other bacterial diseases

6310

22531

1.86

307.65

6.6

3.0

1.22

1.23

mmol/l

26.29

5848

19337

Malignant neoplasm, wide definition for exclusion

5346

16628

1.98

307.65

5.3

3.0

1.23

mmol/l

0.31

4969

14205

Hypothyroidism (congenital or acquired)

1562

1630

5.84

307.65

4.2

1.7

1.22

1.23

mmol/l

7.76

1358

1362

Hypertensive diseases (excluding secondary)

3135

7231

2.68

307.65

5.6

2.7

1.23

mmol/l

5.74

2865

6163

Any event in cancer register

5431

17892

1.87

307.65

5.0

3.1

1.23

mmol/l

0.68

4999

15316

Condition for Implicit Sepsis (Organ dysfunction codes)

5490

21299

1.86

307.65

5.6

3.1

1.22

1.23

mmol/l

36.29

4968

18339

General symptoms and signs

6690

17765

1.97

307.65

4.6

3.2

1.22

1.23

mmol/l

14.32

6017

15165

Persons encountering health services in other circumstances

3608

10919

3.72

307.65

4.4

3.3

1.22

1.23

mmol/l

9.53

3044

9262

Inflammatory bowel disease treatment related agents

7360

22573

1.91

307.65

4.6

3.5

1.22

1.23

mmol/l

1.70

6659

19401

All chronic kidney diseases

4085

14703

2.47

307.65

9.8

2.9

1.22

1.23

mmol/l

26.09

3825

12533

All kidney diseases

6637

22952

2.09

307.65

7.1

2.8

1.22

1.23

mmol/l

18.56

6075

19738

Abnormalities of breathing

5575

17273

1.96

307.65

4.2

3.6

1.22

1.23

mmol/l

10.61

4915

15005

ILD medications

6999

21631

1.83

307.65

5.5

3.0

1.22

1.23

mmol/l

2.61

6365

18494

Codes for special purposes

3511

17719

2.11

307.65

5.0

3.6

1.22

1.23

mmol/l

2.15

3223

15351

Anaemias

1678

1549

7.89

307.65

8.2

1.7

1.22

1.23

mmol/l

10.18

1549

1299

ILD medications: immunosuppressive drugs

4184

19128

2.16

307.65

7.0

3.1

1.23

mmol/l

0.36

3907

16417

Cardiovascular diseases

3190

7826

2.29

307.65

4.6

2.6

1.22

1.23

mmol/l

5.33

2857

6625

Renal failure

3605

13865

2.54

307.65

10.9

3.1

1.21

1.23

mmol/l

33.12

3411

11845

Other heart diseases

2770

7223

2.66

307.65

5.4

2.7

1.22

1.23

mmol/l

22.08

2519

6144

Malaise and fatigue

3540

13024

2.35

307.65

4.7

3.2

1.22

1.23

mmol/l

8.52

3160

11032

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

6265

21245

2.02

307.65

5.6

3.3

1.22

1.23

mmol/l

4.43

5508

18605

Malignant neoplasm

5237

16265

2.01

307.65

5.4

3.0

1.23

mmol/l

0.65

4871

13892

Cardiovascular diseases (excluding rheumatic etc)

3577

8884

2.44

307.65

4.8

2.6

1.22

1.23

mmol/l

6.35

3243

7538

Hypothyroidism and >3 levothyroxin purchases

1542

1626

5.78

307.65

4.1

1.7

1.22

1.23

mmol/l

8.38

1341

1361

Other symptoms and signs involving the nervous and musculoskeletal systems

2952

13559

2.36

307.65

4.0

3.7

1.23

mmol/l

0.85

2701

11775

Solid cancers, helper endpoint

5035

16109

1.94

307.65

5.0

3.0

1.23

mmol/l

0.59

4664

13755

Hypertensive diseases

4657

13586

2.03

307.65

5.2

3.0

1.23

mmol/l

3.24

4240

11692

Chronic kidney disease

2641

9831

2.99

307.65

12.7

3.0

1.21

1.23

mmol/l

21.42

2511

8387

Endocrine, nutritional and metabolic diseases

4644

11400

2.16

307.65

4.5

2.7

1.22

1.23

mmol/l

3.55

4119

9773

Sleep apnoea, including avohilmo

6040

21885

1.79

307.65

3.9

3.8

1.22

1.23

mmol/l

4.36

5194

19275

Dyspnoea

5630

23727

1.84

307.65

4.5

3.7

1.22

1.23

mmol/l

22.78

4965

20691

ILD medications: prednisolone, methylprednisolone, prednisone

6911

21432

1.89

307.65

5.6

3.0

1.22

1.23

mmol/l

2.64

6290

18335

Other antidepressants

6277

18542

1.81

307.65

3.8

3.9

1.23

mmol/l

0.67

5400

16375

Depression medications

1493

1701

4.67

307.65

3.7

1.7

1.23

mmol/l

0.99

1267

1423

Disorders of other endocrine glands

3266

13831

2.54

307.65

8.0

3.2

1.24

1.23

mmol/l

22.35

3035

11915

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1931

6972

3.11

307.65

7.5

3.1

1.22

1.23

mmol/l

1.06

1873

5872

Hypothyroidism, levothyroxine purchases

1542

1626

5.78

307.65

4.1

1.7

1.22

1.23

mmol/l

8.38

1341

1361

Other medical care

3717

13955

2.65

307.65

6.2

2.9

1.22

1.23

mmol/l

10.80

3518

11806

Heart failure, not strict

4716

17869

1.90

306.64

7.5

3.1

1.22

1.23

mmol/l

57.73

4359

15354

Secondary hypertension

699

1547

5.27

298.61

17.7

2.9

1.22

1.23

mmol/l

7.22

684

1289

Any gastric operation

4559

12372

1.92

297.18

4.8

2.3

1.22

1.23

mmol/l

15.21

4079

10471

GASTRO-related operations

4559

12372

1.92

297.18

4.8

2.3

1.22

1.23

mmol/l

15.21

4079

10471

Implicit Sepsis

5007

21042

1.82

296.03

6.1

3.1

1.22

1.23

mmol/l

52.85

4566

18087

Type 2 diabetes, wide definition

4911

17888

1.85

293.71

5.3

3.5

1.22

1.23

mmol/l

13.72

4437

15510

Cardiac arrhythmias

3287

10643

2.10

291.02

4.1

3.1

1.22

1.23

mmol/l

18.92

2946

9149

Polyarthropathies

4218

15008

1.93

290.89

5.2

3.6

1.22

1.23

mmol/l

0.76

3848

13048

Other heart diseases, wide

5231

18512

1.80

289.21

4.9

3.2

1.22

1.23

mmol/l

21.64

4700

16070

Other disorders of fluid, electrolyte and acid-base balance

2308

10003

2.40

288.42

7.2

3.2

1.21

1.23

mmol/l

24.26

2127

8502

Symptoms and signs involving the nervous and musculoskeletal systems

3696

19948

1.97

286.26

4.0

3.8

1.23

mmol/l

0.72

3321

17318

5305

18722

1.79

286.04

5.9

3.1

1.22

1.23

mmol/l

22.35

4843

16054

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5305

18722

1.79

286.04

5.9

3.1

1.22

1.23

mmol/l

22.35

4843

16054

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1422

5261

3.06

283.20

6.0

3.1

1.23

mmol/l

0.24

1371

4423

Implicit Sepsis

4639

20007

1.84

281.90

6.4

3.1

1.21

1.23

mmol/l

55.97

4249

17169

Pneumonias (Asthma/COPD co-morbidities)

5866

23910

1.71

278.10

6.0

3.2

1.22

1.23

mmol/l

22.07

5364

20626

All pneumoniae

5898

23968

1.71

277.70

6.0

3.2

1.22

1.23

mmol/l

22.74

5386

20689

Condition for Implicit Sepsis (Organ dysfunction codes)

5113

21224

1.78

276.62

6.0

3.1

1.22

1.23

mmol/l

50.24

4645

18277

Autoimmune diseases excluding thyroid diseases

5932

19618

1.71

269.68

4.5

3.6

1.22

1.23

mmol/l

3.60

5340

17040

Diabetes mellitus

5940

21216

1.70

266.70

4.6

3.4

1.22

1.23

mmol/l

7.82

5259

18430

Influenza and pneumonia

6063

23808

1.68

265.59

5.9

3.2

1.22

1.23

mmol/l

20.68

5538

20511

Autoimmune diseases

6309

19751

1.68

265.58

4.2

3.6

1.22

1.23

mmol/l

6.97

5584

17154

Cerebrovascular diseases (FINNGEN)

1810

5220

2.62

265.46

4.9

2.8

1.22

1.23

mmol/l

14.52

1674

4405

Pain in throat and chest

4859

16931

1.79

264.86

3.9

3.6

1.23

mmol/l

3.57

4316

14723

Diabetes, varying definitions

5913

21205

1.70

264.61

4.6

3.4

1.22

1.23

mmol/l

7.43

5234

18424

Intracranial trauma

3318

12161

2.01

263.39

3.9

3.7

1.22

1.23

mmol/l

7.83

2897

10556

Autoimmune diseases excluding thyroid diseases, strict definition

5690

18813

1.72

262.42

4.5

3.5

1.22

1.23

mmol/l

3.16

5124

16303

Benzodiazepine use

5948

25358

1.68

262.31

4.3

3.7

1.23

mmol/l

0.88

5112

22215

Heart failure and antihypertensive medication

1607

4041

2.82

262.21

7.4

3.3

1.21

1.23

mmol/l

26.94

1501

3470

Disorders of the thyroid gland

5548

22064

1.70

255.88

4.1

3.7

1.22

1.23

mmol/l

5.58

4845

19239

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5703

23970

1.69

255.83

5.9

3.3

1.22

1.23

mmol/l

20.52

5205

20713

Constipation

5320

22417

1.71

252.43

4.6

3.7

1.22

1.23

mmol/l

2.91

4588

19638

Oxycodone

2610

11789

2.15

251.68

7.4

3.2

1.22

1.23

mmol/l

8.33

2468

10073

Endocrine disorders, other/unspecified

333

460

12.25

250.28

5.9

3.0

1.22

1.23

mmol/l

0.22

298

388

Antihypertensive medication - note that there are other indications

3096

8312

2.05

247.44

4.5

2.9

1.23

mmol/l

1.06

2721

7153

Aplastic and other anaemias

3058

15230

2.00

243.81

8.5

3.4

1.21

1.23

mmol/l

24.95

2823

13078

Hypothyroidism, other/unspecified

5207

20887

1.71

242.10

4.1

3.6

1.22

1.23

mmol/l

8.94

4519

18190

Concussion

2860

12032

2.03

241.91

3.9

3.7

1.22

1.23

mmol/l

4.67

2498

10447

Other diseases of blood and blood-forming organs, wide

1605

6818

2.61

239.17

7.5

3.7

1.22

1.23

mmol/l

3.20

1485

5963

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5441

20190

1.69

238.72

4.7

3.5

1.22

1.23

mmol/l

10.17

4807

17559

Type 2 diabetes

5647

20526

1.67

236.30

4.6

3.4

1.22

1.23

mmol/l

8.76

5011

17838

Hypothyreosis and Thyroxine purchase for inclusion criteria

5392

21902

1.68

236.22

4.1

3.6

1.22

1.23

mmol/l

9.17

4677

19084

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2296

6813

2.23

234.77

5.1

2.7

1.22

1.23

mmol/l

9.34

2084

5795

Disorders of thyroid, IBD co-morbidities

1068

2451

3.28

234.66

3.9

3.0

1.22

1.23

mmol/l

2.17

940

2090

Atrial fibrillation and flutter

1759

4813

2.52

234.24

5.0

2.8

1.22

1.23

mmol/l

22.80

1608

4062

Asthma, unspecified (mode), excluding more controls

2997

11853

1.98

232.27

3.8

2.9

1.22

1.23

mmol/l

16.96

2686

10090

Insulin medication

3605

17142

1.86

232.25

6.2

3.7

1.22

1.23

mmol/l

21.80

3216

14888

Hard cardiovascular diseases

4800

17210

1.74

231.71

4.6

3.6

1.22

1.23

mmol/l

15.53

4359

14893

Other soft tissue disorders, not elsewhere classified

5422

19676

1.68

231.38

4.2

3.7

1.22

1.23

mmol/l

2.37

4795

17083

Persons with potential health hazards related to communicable diseases

2100

9913

2.22

230.17

4.1

3.6

1.22

1.23

mmol/l

6.73

1784

8747

Complications of surgical and medical care, not elsewhere classified

5733

24916

1.63

228.58

5.3

3.5

1.22

1.23

mmol/l

5.28

5216

21577

Bacterial infection, other or unspecified

3550

17044

1.86

226.44

7.9

3.1

1.22

1.23

mmol/l

22.96

3325

14530

Ischemic heart diseases

4788

17413

1.72

225.65

4.9

3.5

1.22

1.23

mmol/l

14.95

4293

15117

Disorders of parathyroid gland

1586

6805

2.56

225.09

11.8

3.2

1.27

1.23

mmol/l

38.99

1492

5800

Care involving dialysis

692

1921

4.30

225.00

32.4

2.8

1.20

1.23

mmol/l

19.15

685

1655

Opioids

5501

17760

1.66

223.79

4.6

3.0

1.22

1.23

mmol/l

3.99

4923

15245

Transplanted organ and tissue status

774

2311

3.89

223.66

19.8

3.8

1.22

1.23

mmol/l

2.94

765

2053

Episodal and paroxysmal disorders

6153

20024

1.61

221.62

3.7

3.8

1.22

1.23

mmol/l

6.07

5405

17380

Covid-19 confirmed case

2393

12212

2.10

221.33

5.9

3.7

1.22

1.23

mmol/l

7.34

2155

10545

Other and unspecified anaemias

2807

14378

1.99

220.70

8.1

3.4

1.21

1.23

mmol/l

21.98

2586

12341

Explicit Sepsis

2813

14094

1.98

220.16

9.3

3.1

1.21

1.23

mmol/l

31.75

2616

12025

Symptoms and signs involving the circulatory and respiratory systems

5535

17311

1.65

219.10

3.9

3.6

1.22

1.23

mmol/l

7.03

4916

15037

Other anaemias

2822

14476

1.98

218.98

8.1

3.4

1.21

1.23

mmol/l

22.50

2601

12418

Sleep disorders (combined)

6405

21817

1.59

218.57

3.7

3.8

1.23

mmol/l

1.96

5552

19093

Septicaemia

2707

13463

2.00

218.30

9.5

3.1

1.21

1.23

mmol/l

28.70

2518

11447

Hypothyroidism, strict autoimmune

4183

16279

1.76

217.41

3.7

3.5

1.23

mmol/l

2.14

3584

14042

Diabetes, insulin treatment (Kela reimbursement)

5740

22161

1.62

216.47

4.7

3.6

1.22

1.23

mmol/l

9.73

5063

19322

Asthma, unspecified (mode)

3103

12836

1.90

213.92

3.9

3.0

1.22

1.23

mmol/l

12.63

2781

10961

Pain in limb

4701

19300

1.69

213.83

4.4

3.7

1.22

1.23

mmol/l

1.33

4138

16772

Percutaneous Coronary Intervention

4537

16911

1.72

211.57

4.7

3.6

1.22

1.23

mmol/l

15.87

4066

14687

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1098

4128

2.99

211.42

6.5

3.0

1.23

mmol/l

3.87

1073

3482

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

778

1587

3.86

211.35

5.1

3.3

1.22

1.23

mmol/l

3.56

718

1337

Insulin, fast-acting

2256

11442

2.10

211.02

7.0

3.6

1.21

1.23

mmol/l

19.44

2015

9945

Osteoporosis

1912

8570

2.29

210.51

6.1

3.4

1.24

1.23

mmol/l

2.64

1797

7278

Codeine

5175

17554

1.66

209.23

4.2

3.1

1.22

1.23

mmol/l

4.38

4586

15086

Other septicaemia

2449

12316

2.04

208.98

9.8

3.1

1.21

1.23

mmol/l

29.35

2284

10453

Bacterial infection, other or unspecified

3287

16252

1.85

208.46

8.2

3.1

1.22

1.23

mmol/l

21.22

3083

13858

Malignant neoplasm of breast

2575

8710

2.05

208.27

4.0

2.7

1.24

mmol/l

6.59

2388

7332

Diabetes medication

5808

22243

1.60

208.00

4.6

3.5

1.22

1.23

mmol/l

5.62

5107

19366

Malignant neoplasm of breast, HER2-negative

2552

8654

2.05

206.97

4.1

2.7

1.24

mmol/l

6.59

2365

7285

Spondylosis

3390

15874

1.83

206.87

3.7

3.9

1.23

mmol/l

0.80

2949

13857

Disorders of gallbladder, biliary tract and pancreas

5665

23070

1.60

206.26

4.5

3.7

1.22

1.23

mmol/l

7.78

5064

20069

Coronary revascularization (ANGIO or CABG)

4513

16916

1.70

204.89

4.7

3.6

1.22

1.23

mmol/l

14.79

4039

14690

L04AD Calcineurin inhibitors

815

2670

3.50

202.25

17.4

3.9

1.22

1.23

mmol/l

1.41

801

2362

Osteopathies and chondropathies

3364

18188

1.81

202.10

6.2

3.5

1.23

mmol/l

0.88

3128

15689

Malignant neoplasm of breast, HER2-negative, including Hilmo

2591

8804

2.02

201.91

4.1

2.7

1.24

mmol/l

6.27

2402

7412

STROKE

3159

12024

1.87

201.59

4.3

3.4

1.22

1.23

mmol/l

10.89

2924

10298

Malignant neoplasm of breast, including Hilmo

2590

8804

2.02

201.54

4.1

2.7

1.24

mmol/l

6.20

2401

7412

Malignant neoplasm of breast, ER-positive, including Hilmo

2078

7911

2.18

201.01

4.3

2.8

1.24

mmol/l

6.58

1945

6637

Malignant neoplasm of breast, HER-positive

2045

7838

2.19

200.55

4.3

2.8

1.24

mmol/l

6.32

1916

6576

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1875

4211

2.32

200.26

3.9

2.7

1.22

1.23

mmol/l

4.82

1646

3516

L04AA Selective immunosuppressants

1486

6589

2.46

199.13

10.8

3.5

1.23

mmol/l

1.12

1419

5776

Drug-induced neutropenia

663

1972

4.10

196.71

10.3

3.8

1.23

mmol/l

0.28

642

1726

Headache

3471

16186

1.78

195.51

3.7

3.1

1.23

mmol/l

3.16

3079

13816

Neurological diseases, wide definition

1494

3058

2.56

195.39

3.8

3.0

1.23

mmol/l

0.75

1304

2602

Other reaction to severe stress, and adjustment disorders

2047

10277

2.10

195.11

4.8

3.5

1.23

mmol/l

1.05

1843

9067

Emergency coronary revascularization (for ACS)

4893

18835

1.64

193.42

4.7

3.7

1.22

1.23

mmol/l

12.42

4379

16353

Insulin, intermediate and long-acting

3249

18418

1.80

192.84

6.1

3.6

1.21

1.23

mmol/l

20.83

2893

16029

Insulin, fast-acting or short human

2263

11852

2.03

192.58

7.0

3.7

1.21

1.23

mmol/l

18.75

2022

10316

Depression or dysthymia

3741

12115

1.77

192.45

4.0

1.23

mmol/l

0.86

3199

10786

Insulin, combination of fast acting with intermediate-acting or long-acting

3608

19744

1.75

191.98

6.2

3.6

1.22

1.23

mmol/l

19.57

3218

17159

Second line medication for Crohn's disease

3283

19235

1.79

191.79

5.2

3.7

1.23

mmol/l

0.03

3037

16702

Nephropathy related operations

920

3337

3.15

191.01

26.8

3.4

1.20

1.22

mmol/l

19.50

911

2939

Tramadol

4373

16577

1.68

190.88

5.2

3.1

1.22

1.23

mmol/l

4.22

3900

14264

Exposure to unspecified factor

5545

26221

1.57

190.69

4.7

3.6

1.22

1.23

mmol/l

14.80

4809

22933

Dialysis, with operation codes

918

3352

3.10

187.35

26.8

3.1

1.20

1.23

mmol/l

24.43

908

2914

Glomerular diseases

1243

5253

2.61

186.98

15.8

3.5

1.21

1.22

mmol/l

11.95

1176

4596

Atrial fibrillation and flutter with reimbursement

1443

3922

2.50

186.82

4.2

2.9

1.22

1.24

mmol/l

16.25

1301

3271

Chronic apical periodontitis

6229

23780

1.54

186.53

4.5

3.6

1.22

1.23

mmol/l

3.54

5469

20748

Type 2 diabetes, definitions combined

5252

19953

1.60

186.39

4.1

3.4

1.22

1.23

mmol/l

4.53

4647

17343

Obesity due to excess calories

2645

14693

1.89

186.09

5.0

3.6

1.22

1.23

mmol/l

14.69

2352

12841

Other endocrine disorders

451

994

5.21

185.94

6.3

3.6

1.22

1.23

mmol/l

0.74

412

855

Asthma, excluding more controls

3977

12449

1.72

185.23

3.7

2.9

1.22

1.23

mmol/l

12.46

3563

10594

Syncope and collapse

2604

12244

1.91

184.67

4.3

3.2

1.22

1.23

mmol/l

11.41

2323

10345

L04AX Other immunosuppressants

3186

18756

1.78

183.02

5.3

3.7

1.23

mmol/l

0.10

2952

16295

Heart failure,strict

3206

13172

1.81

182.65

6.6

3.2

1.21

1.23

mmol/l

64.71

2965

11212

Neoplasms

3858

12233

1.72

181.63

4.8

2.8

1.22

mmol/l

0.07

3501

10373

Type 2 diabetes, strict (exclude DM1)

5261

20118

1.59

181.46

4.1

3.5

1.22

1.23

mmol/l

4.69

4656

17496

Neurological diseases

4618

14535

1.65

180.20

3.9

3.8

1.22

1.23

mmol/l

3.45

4061

12638

Type 2 diabetes, definitions combined, including avohilmo

5236

19866

1.59

179.88

4.1

3.5

1.23

mmol/l

3.89

4629

17282

Kidney transplant status

472

1176

4.92

179.56

24.7

3.6

1.22

1.23

mmol/l

1.24

472

1036

Adjustment and management of implanted device

1296

5688

2.51

178.91

5.0

2.9

1.22

1.23

mmol/l

9.50

1145

4751

COPD/asthma related infections

5674

18727

1.56

178.42

4.6

3.1

1.22

1.23

mmol/l

10.58

5079

16059

COPD/asthma/ILD related infections

5674

18727

1.56

178.42

4.6

3.1

1.22

1.23

mmol/l

10.58

5079

16059

Acute tubulo-interstitial nephritis

3556

18602

1.72

178.30

5.8

2.9

1.22

1.23

mmol/l

11.25

3218

15888

Hypo-osmolality and hyponatraemia

1289

5634

2.52

177.78

5.9

3.2

1.21

1.23

mmol/l

15.68

1172

4752

Any mental disorder

6054

20284

1.54

177.35

4.1

3.7

1.23

mmol/l

1.34

5255

17820

Psychiatric diseases

5423

17758

1.58

176.65

4.0

3.8

1.23

mmol/l

0.74

4682

15647

Exclusions for E4_PCOS_BROAD

1127

4674

2.64

175.35

5.6

3.8

1.22

1.23

mmol/l

2.72

1050

4093

Finngen Rheumatological endpoints

5191

19275

1.58

175.14

4.0

3.6

1.23

mmol/l

0.04

4662

16685

Major coronary heart disease event

4707

18253

1.62

174.53

4.7

3.7

1.22

1.23

mmol/l

12.96

4219

15847

Nausea and vomiting

1713

8256

2.17

173.75

6.4

3.5

1.22

1.23

mmol/l

12.80

1550

7050

Asthma (only as main-diagnosis), excluding more controls

3631

12449

1.72

173.44

3.7

2.9

1.23

mmol/l

7.32

3245

10594

Asthma

4158

13507

1.67

171.76

3.7

3.0

1.22

1.23

mmol/l

9.30

3720

11532

Codeine or tramadol medication

6240

23240

1.51

171.72

4.2

3.6

1.22

1.23

mmol/l

2.99

5518

20195

Other arrhythmias

3484

15899

1.72

171.56

3.8

3.2

1.23

mmol/l

11.76

3065

13772

Bleeding

4678

21606

1.60

170.67

5.4

3.6

1.22

1.23

mmol/l

21.40

4176

18768

Autoimmune diseases related-to ILD

4646

25912

1.59

170.48

4.0

3.8

1.22

1.23

mmol/l

2.11

4145

22533

Valvular heart disease excluding rheumatic fever

2747

11262

1.85

170.35

5.5

3.4

1.22

1.23

mmol/l

24.15

2423

9678

Extracorporeal dialysis

544

1561

4.24

170.08

36.2

3.5

1.19

1.22

mmol/l

19.61

538

1377

Non-rheumatic valve diseases

2738

11219

1.85

169.71

5.5

3.4

1.22

1.23

mmol/l

23.95

2415

9638

Mood disorders, excluding more controls

5063

19823

1.57

169.25

4.1

3.7

1.23

mmol/l

1.70

4364

17413

Hyperparathyroidism

1326

5968

2.42

168.14

11.9

3.2

1.28

1.23

mmol/l

64.71

1243

5090

Acute renal failure

1447

6813

2.31

167.97

10.1

3.0

1.20

1.23

mmol/l

31.03

1374

5820

Agranulocytosis

850

3176

3.05

167.12

9.9

3.7

1.22

1.23

mmol/l

1.33

815

2759

Hypothyroidism, strict autoimmune, 3 medication purchases required

4655

20468

1.59

165.60

3.7

3.6

1.23

mmol/l

1.39

3971

17837

Symptoms and signs involving the digestive system and abdomen

5428

18084

1.55

163.51

4.4

3.5

1.22

1.23

mmol/l

5.16

4811

15671

Disorders of mineral metabolism

683

2306

3.42

162.04

12.9

3.2

1.24

1.23

mmol/l

0.97

641

1977

Other general symptoms and signs

425

1033

4.77

162.02

3.7

2.9

1.23

mmol/l

0.32

363

872

Diseases of arteries, arterioles and capillaries (FINNGEN)

1277

3863

2.43

160.26

7.6

2.9

1.22

1.23

mmol/l

19.07

1161

3222

Anxiety disorders, excluding more controls

4362

18312

1.60

159.59

4.1

3.7

1.23

mmol/l

1.49

3818

16088

Infections, IBD-co-morbidities

850

2179

2.97

159.55

10.0

3.1

1.22

1.23

mmol/l

3.17

790

1859

Heart failure, strict

3474

15133

1.70

158.60

6.4

3.6

1.21

1.23

mmol/l

60.89

3196

12969

Paroxysmal tachycardia

1197

4357

2.44

158.51

4.1

2.8

1.22

1.23

mmol/l

11.65

1077

3643

Selective serotonin reuptake inhibitors

5310

18582

1.53

155.37

3.7

3.9

1.23

mmol/l

0.26

4515

16411

Abdominal and pelvic pain

5366

18084

1.53

154.97

4.2

3.5

1.22

1.23

mmol/l

4.28

4742

15671

Asthma (mode)

4018

13584

1.63

154.48

3.6

3.0

1.23

mmol/l

6.77

3595

11600

Spondylopathies

4475

17463

1.58

153.46

4.0

3.8

1.23

mmol/l

0.59

3921

15261

All-cause Heart Failure

3415

14949

1.69

153.45

6.4

3.6

1.21

1.23

mmol/l

60.07

3139

12803

Asthma (only as main-diagnosis)

3736

13507

1.65

152.76

3.6

3.0

1.23

mmol/l

4.26

3336

11532

Low back pain

4123

19175

1.60

151.34

4.1

3.8

1.23

mmol/l

0.17

3642

16716

ILD differential diagnosis

4229

13584

1.61

149.91

4.3

3.0

1.23

mmol/l

6.48

3792

11600

COPD differential diagnosis

4230

13589

1.61

149.88

4.3

3.0

1.23

mmol/l

6.52

3793

11605

Other disorders of adrenal gland

415

1082

4.68

148.64

7.0

3.2

1.22

1.23

mmol/l

2.03

400

924

Excluding asthma or asthma-COPD overlap

4241

13660

1.60

148.60

4.3

3.0

1.23

mmol/l

7.21

3799

11673

Other nutritional deficiencies

3482

20750

1.64

148.18

4.8

3.7

1.22

1.23

mmol/l

20.55

3096

18091

Diseases of pulp and periapical tissues, including avohilmo

5693

20290

1.49

146.44

4.1

3.6

1.22

1.23

mmol/l

2.89

4982

17676

Other (not insulin) diabetes medications

5237

21168

1.51

146.19

4.1

3.5

1.22

1.23

mmol/l

4.00

4600

18449

Invasive ventilation

577

1878

3.58

146.06

9.3

3.7

1.20

1.22

mmol/l

17.33

527

1622

Other pulmonary diagnosis

4227

13660

1.60

146.00

4.4

3.0

1.22

1.23

mmol/l

8.47

3787

11673

Bronchitis

5784

25353

1.48

145.83

4.8

3.5

1.22

1.23

mmol/l

17.03

5172

21959

Reimbursement for rheumatic diseases

3191

19848

1.67

145.70

3.6

3.8

1.23

mmol/l

1.35

2912

17184

Intracranial injury

3242

19180

1.66

145.30

4.0

3.7

1.22

1.23

mmol/l

5.96

2828

16680

Schizophrenia or delusion, excluding more controls

1590

8022

2.06

144.87

3.7

3.6

1.23

mmol/l

0.61

1377

7085

6198

22445

1.46

144.59

4.5

3.5

1.22

1.23

mmol/l

10.88

5497

19391

Adrenocortical insufficiency

360

875

5.19

142.86

7.1

3.2

1.22

1.23

mmol/l

2.27

347

749

Bacterial Sepsis

2724

13990

1.74

142.27

8.3

3.2

1.21

1.23

mmol/l

38.01

2529

11924

Erysipelas

3908

19425

1.59

142.26

5.1

3.1

1.22

1.23

mmol/l

20.18

3558

16649

778

2984

2.83

141.31

5.9

3.2

1.22

1.23

mmol/l

4.68

705

2542

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3701

21528

1.60

140.25

4.7

3.8

1.22

1.23

mmol/l

2.40

3381

18623

Use of hypnotics and sedatives

5702

22836

1.47

139.75

4.5

3.7

1.22

1.23

mmol/l

1.51

4973

20013

Mood disorders

5431

24390

1.48

139.69

4.1

3.8

1.23

mmol/l

1.45

4675

21386

Mood [affective] disorders

5418

24371

1.48

139.40

4.1

3.8

1.23

mmol/l

1.46

4661

21372

Other disorders of urethra and urinary system

3871

18201

1.59

139.24

4.7

3.5

1.23

mmol/l

1.09

3386

15826

Covid-19 suspected case

1252

5988

2.23

137.34

3.6

3.5

1.23

mmol/l

2.15

1201

5203

Implicit bacterial Sepsis

2615

13576

1.75

136.86

8.0

3.2

1.21

1.23

mmol/l

38.12

2424

11571

Enlarged lymph nodes

965

4172

2.50

136.05

5.9

3.2

1.23

mmol/l

0.15

922

3571

Depression

4980

23241

1.49

134.54

4.0

3.8

1.22

1.23

mmol/l

3.18

4283

20392

Oedema, not elsewhere classified

1812

9776

1.93

134.25

5.0

3.2

1.22

1.23

mmol/l

5.56

1636

8294

Kela-code for severe mental illness

1956

10962

1.87

133.59

3.6

3.8

1.23

mmol/l

3.32

1694

9622

Primary hyperparathyroidism

829

3429

2.75

133.28

7.5

3.5

1.31

1.23

mmol/l

88.31

767

2964

Glomerular disorders in diseases classified elsewhere

797

3223

2.76

132.66

17.8

3.6

1.20

1.22

mmol/l

11.26

751

2812

Unspecified mental disorder

2130

12256

1.82

132.48

3.6

3.7

1.23

mmol/l

3.39

1852

10771

Recurrent or chronic depression

1993

7741

1.88

132.44

3.6

3.8

1.23

mmol/l

1.98

1688

6906

Convulsions, not elsewhere classified

1245

5927

2.19

132.13

4.7

3.2

1.21

1.23

mmol/l

17.97

1141

5076

Iron deficiency anaemia

2469

14631

1.75

131.69

5.8

3.6

1.22

1.23

mmol/l

12.96

2231

12610

Abnormalities of heart beat

2005

11134

1.85

131.64

3.9

3.5

1.23

mmol/l

4.13

1740

9585

Nutritional anaemias

2840

17047

1.68

131.25

5.6

3.6

1.22

1.23

mmol/l

14.89

2552

14716

Presbycusis

1039

4702

2.41

130.93

4.1

3.8

1.22

1.23

mmol/l

0.74

826

4053

Complications of procedures, not elsewhere classified

4319

24261

1.52

130.45

5.3

3.5

1.22

1.23

mmol/l

6.37

3921

21023

Disorders of calcium metabolism

531

1765

3.52

130.20

14.6

3.2

1.24

1.23

mmol/l

1.39

504

1516

Other retinal disorders

3611

18412

1.59

130.01

5.2

3.7

1.22

1.23

mmol/l

11.28

3048

16081

Medicines for HER+ breast cancer

2147

11836

1.82

129.88

4.3

3.4

1.24

mmol/l

7.43

2006

10106

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1935

10939

1.87

129.64

5.0

3.6

1.22

1.23

mmol/l

22.68

1762

9519

Genitourinary diseases

2914

8869

1.70

128.50

5.2

2.8

1.22

1.23

mmol/l

4.99

2587

7688

Diarrhoea and gastroenteritis of presumed infectious origin

3740

22315

1.56

128.47

5.8

3.4

1.22

1.23

mmol/l

10.90

3352

19369

Venous thromboembolism

3076

18961

1.63

128.24

5.6

3.6

1.23

mmol/l

1.63

2792

16394

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1336

6674

2.09

126.91

3.9

3.5

1.22

1.23

mmol/l

4.13

1148

5941

Other acute lower respiratory infections

2865

17147

1.65

126.43

5.3

3.6

1.22

1.23

mmol/l

11.06

2574

14854

Other diseases of pleura

2608

14039

1.71

126.33

5.9

3.8

1.21

1.23

mmol/l

18.66

2397

12102

Anxiety disorders

4601

22034

1.50

126.30

4.1

3.7

1.23

mmol/l

1.83

4020

19263

Other abnormal findings of blood chemistry

406

1170

4.18

125.98

3.7

3.6

1.23

mmol/l

0.09

383

1010

Implicit bacterial Sepsis

2386

12711

1.75

125.60

8.4

3.2

1.21

1.23

mmol/l

36.40

2217

10820

Other arthritis (FG)

1749

9695

1.90

124.51

4.7

3.6

1.23

mmol/l

0.08

1581

8353

General examination and investigation of persons without complaint and reported diagnosis

3862

13271

1.57

123.96

3.8

3.7

1.23

1.22

mmol/l

3.89

3626

11294

Cholelithiasis, broad definition with cholecystitis

4680

21796

1.49

123.90

4.1

3.6

1.22

1.23

mmol/l

3.01

4135

18901

Disorders of choroid and retina

4400

21473

1.50

122.89

5.0

3.7

1.22

1.23

mmol/l

7.76

3722

18834

Primary_lymphoid and hematopoietic malignant neoplasms

1483

7876

2.02

122.87

10.3

3.6

1.22

1.23

mmol/l

0.36

1431

6783

Injuries to the head

5808

25622

1.43

122.80

4.1

3.7

1.22

1.23

mmol/l

9.81

5092

22332

Obesity

3208

20091

1.59

122.70

4.8

3.7

1.22

1.23

mmol/l

16.85

2850

17539

Disorders of lens

3578

14632

1.58

122.61

5.6

3.7

1.22

1.23

mmol/l

4.50

3139

12916

L02BG Aromatase inhibitors

1811

10234

1.89

122.39

4.4

3.4

1.25

1.24

mmol/l

7.74

1694

8703

Neurotic, stress-related and somatoform disorders

4530

21856

1.49

122.22

4.1

3.7

1.23

mmol/l

2.07

3953

19110

Personality disorders, excluding more controls

1228

6062

2.12

122.05

3.5

1.22

1.23

mmol/l

1.61

1042

5409

Ischaemic heart disease, wide definition

4174

17520

1.53

122.02

4.8

3.7

1.22

1.23

mmol/l

15.35

3693

15257

Cholelithiasis

4519

21511

1.49

121.55

4.1

3.6

1.23

mmol/l

2.67

3988

18642

Obesity and other hyperalimentation

3217

20184

1.59

121.22

4.9

3.7

1.22

1.23

mmol/l

17.24

2859

17620

Acute bronchitis

2279

13424

1.74

121.21

5.4

3.6

1.22

1.23

mmol/l

10.55

2025

11612

Care involving use of rehabilitation procedures

3277

19673

1.58

121.01

4.0

2.9

1.22

1.23

mmol/l

6.14

2913

16828

Certain infectious and parasitic diseases

5125

17923

1.47

120.80

5.0

2.7

1.22

1.23

mmol/l

16.55

4625

15295

Obesity related asthma

1915

11015

1.83

120.62

4.1

3.8

1.22

1.23

mmol/l

9.97

1728

9596

Other diseases of urinary system

5277

20940

1.45

120.55

4.4

3.6

1.22

1.23

mmol/l

4.85

4602

18285

Biguanides

5044

21604

1.46

120.44

3.8

3.7

1.22

1.23

mmol/l

3.02

4428

18845

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1741

9741

1.88

120.33

4.5

3.7

1.23

mmol/l

0.31

1589

8495

Pacemaker

2008

11243

1.82

120.25

4.8

3.9

1.22

1.23

mmol/l

9.16

1784

9684

Other functional intestinal disorders

2614

15103

1.67

119.76

4.8

3.6

1.23

mmol/l

2.65

2301

13023

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3076

15891

1.62

119.13

4.9

3.9

1.22

1.23

mmol/l

6.99

2702

13780

Other CVD (FINNGEN)

701

2112

2.80

117.81

6.1

3.0

1.22

1.23

mmol/l

7.65

635

1727

Other specified/unspecified arthritis

1555

8478

1.94

117.07

4.6

3.6

1.23

mmol/l

0.10

1412

7336

Other disorders of bladder

805

3464

2.57

116.85

4.1

4.0

1.22

mmol/l

0.46

644

3033

Substance abuse, excluding more controls

2751

14788

1.64

116.64

4.1

3.8

1.21

1.22

mmol/l

15.23

2421

13069

Dorsalgia

5180

19597

1.45

116.61

3.8

1.23

mmol/l

0.33

4529

17072

Implicit viral Sepsis

1242

6321

2.11

116.18

9.2

3.1

1.21

1.23

mmol/l

16.76

1171

5360

Problems related to lifestyle

579

2112

2.97

115.92

4.7

3.3

1.21

1.23

mmol/l

5.33

530

1820

Viral Sepsis

1242

6331

2.10

115.65

9.2

3.1

1.21

1.23

mmol/l

16.79

1171

5370

Symptoms and signs involving cognition, perception, emotional state and behaviour

5081

24634

1.44

115.61

3.9

3.8

1.22

1.23

mmol/l

2.00

4444

21523

Disorders of lipoprotein metabolism and other lipidaemias

4291

18277

1.50

115.44

4.7

3.2

1.22

1.23

mmol/l

5.67

3898

15722

Other diseases of intestines

5446

22167

1.43

115.08

4.3

3.6

1.22

1.23

mmol/l

4.78

4827

19231

Implicit viral Sepsis

1697

9579

1.87

114.34

7.8

3.1

1.21

1.23

mmol/l

21.26

1585

8134

Other metabolic disorders

842

3723

2.46

113.67

6.5

2.9

1.21

1.23

mmol/l

26.34

768

3178

Secondary uncertain malignant neoplasm

811

3542

2.50

112.88

7.4

3.0

1.23

mmol/l

0.66

782

2987

Pain, not elsewhere classified

1453

7832

1.95

112.40

4.5

3.1

1.23

mmol/l

1.94

1306

6659

Heart failure and coronary heart disease

2429

10610

1.70

112.00

6.6

3.8

1.21

1.23

mmol/l

42.59

2229

9079

Type of accident

1621

9075

1.88

111.98

4.5

3.8

1.23

mmol/l

0.13

1476

7894

Vocal cord dysfunction

689

2465

2.66

111.78

4.7

3.0

1.22

1.23

mmol/l

7.10

610

2126

Pulmonary heart disease, diseases of pulmonary circulation

1875

10978

1.80

111.49

6.0

3.8

1.22

1.23

mmol/l

3.78

1753

9446

Malignant neoplasm of endocrine gland

485

1660

3.31

111.48

7.6

2.9

1.21

1.23

mmol/l

11.44

456

1375

Type 1 diabetes, wide definition, subgroup 1

1092

5368

2.15

110.52

7.8

3.4

1.21

1.23

mmol/l

11.37

963

4672

Senile cataract

3306

13383

1.57

108.89

5.3

3.7

1.22

1.23

mmol/l

3.65

2884

11789

Fall on same level

5852

23328

1.40

108.87

4.4

3.6

1.22

1.23

mmol/l

5.33

5098

20376

Systemic connective tissue disorders

2021

12148

1.75

108.87

4.2

3.6

1.23

mmol/l

1.73

1833

10490

Chronic lower respiratory diseases

6204

24343

1.39

108.58

3.9

3.8

1.22

1.23

mmol/l

4.95

5513

21140

DVT of lower extremities and pulmonary embolism

2363

14710

1.67

108.48

5.7

3.7

1.22

1.23

mmol/l

1.23

2167

12691

Heart failure and bmi 25plus

2011

8051

1.78

107.16

6.2

3.8

1.21

1.23

mmol/l

33.38

1832

6968

Angina pectoris

3060

13355

1.59

107.13

4.6

3.6

1.22

1.23

mmol/l

7.69

2719

11486

Acute upper respiratory infections of multiple and unspecified sites

3822

19441

1.50

106.80

4.8

3.6

1.22

1.23

mmol/l

8.69

3436

16889

Postprocedural endocrine and metabolic disorders, not elsewhere classified

779

3424

2.48

106.75

6.6

2.9

1.20

1.23

mmol/l

26.94

711

2933

Other disorders of kidney and ureter

846

3866

2.41

106.70

14.3

3.8

1.22

1.23

mmol/l

1.57

793

3390

Type 1 diabetes

1300

6885

1.98

105.83

7.4

3.5

1.21

1.23

mmol/l

12.34

1145

5999

Certain disorders involving the immune mechanism

1106

5593

2.12

105.50

6.9

3.9

1.23

mmol/l

0.01

1035

4907

Symptoms and signs involving the urinary system

4040

21462

1.48

105.14

5.1

3.7

1.22

1.23

mmol/l

7.39

3559

18680

Diagnoses used for exclusion with ILD

1485

8276

1.90

104.80

5.0

3.8

1.22

1.23

mmol/l

0.67

1370

7204

Erysipelas

2953

17243

1.57

103.84

5.5

3.1

1.22

1.23

mmol/l

16.34

2680

14782

Other and unspecified iron deficiency

1902

11378

1.76

103.80

5.5

3.5

1.22

1.23

mmol/l

9.06

1720

9804

Lower back pain or/and sciatica

5427

25974

1.40

102.40

3.9

3.8

1.23

mmol/l

0.02

4783

22624

Hydronephrosis

732

3216

2.49

100.80

7.8

2.9

1.22

1.23

mmol/l

3.85

679

2756

Pulmonary embolism

1710

10060

1.80

100.05

6.0

3.8

1.22

1.23

mmol/l

2.64

1600

8656

Drug-induced adrenocortical insufficiency

205

427

6.50

99.85

6.7

3.8

1.22

1.23

mmol/l

1.12

196

371

Pulmonary heart disease

1710

10079

1.79

99.37

6.0

3.8

1.22

1.23

mmol/l

2.55

1600

8669

Anxiety (asthma-related co-morbidities)

2797

14146

1.57

99.28

3.4

3.7

1.23

mmol/l

2.33

2388

12459

Other cataract

2352

11254

1.65

98.15

5.1

3.6

1.22

1.23

mmol/l

3.24

1996

9880

Non-selective monoamine reuptake inhibitors

2024

12006

1.69

97.88

3.7

3.8

1.23

mmol/l

0.90

1766

10574

Gout

1568

7920

1.84

97.81

8.2

3.8

1.21

1.22

mmol/l

4.64

1434

6824

Thrombocytopenia, unspecified

511

1939

2.99

97.62

10.8

3.6

1.22

mmol/l

2.46

479

1671

Other systemic involvement of connective tissue (FG)

1479

8290

1.86

97.46

3.7

3.5

1.23

mmol/l

0.42

1322

7070

Malignant neoplasm of thyroid gland, including Hilmo

486

1792

3.03

97.21

7.4

2.8

1.21

1.23

mmol/l

13.92

454

1484

Intestinal infectious diseases

4793

26474

1.41

96.56

5.8

3.4

1.22

1.23

mmol/l

14.02

4287

22988

Schizophrenia or delusion

1590

9256

1.79

95.25

3.7

1.23

mmol/l

1.37

1377

8156

Glomerulonephritis

629

2655

2.61

95.22

14.1

3.8

1.22

mmol/l

1.67

601

2319

Schizophrenia, schizotypal and delusional disorders

1601

9341

1.79

95.15

3.8

3.7

1.23

mmol/l

1.23

1388

8221

Factors influencing health status and contact with health services

1510

4153

1.88

94.70

4.4

2.7

1.22

1.23

mmol/l

0.91

1335

3459

Diseases of the digestive system

2479

16073

1.59

94.61

5.9

3.7

1.22

1.23

mmol/l

7.95

2241

13896

ILD, hospital admission 2, with pulmonary infections

649

2790

2.57

94.46

5.6

3.3

1.22

1.23

mmol/l

4.10

608

2385

Malignant neoplasm of thyroid gland

436

1542

3.18

94.42

7.6

2.8

1.20

1.23

mmol/l

13.35

408

1275

Cardiodefibrillation

2007

12476

1.69

94.40

4.3

4.1

1.21

1.23

mmol/l

15.56

1777

10816

Complications of medical and surgical care

3815

24818

1.45

94.15

5.6

3.6

1.22

1.23

mmol/l

5.82

3493

21523

Pain (limb, back, neck, head abdominally)

3713

12813

1.49

93.99

4.2

3.7

1.22

1.23

mmol/l

1.23

3274

11110

Type 1 diabetes, wide definition

1115

5845

2.00

93.81

7.8

3.5

1.21

1.23

mmol/l

11.56

983

5085

Gastrointestinal diseases

2945

9688

1.56

93.78

4.1

2.9

1.22

1.23

mmol/l

4.83

2603

8220

Non-Hodgkin lymphoma, all, including Hilmo

777

3608

2.34

93.38

9.1

3.1

1.23

mmol/l

1.30

753

3036

Hernia of abdominal wall, postoperative

995

5046

2.09

93.05

6.5

2.4

1.22

1.23

mmol/l

8.96

885

4252

Asthma-related infections

3013

20049

1.52

92.90

4.1

3.8

1.22

1.23

mmol/l

6.61

2730

17357

Asthma, hospital admission 2, infections

3013

20049

1.52

92.90

4.1

3.8

1.22

1.23

mmol/l

6.61

2730

17357

Diseases of liver

1832

11187

1.71

92.51

4.7

3.9

1.22

1.23

mmol/l

7.37

1682

9765

Asthma (diagnoses ohter than nonallergic)

4412

26534

1.41

92.47

3.7

3.8

1.22

1.23

mmol/l

2.79

3961

23031

Mental and behavioural disorders due to psychoactive substance use

2919

18282

1.52

91.56

4.2

3.9

1.21

1.22

mmol/l

14.93

2567

16071

Fibromyalgia

567

2322

2.67

91.04

2.8

3.3

1.23

1.24

mmol/l

1.55

497

2005

Coronary atherosclerosis

3313

14393

1.50

91.02

5.2

3.6

1.22

1.23

mmol/l

16.36

2918

12424

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1472

8512

1.82

91.00

3.9

1.22

1.23

mmol/l

4.48

1291

7486

Glucagon-like peptide-1 (GLP-1) analogues

1472

8512

1.82

91.00

3.9

1.22

1.23

mmol/l

4.48

1291

7486

2224

14145

1.61

90.41

4.0

3.7

1.22

1.23

mmol/l

5.95

2001

12237

Malignant neoplasm of digestive organs

1949

9504

1.69

90.20

5.0

3.1

1.22

1.23

mmol/l

6.91

1801

8003

Retention of urine

1887

9529

1.70

89.69

5.0

3.8

1.22

mmol/l

2.81

1658

8272

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4920

23217

1.39

89.64

4.6

3.7

1.22

1.23

mmol/l

2.93

4375

20254

Volume depletion

620

2670

2.54

89.46

8.5

3.2

1.21

1.23

mmol/l

5.50

576

2288

Coagulation defects, purpura and other haemorrhagic conditions

1093

5826

2.00

89.10

8.0

3.7

1.22

1.23

mmol/l

5.91

1013

5091

Hypopituitarism

424

1519

3.09

88.94

5.2

3.5

1.22

mmol/l

0.76

396

1332

Diseases of oesophagus, stomach and duodenum

5389

24106

1.37

87.73

4.7

3.6

1.22

1.23

mmol/l

7.14

4844

20919

Dermatitis

3162

21913

1.48

86.89

4.9

3.7

1.23

mmol/l

0.24

2796

19091

All anxiety disorders

2845

15193

1.52

86.70

3.4

3.7

1.23

mmol/l

1.20

2432

13336

Conduction disorders

1620

7836

1.75

86.38

4.8

3.3

1.22

1.23

mmol/l

8.21

1455

6661

Diseases of the skin and subcutaneous tissue

5141

19092

1.38

86.18

4.6

3.3

1.23

mmol/l

1.27

4529

16570

Morphin

210

499

5.34

86.15

6.8

2.8

1.20

1.23

mmol/l

4.98

205

409

Diabetic maculopathy, excluding more controls

642

2849

2.44

85.93

9.0

3.5

1.21

1.23

mmol/l

10.38

557

2474

Purpura and other haemorrhagic conditions

800

3884

2.23

85.79

9.0

3.7

1.22

1.23

mmol/l

3.31

745

3384

Other anxiety disorders

2104

11620

1.62

85.44

3.3

3.5

1.22

1.23

mmol/l

1.44

1804

10200

Necrosis of pulp, including avohilmo

2730

18472

1.52

84.96

3.8

3.9

1.22

1.23

mmol/l

2.52

2367

16286

Anaemia in chronic diseases classified elsewhere

222

558

4.97

84.40

18.8

3.2

1.20

1.22

mmol/l

4.93

216

487

Extreme obesity with alveolar hypoventilation

328

1065

3.63

84.19

5.5

3.3

1.20

1.23

mmol/l

8.48

274

920

Dental operations

3239

11440

1.49

83.83

4.4

3.4

1.23

mmol/l

0.15

2828

9955

Haemorrhage from respiratory passages

1845

10381

1.67

83.57

4.8

3.7

1.22

1.23

mmol/l

9.29

1639

8936

Diseases of pulp and periapical tissues and dental caries

3515

12609

1.46

82.61

4.4

3.5

1.23

mmol/l

1.19

3048

10985

Diseases of the musculoskeletal system and connective tissue

2596

8560

1.56

82.06

4.0

3.3

1.22

mmol/l

0.01

2268

7391

Noninfective enteritis and colitis

2302

15237

1.56

80.71

4.8

3.7

1.22

1.23

mmol/l

5.63

2075

13266

2920

17831

1.48

79.82

4.5

3.9

1.21

1.22

mmol/l

17.91

2608

15665

ILD, hospital admissions

912

4774

2.06

79.65

4.9

4.0

1.22

mmol/l

2.41

833

4160

Caries of dentine, including avohilmo

4115

15236

1.41

79.52

4.2

3.7

1.23

mmol/l

1.11

3567

13336

Other interstitial pulmonary diseases

924

4864

2.05

79.31

5.0

4.0

1.22

mmol/l

2.55

845

4235

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

823

4130

2.11

79.27

4.3

3.6

1.21

1.23

mmol/l

6.70

718

3625

Interstitial lung disease

924

4870

2.05

79.03

5.0

4.0

1.22

mmol/l

2.38

845

4239

Interstitial lung disease endpoints

924

4870

2.05

79.03

5.0

4.0

1.22

mmol/l

2.38

845

4239

2793

17404

1.49

78.97

4.4

3.9

1.21

1.22

mmol/l

17.86

2486

15292

Hyperkinetic disorders, excluding more controls

432

1560

2.77

78.89

3.0

3.3

1.22

mmol/l

0.26

360

1370

Certain infectious and parasitic diseases

3796

13599

1.43

78.51

4.7

2.8

1.22

1.23

mmol/l

11.73

3409

11555

Other neurological diseases

3732

21267

1.42

78.35

4.0

3.9

1.22

1.23

mmol/l

2.59

3398

18391

Mental and behavioural disorders due to alcohol

2455

15941

1.53

77.83

4.2

4.0

1.21

1.22

mmol/l

15.22

2173

14035

Cholecystectomy

3639

22738

1.42

77.82

3.9

3.7

1.23

mmol/l

1.14

3216

19771

Hypokalaemia

733

3580

2.21

77.50

5.6

3.1

1.22

1.23

mmol/l

7.03

687

3036

Soft tissue disorders

5124

19876

1.35

76.94

3.9

3.7

1.22

1.23

mmol/l

1.34

4519

17245

ILD, hospital admissions 3, with pneumonia sepsis

559

2470

2.50

76.73

5.9

3.4

1.22

1.23

mmol/l

3.84

525

2109

Leisure time condition

992

5379

1.96

76.62

4.5

3.8

1.23

mmol/l

0.23

882

4706

Any operation in hilmo

165

127

6.90

76.43

3.3

1.3

1.22

1.24

mmol/l

2.18

145

102

Gout, FINNGEN

1568

9653

1.70

76.24

8.2

3.8

1.21

1.22

mmol/l

3.85

1434

8294

Special screening examination for infectious and parasitic diseases

194

4987

0.28

76.14

3.7

3.3

1.22

mmol/l

0.07

162

4297

Other and unspecified nonorganic psychotic disorders

923

4879

1.99

76.11

3.7

3.8

1.23

mmol/l

0.15

810

4291

Hypoparathyroidism

297

970

3.64

75.85

11.6

3.2

1.19

1.23

mmol/l

15.06

286

823

Hypercalcemia

342

1216

3.30

75.22

13.5

3.7

1.29

1.23

mmol/l

17.04

323

1042

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

346

1231

3.22

75.12

10.7

3.1

1.22

1.23

mmol/l

0.13

333

1039

Diseases of the respiratory system

3299

11647

1.45

74.40

4.2

3.0

1.23

mmol/l

4.39

2937

9916

Dental caries, including avohilmo

3873

14376

1.41

74.38

4.2

3.6

1.23

mmol/l

0.67

3351

12584

Falls/tendency to fall

5351

20401

1.34

74.25

4.1

3.6

1.22

1.23

mmol/l

2.97

4681

17829

Substance abuse

2751

18003

1.48

74.14

4.1

4.0

1.21

1.22

mmol/l

14.99

2421

15830

Dizziness and giddiness

3802

22107

1.40

74.08

3.8

1.23

mmol/l

0.71

3321

19257

Lyme disease

445

10204

0.42

73.71

2.6

3.8

1.23

mmol/l

0.51

401

8909

ILD medications: azathioprine

749

3734

2.12

73.59

7.6

3.1

1.22

1.23

mmol/l

1.31

705

3209

Poisoning by medicine

1035

5736

1.89

73.56

4.2

3.6

1.22

1.23

mmol/l

6.60

916

5055

Other and unspecified dermatitis

2602

18020

1.49

73.42

5.0

3.6

1.23

mmol/l

0.07

2308

15683

Other systemic involvement of connective tissue

1509

9318

1.70

73.40

3.8

3.7

1.23

mmol/l

0.61

1350

8025

Other respiratory diseases principally affecting the interstitium

1041

5827

1.90

73.24

5.7

3.9

1.22

1.23

mmol/l

3.79

953

5047

Organic, including symptomatic, mental disorders

2739

13551

1.49

72.92

3.8

4.0

1.23

mmol/l

1.41

2295

11789

Asthma, including avohilmo

5855

25495

1.31

72.80

3.5

3.9

1.23

mmol/l

0.92

5196

22166

Personality disorders

1228

7168

1.78

72.70

3.5

3.7

1.22

1.23

mmol/l

1.24

1042

6335

Sequelae with surgical and medical care as external cause

1146

6608

1.84

72.66

5.6

3.8

1.22

1.23

mmol/l

1.44

1034

5752

Poisoning by drugs, medicaments and biological substances

1128

6435

1.83

72.64

4.3

3.6

1.22

1.23

mmol/l

5.91

1002

5671

Other spirochaetal diseases

457

10310

0.42

72.56

2.6

3.8

1.23

mmol/l

0.61

412

9000

Spirochaetal infections, other/unspecified

455

10279

0.42

72.50

2.8

3.8

1.23

mmol/l

0.52

410

8972

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1336

7984

1.74

72.47

3.9

3.6

1.22

1.23

mmol/l

3.90

1148

7054

Exclusions for E4_PCOS_CONSORTIUM

3482

15732

1.42

72.16

3.9

3.5

1.23

mmol/l

0.16

3033

13719

Other disorders of ear

4575

22586

1.35

71.99

4.3

3.8

1.23

mmol/l

0.07

3926

19864

Other spirochaetal diseases

469

10446

0.43

71.98

2.8

3.8

1.23

mmol/l

0.63

424

9121

Chronic pancreatitis

696

3427

2.19

71.89

6.7

4.1

1.21

1.22

mmol/l

6.27

659

3011

Other ill-defined and unspecified causes of mortality

518

2283

2.51

71.76

5.4

3.9

1.21

1.22

mmol/l

2.93

462

1984

Azathioprine

749

3772

2.10

71.57

7.6

3.5

1.22

1.23

mmol/l

1.26

705

3255

Dorsopathies

5088

19689

1.34

70.85

3.7

3.8

1.23

mmol/l

0.17

4467

17159

Arthropathies

4363

16460

1.37

70.53

3.9

3.6

1.23

mmol/l

0.02

3857

14269

Disorders of adult personality and behaviour

1275

7581

1.75

70.45

3.6

1.22

1.23

mmol/l

2.28

1077

6699

Emotional disorders starting during childhood or adolecense, excluding more controls

203

511

4.17

70.19

3.6

3.2

1.22

mmol/l

0.03

167

439

Secondary and unspecified malignant neoplasm of lymph nodes

475

2028

2.56

69.91

8.3

3.0

1.23

mmol/l

1.10

461

1712

Osteoporosis with pathological fracture (FG)

514

2293

2.51

69.87

6.1

3.3

1.24

mmol/l

0.10

488

1897

Cerebrovascular diseases

3783

19646

1.39

69.52

4.5

3.9

1.22

1.23

mmol/l

8.21

3446

16974

Other dorsopathies, not elsewhere classified

4931

19637

1.34

69.36

3.8

1.23

mmol/l

0.01

4347

17108

Stroke, including SAH

3268

17147

1.42

69.23

4.5

3.9

1.22

1.23

mmol/l

5.25

2982

14736

Rheumatoid arthritis

1694

9723

1.62

69.15

3.6

1.23

mmol/l

0.74

1562

8381

Pleural effusion

884

4791

1.97

69.00

6.4

3.7

1.21

1.23

mmol/l

5.24

827

4127

Chronic nephritic syndrome

283

947

3.44

68.53

18.1

3.5

1.22

mmol/l

0.46

278

825

malignant neoplasm of male genital organs

1340

4860

1.75

67.85

5.0

3.4

1.22

1.21

mmol/l

1.63

1174

4187

Caries of dentine

1085

6067

1.82

67.82

9.6

3.4

1.22

1.23

mmol/l

4.54

1011

5322

External causes of morbidity and mortality

3297

11829

1.43

67.78

4.1

3.3

1.23

mmol/l

2.17

2893

10288

Ill-defined and unknown causes of mortality

551

2549

2.37

67.73

5.4

3.9

1.21

1.22

mmol/l

3.50

490

2214

Sarcoidosis

743

3829

2.08

67.54

4.5

3.9

1.23

mmol/l

1.14

690

3354

Unspecified kidney failure

605

2898

2.26

67.48

12.5

3.0

1.21

1.23

mmol/l

5.70

576

2466

Viral infections characterized by skin and mucous membrane lesions

2027

13591

1.54

67.22

6.6

3.6

1.22

1.23

mmol/l

1.78

1859

11829

Non-ischemic cardiomyopathy

1663

8579

1.63

67.03

5.6

3.4

1.22

1.23

mmol/l

22.81

1521

7296

Nerve, nerve root and plexus disorders

5260

24990

1.31

66.48

4.0

3.8

1.23

mmol/l

0.09

4664

21782

Dental caries

1201

6857

1.75

66.46

9.5

3.4

1.22

1.23

mmol/l

5.18

1115

6014

1660

9315

1.62

66.42

3.8

1.22

1.23

mmol/l

4.01

1363

8047

Acute upper respiratory infections

5154

24563

1.32

66.40

4.4

3.6

1.22

1.23

mmol/l

4.80

4576

21318

Symptoms and signs concerning food and fluid intake

580

2738

2.27

66.22

5.0

3.2

1.22

1.23

mmol/l

1.74

508

2334

Diseases of the eye and adnexa

3719

13655

1.39

66.18

4.3

3.4

1.22

1.23

mmol/l

1.21

3280

12061

Stroke, excluding SAH

3107

16401

1.42

66.10

4.5

3.9

1.22

1.23

mmol/l

4.44

2843

14074

Abnormal findings on examination of blood, without diagnosis

2350

14941

1.49

65.96

5.3

4.0

1.22

mmol/l

0.15

2172

12992

ILD, hospital admissions 1, main diag only

797

4251

2.02

65.91

4.8

4.0

1.22

1.23

mmol/l

1.85

730

3711

Unspecified haematuria

2156

12148

1.52

65.68

5.8

3.8

1.22

mmol/l

3.93

1920

10552

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

783

3624

1.99

65.59

3.2

3.4

1.22

mmol/l

0.27

660

3142

Rheumatism, unspecified

799

4263

2.00

65.47

3.4

3.5

1.23

1.24

mmol/l

1.05

709

3650

Intestinal infectious diseases

5663

25336

1.30

65.36

5.1

3.5

1.22

1.23

mmol/l

9.12

5052

21989

Glaucoma

2923

18114

1.43

65.30

4.1

3.9

1.23

mmol/l

0.26

2506

15733

Diarrhoea and gastroenteritis of presumed infectious origin

4973

25338

1.32

65.24

5.1

3.5

1.22

1.23

mmol/l

10.60

4443

21991

Accidents

4078

15254

1.36

64.74

4.1

3.5

1.23

mmol/l

2.39

3576

13373

Cystitis

4206

18870

1.35

64.67

4.1

3.5

1.23

mmol/l

1.97

3675

16405

Open wound of head

2627

17949

1.45

64.63

4.7

3.9

1.22

1.23

mmol/l

4.89

2273

15672

Meniscus derangement

2775

13258

1.45

64.59

3.8

3.7

1.23

mmol/l

0.19

2426

11544

Alcohol use disorder, Swedish definition

2575

16659

1.46

64.51

4.5

4.0

1.21

1.22

mmol/l

15.81

2308

14649

Other headache syndromes

1959

13147

1.53

64.25

3.4

3.7

1.23

mmol/l

3.24

1719

11410

Sensorineural hearing loss

3844

19549

1.37

64.09

4.2

3.8

1.23

mmol/l

0.36

3278

17154

Bipolar affective disorders

863

4720

1.91

63.94

3.9

3.6

1.23

mmol/l

2.81

754

4191

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

517

2391

2.38

63.82

5.7

3.7

1.22

1.23

mmol/l

0.90

476

2056

Viral infections characterized by skin and mucous membrane lesions

4132

26860

1.34

63.70

4.9

3.6

1.23

mmol/l

0.21

3715

23351

Infections of the skin and subcutaneous tissue

2702

19120

1.43

63.59

5.9

3.6

1.22

1.23

mmol/l

3.12

2455

16685

Viral pneumonia

693

3553

2.07

63.46

7.4

3.2

1.21

1.23

mmol/l

9.97

652

3065

Alcohol use disorder, ICD-based

1928

12962

1.53

63.27

4.2

4.1

1.21

1.22

mmol/l

12.95

1713

11452

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2071

14071

1.51

62.81

4.2

4.1

1.21

1.22

mmol/l

13.82

1837

12422

Dental pulpitis, including avohilmo

4190

20633

1.34

62.78

3.7

3.8

1.22

1.23

mmol/l

3.48

3610

18177

Sequelae of external causes of morbidity and mortality

1345

8401

1.68

62.48

5.4

3.8

1.22

1.23

mmol/l

1.71

1211

7301

Other external causes of accidental injury

4055

15254

1.36

62.00

4.1

3.5

1.23

mmol/l

2.32

3559

13373

Other diseases of liver

942

5395

1.84

60.88

4.4

3.9

1.22

1.23

mmol/l

1.72

857

4740

Gout, unspecified

1093

6534

1.77

60.81

8.0

3.8

1.21

1.22

mmol/l

4.83

985

5681

1213

7001

1.72

60.39

3.9

3.8

1.22

1.23

mmol/l

3.56

986

6026

Carbimazole or st.post thyroidectomy, condition for graves disease

1077

6418

1.76

60.17

5.0

3.5

1.21

1.23

mmol/l

22.17

970

5591

AV-block

994

5050

1.81

60.13

5.3

3.3

1.22

1.23

mmol/l

6.07

889

4275

Other joint disorders

4117

16444

1.34

59.92

3.6

1.23

mmol/l

0.11

3592

14253

Thyrotoxicosis, other and/or unspecified

1012

5939

1.79

59.60

4.0

3.5

1.23

mmol/l

4.32

904

5164

Asthma, hospital admissions , main diagnosis only

3930

26441

1.34

59.55

3.7

3.8

1.23

mmol/l

0.17

3512

22986

Conductive and sensorineural hearing loss

3955

20285

1.34

59.48

4.2

3.8

1.23

mmol/l

0.28

3378

17807

Post-traumatic stress disorder

385

1599

2.55

59.05

3.2

3.1

1.23

mmol/l

0.17

325

1399

Degeneration of macula and posterior pole

2516

14292

1.45

58.96

3.9

3.8

1.22

1.23

mmol/l

4.67

2107

12433

Respiratory conditions due to other external agents

188

544

4.27

58.88

7.2

3.4

1.23

mmol/l

0.00

179

473

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3017

21981

1.39

58.59

5.5

3.6

1.22

1.23

mmol/l

5.29

2754

19019

Migraine

2125

11898

1.48

58.40

3.1

3.6

1.23

mmol/l

2.97

1878

10354

Hyperkalaemia

376

1576

2.64

58.34

13.2

3.2

1.20

1.23

mmol/l

10.31

348

1348

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2730

15651

1.42

57.79

4.0

3.5

1.22

1.23

mmol/l

5.13

2338

13689

Methotrexate

750

4073

1.95

57.69

3.2

3.4

1.23

mmol/l

0.17

693

3483

Gout, idiopatic and unspecified

1290

8141

1.66

57.67

7.8

3.9

1.21

1.22

mmol/l

4.17

1170

7083

Suicide or other Intentional self-harm

1119

6793

1.71

57.51

4.2

3.7

1.22

1.23

mmol/l

3.85

975

6001

Other hearing loss

1498

9559

1.60

57.47

4.6

3.8

1.22

1.23

mmol/l

0.64

1241

8332

Specific personality disorders

1036

6167

1.74

57.23

3.5

3.6

1.22

1.23

mmol/l

1.40

876

5446

GI-bleeding

1653

11016

1.56

57.22

6.4

3.8

1.22

1.23

mmol/l

5.33

1504

9505

Papillary adenocarcinoma of thyroid gland

303

1153

2.91

57.20

7.9

2.8

1.20

1.23

mmol/l

10.10

280

956

Other noninfective gastroenteritis and colitis

1224

7620

1.67

57.05

5.8

3.7

1.22

1.23

mmol/l

6.46

1125

6631

Sulfasalazine

1347

8574

1.63

56.99

3.4

1.23

mmol/l

0.35

1229

7376

Malignant neoplasm of prostate, including Hilmo

1307

4805

1.68

56.94

5.0

3.5

1.22

1.21

mmol/l

0.89

1139

4138

Acute pancreatitis

996

5906

1.77

56.62

5.4

3.8

1.21

1.23

mmol/l

8.97

923

5142

Malignant neoplasm of prostate

1273

4696

1.68

56.29

5.0

3.5

1.22

1.21

mmol/l

0.94

1112

4040

Ischaemic Stroke, excluding all haemorrhages

2887

15807

1.40

55.54

4.5

3.9

1.22

1.23

mmol/l

3.72

2642

13547

136

317

4.85

55.28

2.6

2.8

1.23

mmol/l

0.22

118

264

Gout, strict definition

966

5739

1.78

55.19

8.2

3.9

1.21

1.22

mmol/l

3.02

875

5003

Other respiratory disorders and diseases

1088

6666

1.71

54.84

6.2

3.8

1.21

1.23

mmol/l

7.28

1004

5762

Other diseases of the respiratory system

1088

6666

1.71

54.84

6.2

3.8

1.21

1.23

mmol/l

7.28

1004

5762

Malignant neoplasm of skin

2305

11180

1.45

54.69

4.6

3.0

1.23

mmol/l

0.13

1986

9425

Dementia, including avohilmo

2415

11883

1.44

54.67

3.1

4.1

1.23

mmol/l

2.05

2003

10306

COPD (mode)

1544

7984

1.57

54.58

5.0

3.2

1.21

1.23

mmol/l

25.66

1402

6749

Paralytic ileus and intestinal obstruction

1387

8995

1.60

54.57

5.2

3.6

1.22

1.23

mmol/l

8.29

1245

7722

Other diseases of the digestive system

1638

11007

1.54

54.53

6.4

3.8

1.22

1.23

mmol/l

5.37

1483

9505

Primary open-angle glaucoma, strict

1432

9362

1.60

54.41

4.1

3.9

1.23

mmol/l

0.06

1216

8053

Outcome of delivery

2532

0.22

54.29

2.1

3.3

1.23

mmol/l

0.71

2194

Sub-endpoint used in defining T1D endpoints

1372

8720

1.60

54.14

7.5

3.7

1.21

1.22

mmol/l

8.22

1209

7603

Other disorders of skin and subcutaneous tissue

3401

22938

1.35

53.91

6.0

3.5

1.23

mmol/l

2.28

3059

19913

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2255

10811

1.45

53.88

4.5

3.0

1.23

mmol/l

0.17

1936

9095

Examination and observation for other reasons

1515

13167

0.65

53.69

4.5

3.7

1.22

mmol/l

0.44

1375

11211

Other CVD

1088

6709

1.71

53.68

5.6

3.8

1.22

1.23

mmol/l

3.51

986

5764

Viral hepatitis, IBD co-morbidity

231

774

3.17

53.63

4.5

3.1

1.21

1.23

mmol/l

2.53

207

666

Delirium, not induced by alcohol and other psychoactive substances

673

3623

1.98

53.44

6.2

4.0

1.22

mmol/l

0.27

589

3170

Tracheo-bronchomalasia

13.44

53.35

2.9

2.8

1.23

1.24

mmol/l

0.33

Symptoms and signs involving appearance and behaviour

178

7.16

52.91

4.5

3.4

1.21

1.22

mmol/l

0.86

157

KRA_PSY_EATING, excluding more controls

327

1314

2.60

52.87

3.5

2.7

1.22

1.23

mmol/l

0.40

279

1135

Asthma/COPD (KELA code 203)

4510

24296

1.29

52.41

3.7

3.8

1.23

mmol/l

0.59

3977

21100

Cough

1908

12553

1.48

52.19

4.1

3.5

1.23

mmol/l

1.77

1703

10855

Other diseases of biliary tract

510

2538

2.17

51.64

5.8

3.6

1.22

1.23

mmol/l

4.98

476

2183

Acute sinusitis

2269

15086

1.42

51.27

4.4

3.5

1.22

1.23

mmol/l

6.93

2004

13161

Other or unspecified ileus, impaction or obstruction

1012

6191

1.71

51.22

5.3

3.7

1.22

1.23

mmol/l

6.16

908

5300

Primary open-angle glaucoma

1694

11230

1.52

51.20

4.0

3.9

1.23

mmol/l

0.12

1441

9700

Polyarthrosis

1102

6382

1.68

51.16

3.8

3.7

1.23

mmol/l

0.80

968

5469

Disorders of eyelid, lacrimal system and orbit

4125

24486

1.30

51.10

3.9

3.8

1.23

mmol/l

1.67

3601

21386

Biological medication for rheuma

781

4446

1.84

51.06

2.9

3.8

1.23

mmol/l

0.36

722

3914

Diabetic retinopathy, excluding more controls

1386

5019

1.62

51.04

7.0

3.4

1.22

1.23

mmol/l

8.11

1194

4390

Diseases of the ear and mastoid process

5547

22350

1.26

50.91

4.0

3.7

1.23

mmol/l

0.66

4841

19580

Diabetic nephropathy, excluding more controls

822

3908

1.84

50.69

14.7

3.5

1.20

1.23

mmol/l

19.87

758

3424

Diseases of oral cavity, salivary glands and jaws

3010

11483

1.38

50.64

4.5

3.4

1.23

mmol/l

0.39

2616

9990

Abnormal findings on diagnostic imaging of lung

2405

16837

1.41

50.23

4.9

3.8

1.22

1.23

mmol/l

1.08

2211

14531

Abnormal results of function studies

473

2308

2.20

50.17

4.7

3.8

1.22

1.23

mmol/l

1.78

418

2005

Intestinal stricture

1567

10627

1.53

50.07

5.5

3.8

1.22

1.23

mmol/l

6.59

1413

9203

Hypocalcemia

179

556

3.83

49.76

18.2

3.8

1.14

1.23

mmol/l

32.87

170

486

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2108

10250

1.45

49.60

4.5

3.0

1.23

mmol/l

0.22

1811

8610

Thyrotoxicosis

1265

8224

1.60

49.42

3.9

3.6

1.23

mmol/l

2.51

1121

7131

Respiratory insufficiency

466

2268

2.20

49.34

6.5

3.2

1.20

1.23

mmol/l

13.41

432

1911

Psoriatic and enteropathic arthropathies

591

3137

1.99

48.88

2.9

3.8

1.23

mmol/l

0.10

532

2729

Gonarthrosis [arthrosis of knee](FG)

3570

15927

1.33

48.73

3.7

1.23

mmol/l

0.18

3136

13810

Viral pneumonia (unknown virus, not influenza)

380

1731

2.37

48.14

8.4

3.9

1.21

1.23

mmol/l

5.43

362

1496

Other diseases of pancreas

467

2313

2.19

48.03

4.9

4.1

1.22

1.23

mmol/l

2.08

434

2010

Gingivitis and periodontal diseases

5018

20707

1.27

48.01

4.1

3.7

1.23

mmol/l

0.05

4382

18090

Arthrosis

3397

14221

1.34

47.78

3.7

1.23

mmol/l

0.13

3028

12386

Intestinal malabsorption

282

1135

2.75

47.71

7.3

3.4

1.21

1.23

mmol/l

3.29

254

968

Acute pancreatitis (for exclusion)

996

6180

1.69

47.64

5.4

3.8

1.21

1.22

mmol/l

7.31

923

5381

Injuries to the abdomen, lower back, lumbar spine and pelvis

1907

13393

1.45

47.15

4.6

3.7

1.22

1.23

mmol/l

4.89

1706

11588

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

334

1448

2.46

46.97

3.5

3.6

1.21

1.23

mmol/l

2.44

290

1266

Injury, poisoning and certain other consequences of external causes

2617

9623

1.39

46.73

4.0

3.4

1.23

mmol/l

1.54

2298

8327

Multiple myeloma, including Hilmo

276

1113

2.76

46.70

19.8

3.1

1.21

1.23

mmol/l

2.02

270

941

Other/unspecified dorsalgia

1780

12397

1.46

46.53

4.1

3.7

1.23

mmol/l

0.13

1540

10747

Other and unspecified effects of external causes

1218

7942

1.58

46.39

4.0

3.7

1.22

1.23

mmol/l

2.73

1064

6983

Schizophrenia

732

4209

1.82

46.31

3.4

3.9

1.23

mmol/l

1.72

634

3727

Dysphagia

1233

8090

1.58

46.09

5.0

3.5

1.22

1.23

mmol/l

3.59

1087

6950

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2763

20862

1.35

45.98

5.5

3.6

1.22

1.23

mmol/l

4.57

2523

18092

Periodontitis

4603

24646

1.27

45.83

4.2

3.8

1.23

mmol/l

0.75

4083

21542

Hypotension

930

5744

1.70

45.76

5.6

3.8

1.22

1.23

mmol/l

4.29

837

4945

Tumor necrosis factor alpha inhibitors

695

3952

1.84

45.69

2.8

3.8

1.23

mmol/l

0.51

640

3477

Zoster [herpes zoster]

2415

17650

1.38

45.54

4.4

3.6

1.23

mmol/l

0.11

2173

15250

Unspecified fall

2372

17293

1.38

45.44

4.3

3.8

1.22

1.23

mmol/l

4.39

2057

15025

Other complications of surgical and medical care, not elsewhere classified

516

2690

2.04

45.37

5.5

3.3

1.23

mmol/l

0.54

480

2308

Actinic keratosis

1972

13152

1.44

45.22

4.7

3.8

1.23

mmol/l

0.60

1685

11350

Substance use, excluding alcohol

860

5196

1.72

45.13

3.9

1.22

1.23

mmol/l

3.45

749

4601

Dermatitis and eczema

5234

26355

1.25

44.87

4.6

3.6

1.23

mmol/l

0.26

4615

22972

Injuries to the thorax

2135

15582

1.41

44.71

4.8

3.9

1.22

1.23

mmol/l

3.93

1919

13543

Lung diseases due to external agents

723

4199

1.81

44.66

5.7

4.0

1.22

mmol/l

1.89

660

3646

Iron deficiency anaemia secondary to blood loss (chronic)

846

5128

1.73

44.65

6.1

3.6

1.22

1.23

mmol/l

5.76

767

4416

2107

14092

1.42

44.57

4.7

3.8

1.23

mmol/l

0.56

1801

12171

Dementia in Alzheimer disease

978

5162

1.68

44.52

3.2

3.9

1.23

1.22

mmol/l

1.05

767

4481

Ulcerative ileocolitis

238

911

2.88

44.46

4.7

3.7

1.22

1.23

mmol/l

2.14

213

787

Pneumonia due to other infectious organisms, not elsewhere classified

219

808

3.05

44.37

9.3

3.5

1.22

mmol/l

0.44

205

685

Acute alcohol intoxication, ICD10

897

5516

1.69

44.10

4.6

4.0

1.21

1.22

mmol/l

10.56

799

4875

Malignant neoplasm of urinary organs

484

2494

2.07

44.05

7.1

3.1

1.23

1.22

mmol/l

0.07

450

2113

Other diseases of blood and blood-forming organs

387

1848

2.27

43.88

4.0

3.8

1.22

1.23

mmol/l

0.38

338

1604

Non-follicular lymphoma

529

2825

2.01

43.79

10.3

4.0

1.23

1.22

mmol/l

1.28

517

2485

Dissociative [conversion] disorders

218

802

2.98

43.70

3.6

3.1

1.22

1.23

mmol/l

0.96

191

702

Diseases of arteries, arterioles and capillaries

3254

18614

1.32

43.67

6.2

3.6

1.22

1.23

mmol/l

20.73

2931

16112

Inflammatory bowel disease

1403

9568

1.51

43.10

4.0

3.8

1.22

1.23

mmol/l

1.24

1248

8413

Chronic periodontitis, including avohilmo

4566

24654

1.26

43.06

4.3

3.8

1.23

mmol/l

0.80

4056

21544

Emotional disorders and disorders of social functioning with onset specific to childhood

215

770

2.92

42.96

4.0

3.4

1.22

1.23

mmol/l

0.20

178

658

Skin changes due to chronic exposure to nonionizing radiation

2001

13439

1.42

42.92

4.7

3.8

1.23

mmol/l

0.48

1708

11602

Other degenerative diseases of the nervous system

1355

6806

1.53

42.82

3.4

3.7

1.23

mmol/l

0.24

1125

5822

Diffuse large B-cell lymphoma, including Hilmo

265

1092

2.69

42.78

12.4

3.0

1.23

mmol/l

1.27

259

914

Diffuse large B-cell lymphoma, helper endpoint

265

1092

2.69

42.78

12.4

3.0

1.23

mmol/l

1.27

259

914

Diffuse large B-cell lymphoma

265

1092

2.69

42.78

12.4

3.0

1.23

mmol/l

1.27

259

914

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

507

2681

2.01

42.74

6.9

3.1

1.23

1.22

mmol/l

0.21

474

2269

Brachial plexus disorders

451

2287

2.09

42.69

3.0

3.6

1.23

mmol/l

0.05

399

2003

Gastro-oesophageal reflux disease

3237

21731

1.31

42.52

4.3

3.7

1.23

mmol/l

1.09

2894

18878

Pain in joint

2560

12203

1.36

42.47

3.6

3.7

1.23

mmol/l

0.03

2269

10598

Hypertrophy of (infrapatellar) fat pad

203

5.71

42.27

4.4

3.5

1.22

1.23

mmol/l

0.43

182

Myocarditis

224

845

2.84

42.23

4.7

2.9

1.22

1.23

mmol/l

1.62

208

712

Asthma-related pneumonia

1759

12540

1.44

42.21

4.7

3.9

1.22

1.23

mmol/l

9.52

1622

10813

Disorders of sclera, cornea, iris and ciliary body

2492

18796

1.36

42.06

4.3

3.8

1.23

mmol/l

0.60

2221

16383

Other condition

683

3966

1.81

42.05

4.3

3.9

1.23

mmol/l

0.32

648

3474

Early onset COPD, excluding more controls

900

5603

1.66

41.91

5.1

3.2

1.21

1.23

mmol/l

9.32

821

4766

Asthma-related pneumonia or sepsis

1759

12557

1.44

41.86

4.7

3.9

1.22

1.23

mmol/l

9.52

1622

10829

Asthma, hospital admissions 3, pneumonia

1759

12557

1.44

41.86

4.7

3.9

1.22

1.23

mmol/l

9.52

1622

10829

Abnormal findings on diagnostic imaging of other body structures

712

4200

1.79

41.83

4.7

3.8

1.23

mmol/l

0.15

653

3645

Collagenous colitis

495

2623

2.02

41.81

5.6

3.6

1.22

1.23

mmol/l

2.83

451

2260

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

204

744

3.00

41.60

9.4

3.3

1.22

1.23

mmol/l

2.51

189

665

Other disorders of white blood cells

316

1425

2.43

41.49

5.5

3.7

1.21

1.23

mmol/l

3.16

283

1230

Major coronary heart disease event excluding revascularizations

2825

14373

1.34

41.41

5.3

3.7

1.22

1.23

mmol/l

20.96

2568

12381

Implicit fungal Sepsis

382

1857

2.23

41.36

8.6

3.0

1.22

1.23

mmol/l

3.70

357

1587

Disturbance of activity and attention

422

2054

2.09

41.35

3.0

3.2

1.22

mmol/l

0.18

351

1780

Phlebitis and thrombophlebitis (not including DVT)

1098

7200

1.58

41.34

5.6

3.7

1.22

1.23

mmol/l

1.50

981

6254

Dementia

2218

11288

1.39

41.21

3.1

4.0

1.23

mmol/l

2.51

1823

9798

Malnutrition

155

494

3.66

41.13

7.2

3.9

1.21

1.23

mmol/l

3.46

143

427

Emotionally unstable personality disorder

512

2736

1.95

41.03

3.5

3.3

1.23

mmol/l

0.34

434

2391

Clear cell adenocarcinoma of kidney

256

1060

2.67

40.89

6.5

2.9

1.23

mmol/l

0.24

238

891

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

716

4101

1.76

40.84

7.5

3.9

1.23

mmol/l

0.23

675

3588

Nontoxic multinodular goitre

1003

6478

1.62

40.77

4.6

3.5

1.22

1.24

mmol/l

7.64

897

5607

Mixed and other personality disorders

376

1815

2.20

40.74

4.2

3.7

1.22

1.23

mmol/l

1.81

318

1599

Missing teeth due to accident, extraction or parodontitis

2848

20709

1.33

40.70

4.6

3.8

1.23

mmol/l

1.82

2452

18089

Special screening examination for other diseases and disorders

608

3448

1.85

40.65

3.7

1.23

mmol/l

0.45

576

2925

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

759

4435

1.73

40.40

7.2

3.9

1.23

mmol/l

0.21

712

3880

In situ neoplasms

1866

13578

1.42

40.38

4.6

3.6

1.23

mmol/l

0.68

1596

11751

Colorectal cancer

1061

6787

1.59

40.14

4.6

3.1

1.22

1.23

mmol/l

1.69

965

5703

Coxarthrosis [arthrosis of hip](FG)

2588

13813

1.35

40.04

3.6

3.8

1.23

mmol/l

1.14

2277

11912

Rheumatoid arthritis, including avohilmo

1853

13485

1.41

40.03

3.6

3.7

1.23

mmol/l

0.09

1706

11658

Epilepsy

1358

9316

1.49

39.72

4.2

3.9

1.22

1.23

mmol/l

8.88

1244

8082

Iron deficiency

162

535

3.37

39.69

2.8

3.1

1.21

1.23

mmol/l

4.50

135

458

Cholangitis (primary sclerosing, PSC)

342

1617

2.28

39.68

5.6

3.6

1.22

1.23

mmol/l

1.16

327

1382

Hypertensive Renal Disease

220

861

2.81

39.36

16.6

3.0

1.20

1.22

mmol/l

2.53

204

726

Multiple myeloma and malignant plasma cell neoplasms

293

1317

2.46

39.18

19.4

3.9

1.22

mmol/l

1.16

287

1132

Abnormal weight loss

491

2652

1.98

39.17

4.2

3.8

1.22

1.23

mmol/l

0.24

429

2309

Malignant neoplasm of kidney, except renal pelvis

434

2252

2.05

38.78

7.2

3.2

1.23

1.22

mmol/l

0.21

405

1906

L02BX Other hormone antagonists and related agents

318

1486

2.37

38.73

7.4

4.7

1.21

mmol/l

0.08

299

1322

Other diseases of pericardium

261

1117

2.56

38.67

9.2

3.5

1.21

1.23

mmol/l

3.53

248

963

Internal derangement of knee

1671

11938

1.43

38.60

4.0

3.7

1.23

mmol/l

0.10

1453

10391

Weight loss

526

2917

1.92

38.48

4.5

3.8

1.22

1.23

mmol/l

0.49

459

2542

Nonorganic sleeping disorders, excluding more controls

766

4678

1.69

38.40

4.0

3.5

1.22

1.23

mmol/l

2.30

680

4150

Irritable bowel syndrome

1280

8781

1.50

38.34

3.3

3.4

1.23

mmol/l

1.51

1130

7580

Polycystic ovarian syndrome, consortium definition

3237

15018

1.30

38.17

3.5

3.3

1.23

mmol/l

0.61

2815

12939

Transient ischemic attack

2552

15817

1.34

38.02

3.8

3.9

1.23

mmol/l

1.13

2344

13559

Seropositive rheumatoid arthritis

1219

8275

1.52

38.00

3.5

3.6

1.23

mmol/l

0.80

1133

7072

All influenza

1144

7691

1.53

37.89

6.9

3.3

1.22

1.23

mmol/l

4.50

1057

6614

Fibrosis and cirrhosis of liver

417

2160

2.08

37.88

5.1

4.1

1.21

1.23

mmol/l

6.42

397

1886

Insulin, fast-acting (human)

628

3665

1.78

37.69

8.3

3.4

1.22

1.23

mmol/l

3.79

555

3196

Injuries to the hip and thigh

2281

15621

1.35

37.56

4.4

3.8

1.22

1.23

mmol/l

1.41

2034

13510

IBD patients in KELA-register

980

6391

1.58

37.43

3.8

3.7

1.22

1.23

mmol/l

0.55

863

5639

Other pleural conditions

530

2971

1.89

37.31

6.3

3.6

1.21

1.22

mmol/l

3.47

494

2562

Congenital malformations, deformations and chromosomal abnormalities

2453

17850

1.33

37.18

4.8

3.6

1.23

mmol/l

0.48

2194

15603

Infective dermatitis

569

3256

1.84

37.18

4.7

3.7

1.23

mmol/l

0.32

498

2855

Emotional disorders starting during childhood or adolescence

204

775

2.77

37.14

3.7

3.5

1.22

1.23

mmol/l

0.31

168

663

Other special examinations and investigations of persons without complaint or reported diagnosis

3344

13304

1.29

37.12

4.1

3.7

1.23

1.22

mmol/l

0.35

2969

11316

Psoriatic arthropathies

496

2726

1.92

36.96

2.9

3.7

1.23

mmol/l

0.05

454

2389

Benign neoplasm of other and unspecified endocrine glands

656

3920

1.76

36.78

4.1

1.23

mmol/l

0.43

606

3428

Streptococcal septicaemia

442

2349

2.00

36.78

9.7

3.1

1.21

1.23

mmol/l

4.09

411

2009

L01XE Protein kinase inhibitors

318

1516

2.30

36.73

9.3

3.8

1.22

1.23

mmol/l

0.37

308

1325

Coxibs

1396

5060

1.49

36.57

3.1

4.7

1.22

mmol/l

0.02

1210

4455

Crohn disease

583

3369

1.81

36.44

4.4

3.7

1.22

1.23

mmol/l

0.96

519

2944

Other disorders involving the immune mechanism, not elsewhere classified

184

687

2.98

36.36

14.9

3.9

1.22

1.23

mmol/l

0.69

177

599

Benign neoplasms

4529

20380

1.24

36.33

4.4

3.6

1.22

mmol/l

0.40

4037

17723

Noninfectious colitis NAS

651

3889

1.75

36.21

5.7

3.7

1.22

1.23

mmol/l

4.08

608

3359

Other specific joint derangements/joint disorders

3132

15903

1.29

36.18

3.7

3.6

1.23

mmol/l

0.48

2774

13813

Gonarthrosis

3005

13361

1.30

36.10

3.7

1.23

mmol/l

0.03

2640

11615

Nonalcoholic fatty liver disease

465

2526

1.95

36.10

3.9

4.0

1.22

1.23

mmol/l

0.89

422

2219

Other necrotizing vasculopathies

401

2087

2.07

36.06

5.8

4.0

1.22

1.23

mmol/l

1.00

378

1816

Acute and transient psychotic disorders

535

3030

1.85

35.95

4.1

3.9

1.23

mmol/l

0.80

481

2656

Artificial joint operation, meniscal resection

4317

22891

1.24

35.84

3.5

4.0

1.23

mmol/l

0.26

3780

20046

Benign neoplasm: Pancreas

195

765

2.94

35.78

5.1

3.7

1.23

mmol/l

0.07

186

666

Panic disorder

579

3347

1.79

35.69

3.3

3.4

1.23

mmol/l

0.41

506

2929

Alzheimer’s disease (Atypical or mixed), excluding more controls

481

2087

1.95

35.66

3.3

3.7

1.23

1.22

mmol/l

2.19

382

1776

Other infectious diseases

468

2561

1.94

35.65

7.7

3.7

1.22

mmol/l

0.11

442

2212

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

456

2483

1.95

35.23

6.1

3.4

1.23

mmol/l

0.46

424

2131

Hyperkinetic disorders

433

2249

1.95

35.12

3.0

3.3

1.22

mmol/l

0.26

361

1951

Carrier of infectious disease

154

534

3.25

35.00

5.3

3.4

1.21

1.23

mmol/l

2.18

143

462

Other symptoms and signs involving the digestive system and abdomen

799

5063

1.64

34.99

4.9

3.4

1.23

1.24

mmol/l

0.75

709

4339

Traumatic subdural haemorrhage

663

3849

1.73

34.96

4.7

3.9

1.21

1.22

mmol/l

4.02

583

3289

5-aminosalicylic acid

879

5679

1.60

34.96

4.2

3.5

1.23

mmol/l

0.36

769

4936

Caries of enamel

2605

24088

0.77

34.93

3.6

3.8

1.23

mmol/l

0.17

2238

21150

Other viral diseases

1174

8029

1.50

34.91

6.7

3.6

1.22

1.23

mmol/l

0.61

1064

7051

Coxarthrosis

2369

11934

1.34

34.90

3.7

3.8

1.23

mmol/l

0.58

2088

10334

Seronegative rheumatoid arthritis

594

3504

1.78

34.88

3.5

3.8

1.23

mmol/l

0.09

548

2975

Basal cell carcinoma, including avohilmo

2008

10319

1.37

34.88

4.2

3.0

1.23

mmol/l

0.04

1711

8667

Undetermined asthma, excluding more controls

585

3424

1.78

34.76

3.7

2.9

1.23

mmol/l

2.83

525

2866

Acute peritonitis

346

1731

2.15

34.68

14.0

4.0

1.21

1.22

mmol/l

2.95

330

1502

Protozoal diseases

189

737

2.89

34.66

9.8

3.7

1.22

1.23

mmol/l

0.75

180

639

Arthropathic psoriasis

535

3076

1.83

34.39

3.0

4.0

1.23

mmol/l

0.39

488

2696

Basal cell carcinoma

1944

10011

1.38

34.37

4.2

3.0

1.23

mmol/l

0.27

1659

8409

Follicular adenocarcinoma of thyroid gland, including Hilmo

208

5.03

34.36

6.3

2.5

1.20

1.23

mmol/l

2.39

178

Thyrotoxicosis with diffuse goitre

645

3896

1.73

34.34

3.8

3.4

1.23

mmol/l

3.03

569

3418

Inflammatory bowel disease, strict (require KELA)

980

6517

1.55

34.25

3.8

1.22

1.23

mmol/l

0.32

863

5764

Other necrotizing vasculopathies (FG)

341

1708

2.16

34.20

5.5

3.7

1.22

1.23

mmol/l

2.89

321

1460

Polymyalgia rheumatica

715

4462

1.69

34.13

3.9

1.23

mmol/l

0.20

649

3845

Attention to artificial openings

229

979

2.56

34.07

5.7

2.8

1.23

1.22

mmol/l

0.16

214

829

Psychotic depression

273

1249

2.31

33.84

4.4

3.7

1.22

1.23

mmol/l

0.69

230

1111

Postmenopausal osteoporosis with pathological fracture

395

2105

2.05

33.66

5.6

3.3

1.24

mmol/l

0.00

372

1783

Alcohol dependence

1143

7869

1.50

33.66

4.4

4.1

1.21

1.22

mmol/l

7.04

1020

6955

Faecal incontinence

497

2824

1.87

33.61

3.9

3.3

1.23

1.24

mmol/l

2.49

423

2403

Zoster [herpes zoster]

904

5958

1.58

33.57

5.6

3.7

1.23

mmol/l

0.17

832

5163

Injuries to the elbow and forearm

3179

22336

1.27

33.56

4.1

3.7

1.23

mmol/l

1.01

2745

19472

Congenital malformations of the urinary system

290

1372

2.27

33.54

13.1

3.6

1.23

mmol/l

0.25

280

1194

Other and unspecified vasculitis limited to skin

163

606

3.06

32.94

5.0

3.5

1.22

1.23

mmol/l

1.09

149

529

Other and unspecified drugs and medicaments

434

2381

1.94

32.90

6.3

3.6

1.23

mmol/l

0.10

405

2073

Psoriasis

1265

8932

1.46

32.65

3.8

3.9

1.23

mmol/l

0.11

1134

7834

Protein-energy malnutrition of moderate and mild degree

224

4.94

32.55

7.0

4.1

1.20

1.23

mmol/l

3.79

198

Alcohol abuse, main dg, excluding more controls

593

3546

1.73

32.49

4.7

3.9

1.21

1.22

mmol/l

7.82

535

3165

Behavioural syndromes associated with physiological disturbances and physical factors

4126

24046

1.23

32.48

3.4

3.8

1.23

mmol/l

1.46

3603

21023

Myocardial infarction

2211

11904

1.34

32.30

5.6

3.6

1.21

1.23

mmol/l

22.68

2005

10236

Explicit bacterial Sepsis

502

2884

1.83

32.26

9.2

3.1

1.21

1.23

mmol/l

4.86

467

2473

Paracetamol or NSAID medication

724

2216

1.68

32.18

4.1

3.6

1.22

mmol/l

0.05

622

1911

Periapical abscess

1928

14582

1.35

32.11

4.3

3.9

1.22

1.23

mmol/l

2.47

1694

12820

Other viral diseases

1475

10614

1.41

32.03

5.9

3.5

1.22

1.23

mmol/l

0.49

1346

9327

Spinal stenosis

2431

14349

1.31

32.03

3.7

3.9

1.23

mmol/l

1.23

2120

12473

Urolithiasis

1456

10570

1.42

31.98

4.2

4.1

1.23

1.22

mmol/l

4.41

1297

9258

Ulcerative colitis

1056

7232

1.50

31.97

4.1

3.7

1.22

1.23

mmol/l

0.83

945

6357

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

166

629

2.93

31.90

14.9

4.0

1.22

1.23

mmol/l

0.34

159

549

Colitis, primary sclerosing

245

4.33

31.82

5.0

3.3

1.22

1.23

mmol/l

0.98

221

Undetermined asthma

585

3511

1.73

31.74

3.7

3.0

1.23

mmol/l

2.30

525

2969

Congenital malformations of the urinary system

301

1476

2.18

31.68

12.8

3.6

1.23

mmol/l

0.21

287

1285

Fracture of rib(s), sternum and thoracic spine

1385

9992

1.43

31.65

4.4

3.9

1.22

1.23

mmol/l

4.23

1246

8684

Fungal Sepsis

234

1045

2.45

31.64

10.9

3.2

1.21

1.23

mmol/l

2.43

213

891

Abnormal findings on diagnostic imaging of central nervous system

253

1164

2.35

31.54

3.7

3.5

1.22

1.23

mmol/l

0.65

231

998

Eosinophilic disease (BM)

109

329

3.83

31.50

5.0

3.0

1.22

1.23

mmol/l

0.45

276

Cholangitis (primary sclerosing, PSC), with reimbursement 202

116

363

3.63

31.45

5.3

4.0

1.23

mmol/l

0.07

110

317

Statin medication

3032

13554

1.28

31.18

4.3

3.5

1.23

mmol/l

2.26

2685

11890

149

541

3.06

31.03

4.8

3.6

1.22

1.23

mmol/l

1.46

116

471

Diabetic nephropathy

829

5406

1.59

30.98

14.6

3.8

1.20

1.22

mmol/l

12.95

762

4762

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

585

3537

1.73

30.97

5.6

3.1

1.22

1.23

mmol/l

0.18

515

2948

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1055

4544

1.51

30.73

2.7

2.9

1.22

1.23

mmol/l

1.56

912

3950

Mental and behavioural disorders due to opioids

177

700

2.72

30.69

5.5

3.5

1.21

1.23

mmol/l

3.94

151

607

Dermatographic urticaria

322

1637

2.09

30.60

4.0

3.3

1.23

mmol/l

0.22

277

1411

Diseases of male genital organs

2067

7888

1.34

30.56

5.0

4.4

1.22

mmol/l

0.02

1833

7027

Malignant neoplasm of colon, including Hilmo

835

5524

1.57

30.16

4.3

3.1

1.22

1.23

mmol/l

0.85

766

4611

Phobic anxiety disorders

481

2765

1.79

30.09

3.7

3.4

1.22

1.23

mmol/l

0.66

396

2426

Other eating disorders

205

872

2.48

30.05

3.8

2.8

1.22

1.23

mmol/l

1.15

176

746

Cystic kidney disease

196

831

2.59

29.87

15.2

3.7

1.23

mmol/l

0.01

191

716

Other psoriatic arthropathies

474

2744

1.82

29.84

2.8

4.1

1.23

mmol/l

0.14

434

2406

Schizoaffective disorder

346

1818

2.01

29.74

3.7

1.24

1.23

mmol/l

2.01

309

1596

Diabetic retinopathy

1701

7921

1.38

29.73

6.7

4.2

1.22

mmol/l

6.59

1462

7041

Obesity, other/unspecified

1379

10026

1.41

29.71

4.0

3.5

1.22

1.23

mmol/l

6.04

1206

8788

COPD

2110

13341

1.32

29.40

4.8

4.0

1.21

1.23

mmol/l

18.09

1906

11506

Other specified and unspecified personality disorders

394

2164

1.91

29.40

3.9

3.7

1.22

1.23

mmol/l

1.76

344

1889

Other obstetric conditions, not elsewhere classified

1073

4689

1.48

29.33

2.7

2.9

1.22

1.23

mmol/l

1.72

929

4087

Congenital malformations, deformations and chromosomal abnormalities

2658

19484

1.28

29.32

4.7

3.6

1.23

mmol/l

0.62

2376

17006

Elevated blood glucose level

405

2253

1.90

29.31

6.1

3.7

1.22

1.23

mmol/l

1.38

372

1957

Persons encountering health services for specific procedures, not carried out

372

2015

1.94

29.02

5.8

2.6

1.21

1.23

mmol/l

7.32

327

1713

Acute alcohol intoxication

1080

7567

1.47

29.00

4.7

4.1

1.21

1.22

mmol/l

9.92

965

6654

Psoriatic arthropathies, ICD10

482

2829

1.79

28.89

2.8

4.1

1.23

mmol/l

0.06

442

2481

Cardiomyopathy

771

5065

1.58

28.85

5.2

3.4

1.21

1.23

mmol/l

11.27

714

4342

Calculus of kidney and ureter

1332

9698

1.41

28.83

4.2

4.1

1.23

1.22

mmol/l

3.67

1189

8496

Disorders of ocular muscles, binocular movement, accommodation and refraction

1938

14751

1.33

28.82

4.4

3.7

1.23

mmol/l

0.03

1650

12921

Disease of hard tissues of teeth, NOS

2627

10842

1.29

28.71

3.6

3.5

1.23

mmol/l

0.82

2269

9477

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

671

4291

1.63

28.63

5.3

4.2

1.20

1.22

mmol/l

11.53

631

3782

Injuries to the shoulder and upper arm

3817

25464

1.22

28.52

4.1

3.8

1.23

mmol/l

0.95

3344

22251

Haemorrhage, not elsewhere classified

214

961

2.42

28.44

7.1

2.8

1.21

1.23

mmol/l

2.30

195

811

Panhypopituitarism

119

404

3.37

28.38

4.7

3.6

1.22

mmol/l

0.75

112

352

Vasculitis limited to skin, not elsewhere classified

170

695

2.74

28.37

5.1

3.3

1.22

1.23

mmol/l

0.95

155

603

Varicose veins

2916

17747

1.26

28.34

4.0

3.6

1.23

mmol/l

1.09

2559

15405

Papulosquamous disorders

1735

13176

1.35

28.33

3.7

3.8

1.23

mmol/l

0.95

1548

11508

Diabetic retinopathy, strict definition

859

5130

1.55

28.19

8.5

4.2

1.21

1.22

mmol/l

5.83

739

4571

Mental and behavioural disorders due to sedatives or hypnotics

311

1607

2.05

28.15

4.4

3.7

1.21

1.23

mmol/l

3.40

263

1402

Wide developmental disorders, excluding more controls

109

340

3.33

27.90

3.2

3.9

1.22

1.23

mmol/l

0.91

297

Iridocyclitis

1007

7027

1.48

27.89

4.1

3.8

1.23

mmol/l

0.25

900

6156

Sleep disorders

3911

23466

1.22

27.88

3.2

3.8

1.23

mmol/l

1.03

3427

20502

Other disorders of glucose regulation and pancreatic internal secretion

391

2182

1.89

27.87

7.4

3.7

1.21

1.23

mmol/l

4.64

350

1899

Migraine with aura

923

6317

1.50

27.81

3.2

3.4

1.23

mmol/l

1.85

840

5499

Glaucoma suspect

1689

12830

1.35

27.78

3.9

3.8

1.23

mmol/l

0.10

1416

11153

Cutaneous abscess, furuncle and carbuncle

1081

7637

1.45

27.76

6.2

3.6

1.22

1.23

mmol/l

3.69

985

6707

Crohn's disease NAS

299

1533

2.07

27.71

4.3

3.5

1.22

1.23

mmol/l

0.52

270

1333

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

302

1556

2.06

27.69

4.8

3.0

1.21

1.22

mmol/l

2.05

282

1306

Sicca syndrome [Sjögren]

433

2505

1.83

27.64

3.7

1.23

1.24

mmol/l

1.29

376

2176

Nontoxic goitre/thyroid nodule

1409

10439

1.39

27.58

4.3

3.6

1.23

mmol/l

5.20

1262

9020

Hyperplasia of prostate

1508

6304

1.39

27.58

4.5

4.6

1.22

1.21

mmol/l

0.11

1339

5596

Diseases of peritoneum

491

2938

1.76

27.53

11.1

3.9

1.21

1.23

mmol/l

3.21

450

2565

Maternal care for other conditions predominantly related to pregnancy

747

4824

1.56

27.16

2.7

3.2

1.23

mmol/l

0.54

652

4255

Cellulitis

955

6631

1.48

27.13

6.8

3.6

1.22

1.23

mmol/l

3.97

875

5807

Viral and other specified intestinal infections

1061

7217

1.45

27.07

5.7

3.3

1.22

1.23

mmol/l

3.50

963

6241

Alzheimer disease, excluding more controls

865

3841

1.54

27.00

3.2

3.8

1.23

mmol/l

0.38

696

3270

Malignant neoplasm of colon

658

4247

1.61

26.84

4.5

3.1

1.22

1.23

mmol/l

1.01

605

3548

Carcinoma in situ of skin of other and unspecified parts of face

454

2694

1.79

26.71

5.7

3.6

1.22

1.23

mmol/l

0.18

378

2323

Other embolism and thrombosis

604

3831

1.64

26.69

6.6

3.7

1.22

1.23

mmol/l

2.30

547

3340

Eating disorder

327

1740

1.95

26.55

3.5

2.7

1.22

1.23

mmol/l

0.45

279

1475

Hypertensive heart and/or renal disease

1114

5913

1.44

26.46

8.3

3.3

1.21

1.23

mmol/l

7.31

1017

4971

Adverse effects, not elsewhere classified

832

5652

1.52

26.45

4.2

3.8

1.23

mmol/l

1.30

724

4941

Implicit fungal Sepsis

210

968

2.37

26.39

11.7

3.2

1.21

1.23

mmol/l

2.07

193

822

Cirrhosis of liver, NAS

280

1437

2.10

26.39

5.7

4.1

1.20

1.22

mmol/l

7.53

267

1253

Other and unspecified tonsillitis

1162

7000

1.42

26.39

4.3

3.5

1.22

mmol/l

1.24

1013

6151

Urticaria and erythema

1509

11342

1.36

26.32

4.6

3.6

1.23

mmol/l

2.01

1312

9901

Wet age-related macular degeneration

887

5943

1.51

26.28

3.3

3.8

1.22

1.23

mmol/l

2.01

725

5106

Acute and subacute iridocyclitis

846

5781

1.51

26.25

4.3

3.9

1.23

mmol/l

0.63

753

5078

Adalimumab

404

2315

1.82

26.21

2.7

3.9

1.23

mmol/l

0.24

364

2025

Ovarian cyst

1556

6702

1.37

26.09

3.5

3.4

1.23

mmol/l

0.55

1355

5793

Ulcerative colitis (strict) with PSC

127

5.41

26.02

4.9

3.5

1.22

1.23

mmol/l

0.64

116

Fracture of femur

1310

8759

1.39

26.00

4.8

3.8

1.22

1.23

mmol/l

1.36

1163

7486

Testicular hypofunction

153

614

2.70

25.97

5.7

3.9

1.21

1.22

mmol/l

0.67

137

557

Hypogonadotropic hypogonadism

140

539

2.83

25.90

4.4

1.22

1.23

mmol/l

0.94

125

488

Malignant neoplasm of small intestine, including Hilmo

161

666

2.65

25.90

5.5

3.0

1.21

1.22

mmol/l

1.33

155

559

Artrosis, including avohilmo

3804

17296

1.22

25.88

3.5

4.0

1.23

mmol/l

0.05

3354

15196

IBD (strict) with PSC

161

4.76

25.78

5.7

3.4

1.22

1.23

mmol/l

0.99

145

L02BB Anti-androgens

447

2659

1.77

25.74

6.7

4.2

1.21

mmol/l

0.35

418

2318

Colorectal adenocarcinoma

835

5697

1.51

25.74

4.5

3.1

1.22

1.23

mmol/l

1.42

757

4769

Other chronic obstructive pulmonary disease, including avohilmo

2471

16373

1.27

25.67

4.6

3.9

1.22

1.23

mmol/l

16.13

2213

14186

Eosinophilia

109

374

3.34

25.63

5.0

3.5

1.22

1.23

mmol/l

0.38

329

Other diseases of anus and rectum

1418

10602

1.37

25.53

4.3

3.6

1.23

mmol/l

1.45

1253

9130

Lung cancer and mesothelioma

900

5338

1.49

25.51

5.6

3.2

1.23

mmol/l

0.02

850

4481

Speech therapy

1204

8808

1.41

25.50

3.2

3.8

1.24

1.23

mmol/l

11.02

1162

7642

Follicular lymphoma, hilmo

238

1170

2.22

25.50

7.9

3.9

1.23

mmol/l

1.56

229

1013

Molar incisor enamel hypoplasia, with caries

7.54

25.49

20.0

7.4

1.23

mmol/l

0.00

Colitis, primary sclerosing, strict definition

180

4.49

25.48

4.3

3.6

1.21

1.23

mmol/l

2.11

164

Disorders of refraction and accommodation

1062

7562

1.43

25.45

4.7

3.7

1.23

mmol/l

0.30

883

6645

Other infectious diseases

375

2131

1.86

25.39

8.5

3.7

1.22

mmol/l

0.53

355

1838

Other ulcerative colitis

269

1373

2.08

25.36

5.2

3.5

1.23

mmol/l

0.01

248

1188

IgA nephropathy (IgA glomerulonephritis)

137

531

2.87

25.35

15.6

4.1

1.23

1.22

mmol/l

0.08

131

469

Calcific aortic valvular stenosis, operated

1430

10433

1.37

25.15

5.6

3.8

1.22

mmol/l

4.47

1256

8992

Calcific aortic valvular stenosis

1430

10433

1.37

25.15

5.6

3.8

1.22

mmol/l

4.47

1256

8992

Operations 2 for CAVS

1429

10425

1.37

25.14

5.6

3.8

1.22

mmol/l

4.38

1255

8985

Calcific aortic valvular stenosis, diagnosis (helper)

1429

10425

1.37

25.14

5.6

3.8

1.22

mmol/l

4.38

1255

8985

Normotensive glaucoma

457

2764

1.76

25.07

4.0

3.7

1.23

mmol/l

0.25

376

2374

Vitreous haemorrhage

478

2914

1.72

25.02

8.5

4.1

1.22

1.23

mmol/l

2.39

430

2544

Calcific aortic valvular stenosis, including rheumatic fever

1434

10465

1.36

25.01

5.6

3.8

1.22

mmol/l

4.48

1260

9020

Generalized anxiety disorder

569

3596

1.63

24.96

3.2

3.4

1.23

mmol/l

0.53

473

3151

Autism spe, excluding more controls

263

3.55

24.95

2.5

4.2

1.22

mmol/l

0.73

225

Ascites

368

2093

1.86

24.89

6.5

3.8

1.20

1.23

mmol/l

11.93

352

1804

Combinations of oral blood glucose lowering drugs

1229

9054

1.39

24.86

3.7

4.0

1.22

1.23

mmol/l

1.93

1087

7892

Radiculopathy

773

5251

1.52

24.85

3.8

1.22

1.23

mmol/l

0.97

648

4543

Eating disorders

395

2275

1.80

24.80

3.6

3.0

1.22

1.23

mmol/l

0.53

335

1944

Other specified disorders of kidney and ureter

183

820

2.44

24.68

10.6

3.6

1.22

1.23

mmol/l

0.22

164

713

Other abnormal uterine and vaginal bleeding

1060

5422

1.44

24.62

3.3

3.5

1.24

mmol/l

0.29

918

4688

Viral and other specified intestinal infections

784

5194

1.51

24.62

6.8

3.3

1.22

1.23

mmol/l

2.27

716

4465

Mouth breathing

1630

12499

1.33

24.56

4.0

4.1

1.22

1.23

mmol/l

0.27

1394

11067

Non-small cell lung cancer, including Hilmo

666

4141

1.57

24.31

5.3

3.1

1.23

1.22

mmol/l

2.70

626

3481

Migraine without aura

695

4618

1.54

24.28

3.3

3.4

1.22

1.23

mmol/l

2.23

622

4034

Maltreatment syndromes

217

1037

2.21

24.28

3.4

3.2

1.22

1.23

mmol/l

2.07

190

899

Fracture of lumbar spine and pelvis

1038

7463

1.43

24.27

5.1

3.8

1.22

1.23

mmol/l

2.11

928

6424

Abnormal findings on examination of urine, without diagnosis

224

1092

2.21

24.25

10.0

3.8

1.22

mmol/l

0.05

212

944

Hypoglycaemia, other or unspecified

312

1698

1.94

24.23

7.4

3.8

1.21

1.22

mmol/l

3.03

280

1472

Disorders of skin appendages

1951

15331

1.29

24.15

4.9

3.6

1.23

mmol/l

0.47

1719

13400

Disorders of lacrimal system

1934

15188

1.30

24.09

4.1

3.7

1.23

mmol/l

1.10

1689

13204

Etanercept

292

1562

1.97

23.95

2.8

3.7

1.23

mmol/l

0.02

272

1358

Benign paroxysmal vertigo

1356

10208

1.36

23.90

3.8

1.23

mmol/l

0.47

1177

8855

Ulcerative colitis (strict definition, require KELA)

675

4490

1.55

23.82

3.9

1.22

1.23

mmol/l

0.45

600

3959

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

652

4307

1.56

23.78

3.9

1.22

1.23

mmol/l

0.51

581

3798

Other and unspecified disorders of white blood cells

214

1035

2.24

23.78

5.7

3.6

1.21

1.23

mmol/l

3.28

194

891

Sciatica+with lumbago

2201

16172

1.27

23.77

3.5

3.8

1.23

mmol/l

0.08

1944

14134

Arthropathies in other diseases classified elsewhere

191

883

2.34

23.73

11.5

3.6

1.21

1.23

mmol/l

2.25

176

763

Other follicular disorders

314

1724

1.91

23.64

5.9

3.5

1.23

mmol/l

0.03

280

1499

Testicular dysfunction

162

697

2.49

23.62

5.5

3.8

1.21

1.22

mmol/l

0.57

144

634

Excessive, frequent and irregular menstruation

1652

6909

1.33

23.59

3.5

3.3

1.23

mmol/l

0.33

1444

5954

Transport accidents

1923

13001

1.29

23.43

3.6

1.23

mmol/l

1.05

1728

11419

Insomnia

3758

23036

1.20

23.32

3.2

3.8

1.23

mmol/l

0.83

3293

20118

Anterior Iridocyclitis

882

6214

1.46

23.32

4.3

3.9

1.23

mmol/l

0.57

786

5467

Mental and behavioural disorders due to use of other stimulants, including caffeine

122

461

2.83

23.23

3.4

3.5

1.20

1.23

mmol/l

3.49

107

406

Non-allergic asthma (mode), excluding more controls

784

5345

1.49

23.16

3.6

2.9

1.23

mmol/l

2.71

688

4465

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1195

8871

1.39

23.15

3.6

3.8

1.23

mmol/l

0.94

1112

7659

Other chronic obstructive pulmonary disease

1981

12931

1.29

22.99

4.9

4.0

1.21

1.23

mmol/l

17.93

1797

11147

Other and unspecified glaucoma

360

2087

1.83

22.97

4.2

3.6

1.23

mmol/l

0.21

321

1798

Osteonecrosis

301

1654

1.94

22.97

9.3

3.6

1.23

mmol/l

0.14

287

1430

Asthma mixed form (mode), excluding more controls

240

1216

2.08

22.97

3.5

3.0

1.23

mmol/l

0.28

225

1019

Secondary polycythaemia

135

547

2.73

22.85

3.7

1.22

1.23

mmol/l

0.19

121

480

Ulcer of lower limb, not elsewhere classified

676

4555

1.54

22.83

10.4

3.6

1.21

1.23

mmol/l

5.73

637

3937

Myeloproliferative diseases

410

2466

1.76

22.83

3.3

3.8

1.22

1.23

mmol/l

2.10

356

2143

Diabetic maculopathy

626

3917

1.58

22.82

8.9

4.2

1.21

1.22

mmol/l

7.68

544

3505

Other diseases of hard tissues of teeth

2697

11343

1.25

22.66

4.1

3.4

1.23

mmol/l

0.32

2311

9884

Dentofacial anomalies [including malocclusion]

2835

18738

1.23

22.60

3.4

3.7

1.23

mmol/l

0.57

2432

16439

Other disorders of lacrimal gland

1559

12053

1.32

22.53

4.3

3.7

1.23

mmol/l

1.62

1360

10479

Other/unspecified seropositive rheumatoid arthritis

1208

9019

1.38

22.53

3.5

3.8

1.23

mmol/l

0.92

1123

7786

Colectomy operation

784

5454

1.49

22.47

5.0

3.9

1.22

1.23

mmol/l

1.04

715

4731

DVT of lower extremities

860

6078

1.46

22.44

5.4

3.7

1.23

mmol/l

0.07

762

5281

Aortic aneurysm

1045

7482

1.41

22.43

5.1

3.7

1.21

1.22

mmol/l

3.51

936

6514

Fall on same level involving ice and snow

2489

20322

1.24

22.32

4.1

3.8

1.23

mmol/l

1.14

2187

17707

Seropositive rheumatoid arthritis, wide

1219

9128

1.37

22.29

3.5

3.8

1.23

mmol/l

0.92

1133

7877

Emphysema

348

2011

1.82

22.28

4.1

4.3

1.21

1.22

mmol/l

1.37

305

1745

Ulcerative colitis, NAS

573

3739

1.58

22.22

4.5

3.7

1.22

1.23

mmol/l

1.29

514

3265

Use of pramipexole

1017

7420

1.41

22.11

4.6

3.9

1.23

mmol/l

0.81

862

6452

Injuries to the ankle and foot

2876

21139

1.22

22.11

4.2

3.7

1.22

1.23

mmol/l

2.41

2508

18518

Other (seronegative) rheumatoid arthritis, wide

875

6227

1.45

22.06

3.9

3.8

1.23

mmol/l

0.41

804

5388

Parkinson's disease, excluding more controls

594

3684

1.57

22.00

3.1

3.8

1.23

mmol/l

0.80

507

3161

Excessive attrition of teeth

2265

18330

1.25

21.99

3.8

1.23

mmol/l

0.06

1946

16129

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

716

4903

1.50

21.92

3.8

3.9

1.22

1.23

mmol/l

0.76

631

4320

Endocarditis

181

846

2.30

21.87

10.1

3.4

1.21

1.23

mmol/l

3.91

169

727

Total colectomy

201

979

2.20

21.79

6.2

3.8

1.22

1.23

mmol/l

0.62

183

852

Total colectomy operation

201

979

2.20

21.79

6.2

3.8

1.22

1.23

mmol/l

0.62

183

852

Other sleep disorders

462

2883

1.66

21.77

4.2

3.9

1.22

mmol/l

0.02

406

2515

Other and unspecified myopathies

411

2502

1.73

21.75

5.7

3.8

1.21

1.22

mmol/l

3.04

367

2178

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

226

1149

2.09

21.70

5.2

2.9

1.21

1.22

mmol/l

2.64

211

971

Unspecific neurodegenerative disorder

2030

11074

1.28

21.68

2.9

4.0

1.23

mmol/l

2.44

1636

9600

Other disorders starting during childhood or adolecense, excluding more controls

137

537

2.53

21.56

5.0

3.4

1.23

mmol/l

0.11

122

469

Pleural plaque

454

2842

1.68

21.52

3.6

3.9

1.21

1.22

mmol/l

2.63

392

2450

Deforming dorsopathies

1204

9035

1.36

21.48

3.5

3.7

1.23

mmol/l

0.02

1064

7832

Type 1 diabetes, definitions combined

340

1953

1.79

21.46

4.0

3.3

1.22

1.23

mmol/l

0.48

290

1696

Hyperfunction of pituitary gland

213

1064

2.12

21.34

4.7

2.7

1.23

mmol/l

0.35

190

908

Nonischemic cardiomyopathy

438

2717

1.68

21.29

5.0

3.7

1.21

1.23

mmol/l

4.88

412

2354

Any death

2911

17316

1.22

21.28

7.6

3.4

1.22

1.23

mmol/l

20.25

2738

14915

Cardiomyopathies, Primary/intrinsic

523

3384

1.60

21.21

4.9

3.4

1.21

1.23

mmol/l

8.59

486

2919

Temporomandibular joint disorders, including avohilmo

1714

13297

1.29

21.18

3.1

3.6

1.23

mmol/l

0.28

1483

11610

Asthma mixed form (mode)

240

1252

2.02

21.17

3.5

3.1

1.23

mmol/l

0.53

225

1055

Type 1 diabetes, strict (exclude DM2)

338

1947

1.79

21.14

4.1

3.3

1.22

1.23

mmol/l

0.46

289

1692

Childhood asthma (age<16), excluding more controls

383

1779

1.73

21.08

3.0

2.6

1.23

mmol/l

0.00

334

1525

Hernia of abdominal wall

1966

15764

1.27

21.00

5.2

3.9

1.22

1.23

mmol/l

5.69

1741

13777

Malignant neoplasm of bladder, including Hilmo

494

3140

1.62

20.98

4.7

3.3

1.22

mmol/l

0.46

435

2655

Squamous cell neoplasms and carcinomas of the skin

376

2254

1.75

20.96

6.0

3.1

1.22

mmol/l

0.07

331

1892

Pain and other conditions associated with female genital organs and menstrual cycle

769

4932

1.47

20.90

2.7

3.2

1.23

mmol/l

0.22

653

4283

Unspecified nephritic syndrome

128

529

2.67

20.85

9.9

3.7

1.22

1.23

mmol/l

0.89

119

460

Fracture of shoulder and upper arm

1582

12363

1.30

20.78

4.4

3.8

1.23

mmol/l

1.43

1405

10712

Gonarthrosis, primary, with knee surgery

2691

17734

1.23

20.70

3.3

4.0

1.23

mmol/l

0.96

2304

15425

Complications of internal orthopaedic prosthetic devices, implants and grafts

1061

7879

1.39

20.66

4.6

3.5

1.23

mmol/l

1.67

956

6712

Migraine with aura and triptan purchases

570

3769

1.55

20.63

2.7

3.4

1.23

mmol/l

0.19

512

3310

Injuries to the knee and lower leg

5372

25970

1.16

20.62

4.2

3.7

1.23

mmol/l

1.35

4750

22603

Personal history of certain other diseases

326

3.10

20.59

4.2

2.8

1.21

1.23

mmol/l

1.84

272

Vitamin D deficiency

104

390

2.95

20.55

5.6

3.5

1.21

1.23

mmol/l

1.96

342

Impingement syndrome of shoulder

506

7687

0.64

20.54

4.0

3.9

1.23

mmol/l

0.47

459

6742

Benign neoplasm: Pituitary gland, craniopharyngeal duct

244

1299

1.99

20.54

3.7

3.8

1.23

mmol/l

0.02

221

1127

Intentional self-harm by sharp object

114

445

2.75

20.47

4.0

3.0

1.22

1.23

mmol/l

0.38

100

386

Endometriosis

1461

6575

1.33

20.45

3.1

3.4

1.23

mmol/l

0.46

1238

5687

FESS (DNB20)

520

3391

1.59

20.39

3.9

4.0

1.23

mmol/l

0.20

444

2984

Other obstructive and reflux uropathy

202

1010

2.12

20.28

8.8

2.7

1.22

1.23

mmol/l

0.28

181

851

Diseases of the myoneural junction and muscle

544

3592

1.57

20.28

5.5

3.9

1.21

1.22

mmol/l

2.95

485

3139

Other Crohn's disease

287

1608

1.87

20.26

4.7

3.3

1.23

mmol/l

0.41

245

1395

Diverticular disease of intestine

3256

17480

1.20

20.21

4.4

3.7

1.23

mmol/l

1.06

2895

15146

Herpesviral [herpes simplex] infections

502

3256

1.60

20.21

7.3

3.5

1.22

1.23

mmol/l

2.16

461

2822

Graves disease, strict definition

430

2692

1.66

20.16

3.8

3.5

1.22

1.23

mmol/l

1.76

382

2351

Childhood asthma (age<16)

383

1804

1.71

20.09

3.0

2.7

1.23

mmol/l

0.02

334

1548

Superficial injury of abdomen, lower back and pelvis

622

4219

1.52

20.09

4.2

3.6

1.22

1.23

mmol/l

1.81

555

3678

L04AC Interleukin inhibitors

247

1326

1.96

20.08

3.0

3.7

1.23

mmol/l

0.52

232

1156

Myeloproliferative diseases (CML excluded)

368

2228

1.74

20.07

3.2

3.9

1.22

1.23

mmol/l

1.63

316

1937

Mixed disorders of conduct and emotions, excluding more controls

228

3.42

20.02

3.8

2.6

1.22

mmol/l

0.20

197

Valvular operations

616

4178

1.52

20.01

4.5

3.3

1.21

1.23

mmol/l

8.23

548

3571

Malignant neoplasm of bronchus and lung, including Hilmo

893

5398

1.42

19.99

5.5

3.1

1.23

1.22

mmol/l

1.70

841

4515

Acute pharyngitis

510

3283

1.58

19.98

4.5

3.5

1.22

mmol/l

0.18

457

2848

Crohn's disease of small intestine

288

1624

1.86

19.94

4.7

3.3

1.23

mmol/l

0.13

261

1413

Cardiomyopathy (excluding other)

533

3514

1.57

19.87

4.9

3.5

1.21

1.23

mmol/l

9.00

495

3025

Chronic diseases of tonsils and adenoids

2401

18446

0.81

19.80

3.7

3.8

1.23

mmol/l

0.19

2122

16122

Carcinoid syndrome

244

3.68

19.75

5.5

3.5

1.22

mmol/l

0.51

209

Benign neoplasm: Adrenal gland

366

2223

1.74

19.72

3.7

4.0

1.23

mmol/l

0.38

342

1947

Malignant melanoma, including Hilmo

701

4889

1.48

19.67

5.2

3.1

1.23

mmol/l

0.46

618

4102

Non-allergic asthma (mode)

784

5514

1.44

19.66

3.6

3.1

1.23

mmol/l

1.60

688

4637

Functional dyspepsia

1173

8891

1.35

19.66

3.9

3.5

1.23

mmol/l

0.54

1055

7676

L01XX Other antineoplastic agents

294

1688

1.86

19.61

4.5

4.0

1.22

mmol/l

1.93

259

1464

Coeliac disease

516

3389

1.58

19.61

4.5

3.7

1.22

1.23

mmol/l

2.67

455

2934

Alzheimer’s disease (Atypical or mixed)

507

3303

1.59

19.57

3.3

3.6

1.23

1.22

mmol/l

3.25

403

2843

Isolated proteinuria

148

670

2.40

19.51

11.9

3.6

1.22

mmol/l

0.13

141

573

Unstable angina pectoris

1655

10320

1.29

19.51

4.5

3.8

1.22

1.23

mmol/l

8.33

1508

8832

Disturbances of skin sensation

1111

8359

1.36

19.49

3.5

3.6

1.23

mmol/l

1.17

999

7325

Septal defects

251

1337

1.93

19.44

3.7

4.1

1.22

1.23

mmol/l

1.01

236

1162

Assault

474

3052

1.60

19.42

4.6

3.8

1.22

1.23

mmol/l

1.72

418

2700

Nontoxic single thyroid nodule

335

1994

1.77

19.37

4.3

3.5

1.23

mmol/l

0.08

305

1729

Crystal arthropathies, rheuma endpoint

118

489

2.69

19.29

4.8

3.5

1.22

1.23

mmol/l

0.49

109

410

Tubulo-interstitial nephritis, not specified as acute or chronic

314

1835

1.79

19.29

6.7

2.8

1.22

1.23

mmol/l

2.13

275

1544

Disorders of adrenal gland, other and/or unspecified

113

5.23

19.26

4.3

2.9

1.22

1.23

mmol/l

0.64

Lung transplant status

162

4.29

19.21

11.6

4.6

1.22

mmol/l

0.15

145

Lung transplantation

162

4.29

19.20

11.6

4.6

1.22

mmol/l

0.15

145

Somatoform disorder

662

4587

1.48

19.18

3.6

1.22

1.23

mmol/l

1.71

585

4040

Mucosal proctocolitis

494

3225

1.58

19.16

3.5

3.7

1.22

1.23

mmol/l

0.79

443

2813

Fentanyl

477

3093

1.60

19.11

8.2

3.3

1.23

mmol/l

0.20

450

2609

Primary biliary cholangitis (PBC)

123

520

2.60

19.10

5.1

3.5

1.23

mmol/l

1.14

118

457

Later onset COPD, excluding more controls

992

5673

1.39

19.07

4.8

3.2

1.21

1.23

mmol/l

14.82

893

4736

Any dementia, excluding more controls

1693

9249

1.29

19.03

3.4

3.8

1.23

mmol/l

0.56

1401

7967

Hypoplasia of dental enamel

5.67

19.00

23.8

8.1

1.23

1.24

mmol/l

0.09

Intussusception

126

540

2.57

19.00

3.4

3.3

1.23

mmol/l

0.27

117

452

Ethmoidectomy

533

3551

1.55

18.95

3.9

1.23

mmol/l

0.10

454

3131

Hyperaldosteronism

149

687

2.36

18.88

5.9

3.7

1.22

mmol/l

0.57

139

596

Malignant neoplasm of breast, HER-negative

827

5873

1.42

18.85

3.5

2.8

1.24

mmol/l

0.55

733

4881

Keratitis

1472

11555

1.30

18.84

4.5

3.7

1.22

1.23

mmol/l

1.33

1310

10055

Thyroiditis, ILD-related definition

482

3148

1.59

18.80

3.7

3.4

1.23

mmol/l

0.41

413

2715

Malignant neoplasm of breast, ER-negative, including Hilmo

908

6352

1.40

18.77

3.5

2.8

1.24

mmol/l

0.34

805

5289

Congenital malformations of cardiac septa

260

1399

1.88

18.75

3.9

4.0

1.22

1.23

mmol/l

0.84

245

1219

Idiopathic pulmonary fibrosis

370

2283

1.71

18.75

4.0

3.9

1.21

1.22

mmol/l

1.88

338

1986

Disorders of vitreous body and globe

2281

18064

1.23

18.74

4.7

3.8

1.23

mmol/l

0.49

1991

15710

Vitamin deficiency, wide

224

1198

1.98

18.61

5.3

3.4

1.22

1.23

mmol/l

2.31

206

1021

Vitamin deficiency

224

1198

1.98

18.61

5.3

3.4

1.22

1.23

mmol/l

2.31

206

1021

Mental and behavioural disorders due to cannabinoids

118

489

2.55

18.61

2.2

3.5

1.22

1.23

mmol/l

0.63

431

Pleural plaque with presence of asbestos

349

2127

1.73

18.60

3.7

4.4

1.21

1.22

mmol/l

1.01

302

1870

Other specified/unspecified inflammatory spondylopathies

206

1069

2.03

18.57

4.3

3.4

1.22

1.23

mmol/l

0.50

188

922

Simple and mucopurulent chronic bronchitis

204

1060

2.04

18.48

3.9

4.0

1.22

mmol/l

0.02

177

907

Other diseases of oesophagus

442

2850

1.62

18.42

4.9

3.9

1.22

1.23

mmol/l

1.14

390

2455

Chronic myeloproliferative disease

330

3.09

18.37

3.6

1.20

1.23

mmol/l

3.70

283

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

975

7164

1.37

18.33

4.7

3.4

1.23

mmol/l

0.11

840

6286

Spondyloarthritis

723

5131

1.44

18.31

4.7

3.8

1.22

1.23

mmol/l

0.74

659

4476

Autoimmune hyperthyroidism

265

1497

1.85

18.30

3.7

3.5

1.22

1.23

mmol/l

2.39

242

1295

Immunodeficiencies

217

1157

1.99

18.23

9.2

3.6

1.23

mmol/l

0.59

204

999

Non-Hodgkin lymphoma, all

199

1031

2.05

18.22

12.9

2.9

1.23

1.22

mmol/l

1.06

194

863

Injuries to the neck

892

6564

1.39

18.17

3.4

3.8

1.22

1.23

mmol/l

0.95

777

5761

Other arthrosis

2251

12812

1.23

18.11

3.7

1.23

mmol/l

0.41

1972

11150

Disorders of vitreous body

2216

17664

1.23

18.09

4.7

3.8

1.23

mmol/l

0.38

1939

15365

Urticaria

1167

8945

1.33

17.93

4.2

3.6

1.23

mmol/l

1.30

1004

7842

Spondylopathies (FG)

536

3612

1.53

17.90

3.7

1.23

mmol/l

0.07

484

3136

Seropositive rheumatoid arthritis, strict definition

664

4677

1.47

17.88

3.3

3.7

1.23

mmol/l

1.61

611

4073

Unspecified jaundice

232

1271

1.93

17.85

5.0

3.8

1.22

1.23

mmol/l

0.66

212

1080

Gonarthrosis,primary

4046

21547

1.17

17.82

3.6

4.0

1.23

mmol/l

0.19

3552

18853

Giant cell arteritis

223

1217

1.97

17.76

4.6

3.7

1.22

1.23

mmol/l

0.68

208

1041

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2216

17779

1.23

17.75

3.7

4.0

1.22

1.23

mmol/l

1.11

1944

15569

Haemorrhage in early pregnancy

1023

7504

1.35

17.67

3.0

3.3

1.23

mmol/l

0.50

878

6579

Superficial injury of hip and thigh

650

4564

1.47

17.66

4.3

3.8

1.22

1.23

mmol/l

0.51

583

3939

Ventral hernia

1076

8192

1.35

17.65

5.4

3.8

1.22

1.23

mmol/l

3.00

955

7103

severe traumatic brain injury, does not include concussion

971

7282

1.37

17.65

4.3

4.0

1.22

mmol/l

3.86

840

6323

Malignant neoplasm of pancreas, including Hilmo

359

2226

1.68

17.64

5.5

3.0

1.22

1.23

mmol/l

1.19

339

1881

Polyglandular dysfunction

8.42

17.62

17.2

3.0

1.21

1.23

mmol/l

0.66

Myocardial infarction, without ST-elevation

1813

13388

1.26

17.60

5.8

3.9

1.21

1.22

mmol/l

12.90

1629

11553

Mental retardation, excluding more controls

141

628

2.30

17.57

4.5

4.2

1.24

1.23

mmol/l

0.46

128

555

Focal epilepsy

868

6406

1.39

17.42

4.1

3.9

1.21

1.23

mmol/l

7.85

809

5585

Intentional self-harm by unspecified means

215

3.43

17.41

3.3

2.6

1.22

1.23

mmol/l

0.49

187

Pericarditis

167

827

2.15

17.36

7.1

3.4

1.22

1.23

mmol/l

1.22

161

709

Budesonide

541

3677

1.51

17.34

3.8

3.4

1.23

mmol/l

0.04

490

3165

Traumatic subarachnoid haemorrhage

175

882

2.11

17.34

3.9

3.7

1.22

1.23

mmol/l

0.67

154

759

Crohn's disease of large intestine

219

1188

1.94

17.33

5.4

3.5

1.22

1.23

mmol/l

1.16

193

1026

Manic episode

142

662

2.29

17.27

4.4

3.6

1.24

1.23

mmol/l

1.37

124

574

Unspecified acute lower respiratory infection

597

4141

1.48

17.27

5.1

3.6

1.22

mmol/l

2.90

561

3624

Other crystal arthropathies

118

516

2.54

17.20

4.8

3.3

1.22

1.23

mmol/l

0.53

109

438

Impotence

231

1281

1.90

17.12

6.5

4.7

1.21

mmol/l

1.16

204

1157

Aortic valve malfunction, age under 60 years

366

2297

1.66

17.07

5.5

4.4

1.21

1.22

mmol/l

2.26

331

2045

Hypertrophy of breast

699

5002

1.44

17.05

3.2

3.3

1.23

1.24

mmol/l

0.34

595

4378

Left ventricular outflow tract obstruction (LVOTO), broad definition

389

2477

1.63

17.03

5.4

4.4

1.22

mmol/l

2.44

353

2200

Myalgia

949

7121

1.36

17.03

3.7

3.5

1.23

mmol/l

1.16

842

6184

Chronic periodontitis, complicated

2330

19260

1.22

17.00

4.6

3.9

1.23

mmol/l

0.20

2052

16853

Other problems related to primary support group, including family circumstances

396

2455

1.61

16.99

5.9

3.4

1.23

mmol/l

0.03

349

2130

Osteomyelitis

285

1684

1.78

16.98

10.9

3.6

1.21

1.22

mmol/l

1.30

270

1449

Obsessive-compulsive disorder

221

1203

1.90

16.98

2.4

3.1

1.22

1.23

mmol/l

0.49

187

1040

Misadventures to patients during surgical and medical care

615

4313

1.47

16.93

6.8

3.6

1.22

1.23

mmol/l

2.63

574

3739

Eustachian salpingitis and obstruction

291

1723

1.75

16.91

3.7

3.4

1.22

1.23

mmol/l

2.15

260

1511

Other viral diseases, not elsewhere classified

690

4914

1.43

16.88

6.2

3.7

1.23

mmol/l

0.21

630

4328

Parkinson's disease, strict definition, excluding more controls

537

3491

1.51

16.84

2.9

3.9

1.23

mmol/l

0.39

458

2992

Malignant neoplasm of stomach, including Hilmo

256

1469

1.83

16.82

4.9

3.0

1.22

mmol/l

0.64

237

1239

Myocardial infarction, strict

1939

11277

1.24

16.78

5.6

3.7

1.22

1.23

mmol/l

17.85

1740

9697

Malignant neoplasm of rectum, including Hilmo

493

3317

1.54

16.78

4.6

3.1

1.22

1.23

mmol/l

0.90

442

2793

Other noninflammatory disorders of uterus, except cervix

992

5033

1.36

16.66

3.6

1.24

mmol/l

0.57

869

4351

Disorders of vestibular function (Vertigo)

2082

16939

1.23

16.66

3.7

3.8

1.23

mmol/l

0.50

1809

14724

Congenital malformations of the circulatory system

535

3548

1.50

16.61

3.9

4.0

1.22

1.23

mmol/l

0.67

488

3118

Other diseases of spinal cord

152

742

2.20

16.60

5.1

3.8

1.22

1.23

mmol/l

1.21

129

645

Irregular menses

1818

11668

1.25

16.58

3.5

3.2

1.23

mmol/l

1.62

1605

10117

Amenorrhoea

247

1404

1.82

16.53

4.2

2.8

1.23

mmol/l

0.16

226

1215

Fracture of forearm

2374

18196

1.21

16.48

4.2

3.7

1.23

mmol/l

1.63

2044

15837

Postprocedural disorders of nervous system

278

1639

1.76

16.48

3.3

3.2

1.22

1.23

mmol/l

0.98

252

1411

SLE (Finngen)

156

770

2.16

16.39

5.0

3.2

1.22

1.23

mmol/l

1.32

146

659

Oesophageal varices

194

1037

1.99

16.32

5.6

4.1

1.20

1.22

mmol/l

4.24

186

898

Ulcerative rectosigmoiditis

329

2034

1.68

16.31

4.0

3.6

1.23

mmol/l

0.06

299

1770

Malignant melanoma

574

4003

1.48

16.26

5.1

3.1

1.23

mmol/l

0.29

504

3365

Pure hypercholesterolaemia

3104

17295

1.18

16.23

4.5

3.2

1.23

mmol/l

3.84

2816

14865

All influenza (not pneumonia)

566

3932

1.48

16.19

6.3

3.2

1.22

1.23

mmol/l

0.31

519

3408

Dislocation, sprain and strain of joints and ligaments at neck level

553

3826

1.48

16.18

3.1

3.6

1.22

1.23

mmol/l

0.55

481

3348

Alcohol abuse, main dg

593

4159

1.46

16.17

4.7

4.0

1.21

1.22

mmol/l

7.75

535

3671

Congenital malformations of heart and great arteries

476

3099

1.53

16.17

3.8

4.1

1.22

1.23

mmol/l

0.61

440

2717

Other and unspecified types of non-Hodgkin lymphoma, hilmo

209

1150

1.94

16.16

8.4

4.0

1.23

1.22

mmol/l

0.45

202

992

Hypertrophy of breast in women and men

782

5750

1.39

16.16

3.4

1.23

mmol/l

0.20

673

5039

Nonorganic sleeping disorders

766

5610

1.40

16.14

4.0

3.6

1.22

1.23

mmol/l

1.86

680

4924

Benign neoplasm of thyroid gland

170

875

2.09

16.13

4.1

3.4

1.22

1.23

mmol/l

1.28

155

754

Candidiasis

1174

9148

1.31

16.10

5.1

3.6

1.22

1.23

mmol/l

1.99

1033

7927

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

271

1600

1.76

16.05

4.7

3.5

1.22

1.23

mmol/l

2.40

246

1382

Other viral diseases, not elsewhere classified

954

7185

1.34

15.98

5.3

3.6

1.23

mmol/l

0.13

876

6313

Malignant neoplasm of adrenal gland, including Hilmo

133

4.19

15.94

6.3

3.2

1.22

1.23

mmol/l

0.11

114

Hepatocellular carcinoma, including Hilmo

134

633

2.27

15.89

4.4

3.1

1.21

1.22

mmol/l

0.44

126

537

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

107

462

2.53

15.86

4.8

2.7

1.21

1.22

mmol/l

2.14

101

395

COPD, hospital admissions

1995

13939

1.23

15.85

4.8

4.0

1.21

1.23

mmol/l

16.31

1810

12044

Menorrhagia

1437

6312

1.28

15.82

3.4

1.23

mmol/l

0.16

1241

5468

Other disorders of nervous system

299

1826

1.72

15.80

5.4

4.0

1.22

1.23

mmol/l

0.45

259

1584

Fitting and adjustment of other devices

1519

11025

1.27

15.77

3.1

2.9

1.23

mmol/l

0.13

1442

9281

Pain in thoracic spine

626

4459

1.44

15.69

3.8

3.6

1.23

mmol/l

0.11

571

3898

Malignant neoplasm of respiratory system and intrathoracic organs

837

5182

1.38

15.66

5.6

3.1

1.23

1.22

mmol/l

1.25

794

4343

Essential (haemorrhagic) thrombocythaemia

167

861

2.06

15.60

3.4

2.9

1.22

1.23

mmol/l

0.55

141

718

Superficial injury of thorax

609

4325

1.45

15.59

5.3

3.8

1.22

1.23

mmol/l

0.84

542

3791

Viral warts

387

2514

1.59

15.55

8.7

3.5

1.22

1.23

mmol/l

0.94

354

2185

Alcohol-induced chronic pancreatitis

269

1606

1.76

15.46

5.9

4.5

1.21

1.22

mmol/l

1.43

253

1425

Redundant prepuce, phimosis and paraphimosis

702

5051

1.40

15.40

5.1

4.3

1.22

mmol/l

0.35

623

4516

Fracture of foot, except ankle

941

7159

1.34

15.40

4.5

3.8

1.22

1.23

mmol/l

1.88

818

6280

Right side

165

4.07

15.39

3.1

4.3

1.24

1.23

mmol/l

1.31

149

Extrapyramidal and movement disorders

1662

13561

1.25

15.39

3.5

3.9

1.23

mmol/l

0.04

1420

11779

Excessive vomiting in pregnancy

302

1856

1.68

15.29

3.0

1.23

mmol/l

0.64

260

1617

Neuromuscular dysfunction of bladder

388

2536

1.59

15.29

5.3

3.8

1.22

1.23

mmol/l

2.09

333

2214

Other abnormalities of plasma proteins

392

2.67

15.26

10.1

4.0

1.21

1.22

mmol/l

1.46

338

Other pulmonary heart/vessel disease

220

1251

1.86

15.20

5.9

3.5

1.21

1.22

mmol/l

1.90

204

1065

Seborrhoeic dermatitis

400

2636

1.57

15.16

6.5

3.8

1.22

mmol/l

0.59

349

2315

Ulcerative colitis (strict definition, all Crohn cases excluded)

538

3753

1.47

15.14

3.3

3.8

1.23

mmol/l

0.02

478

3292

Left side

128

4.66

15.13

2.6

4.7

1.23

1.22

mmol/l

0.69

108

Secondary right heart disease

204

1138

1.91

15.08

5.5

3.3

1.21

1.23

mmol/l

2.46

189

967

Endometriosis of pelvic peritoneum

608

4128

1.44

15.07

2.9

3.4

1.23

mmol/l

1.32

507

3625

Spirochaetal infections, other/unspecified

124

2502

0.48

15.03

3.0

3.9

1.22

1.23

mmol/l

0.42

110

2185

Other coagulation defects

308

1916

1.67

15.01

5.4

3.3

1.22

1.23

mmol/l

2.22

281

1652

Other blood glucose lowering drugs, excl. Insulins

707

5189

1.40

15.01

5.3

3.9

1.22

1.23

mmol/l

3.52

614

4476

COPD, early/later onset

2003

14034

1.22

14.99

4.9

4.0

1.21

1.23

mmol/l

16.22

1817

12125

Abnormalities of gait and mobility

514

3577

1.49

14.91

3.8

4.0

1.22

1.23

mmol/l

0.45

436

3114

Renal agenesis and other reduction defects of kidney

4.87

14.89

15.5

4.4

1.21

1.22

mmol/l

0.45

Non-small cell lung cancer

409

2695

1.55

14.85

5.2

3.1

1.23

1.22

mmol/l

1.11

388

2275

Malignant neoplasm of head and neck

313

1958

1.66

14.84

5.1

3.1

1.23

1.22

mmol/l

0.22

291

1660

Pneumonitis due to solids and liquids

360

2331

1.60

14.82

5.5

3.9

1.21

1.22

mmol/l

2.38

328

2021

Malignant neoplasm of adrenal gland

5.62

14.80

6.7

3.7

1.24

1.22

mmol/l

0.86

Premature rupture of membranes

714

3720

1.40

14.79

2.6

3.3

1.23

mmol/l

0.35

615

3261

Other gastritis (incl. Duodenitis)

990

7641

1.33

14.78

5.2

3.7

1.22

1.23

mmol/l

3.47

906

6587

Shoulder lesions

3333

17455

1.17

14.70

3.8

1.23

mmol/l

0.02

2975

15232

Superficial injury of head

962

7391

1.33

14.69

3.6

3.7

1.23

mmol/l

0.43

851

6418

Diabetes mellitus in pregnancy

1008

4938

1.32

14.63

2.9

3.1

1.22

1.23

mmol/l

3.82

852

4355

Family history of malignant neoplasm

420

2813

1.54

14.62

3.8

3.1

1.23

mmol/l

0.03

379

2458

Heterophoria

311

1952

1.65

14.54

5.1

3.5

1.22

1.23

mmol/l

0.93

272

1682

Early onset COPD

900

6872

1.34

14.54

5.1

4.1

1.21

1.23

mmol/l

6.06

821

6041

Cerebral cysts

236

1383

1.78

14.47

5.1

3.5

1.22

mmol/l

0.85

214

1182

Pneumonia due to Streptococcus pneumoniae

181

982

1.94

14.43

6.1

3.4

1.22

mmol/l

0.33

164

835

Use of disulfiram, acamprosate or naltrexone

329

2097

1.62

14.42

3.8

4.4

1.22

mmol/l

0.02

299

1873

Visual disturbances

2035

17035

1.21

14.39

4.1

3.8

1.22

1.23

mmol/l

3.98

1825

14788

Acidosis

110

503

2.38

14.34

11.4

3.1

1.19

1.22

mmol/l

3.97

104

437

Thiazolidinediones

493

3434

1.49

14.29

5.0

3.9

1.22

1.23

mmol/l

1.72

424

3006

Superficial injury of lower leg

992

7684

1.32

14.27

4.6

3.6

1.22

1.23

mmol/l

2.55

884

6678

Scabies

184

1006

1.92

14.27

6.7

3.9

1.22

mmol/l

0.53

166

880

Focal epilepsy, mode (most common among epilepsy diagnosis)

752

5607

1.37

14.26

4.3

4.0

1.22

1.23

mmol/l

6.03

704

4889

Anorexia (incl.atypical)

214

1220

1.82

14.26

4.1

3.2

1.22

1.23

mmol/l

0.24

186

1053

Other and unspecified follicular disorders

175

945

1.96

14.23

6.8

3.5

1.23

mmol/l

0.29

160

816

Colon adenocarcinoma

482

3343

1.49

14.19

4.4

3.1

1.22

1.23

mmol/l

0.63

439

2809

COPD related to multimorbidity

1738

12111

1.23

14.15

5.1

4.0

1.21

1.22

mmol/l

15.86

1580

10455

Folate deficiency anaemia

196

3.35

14.12

8.2

4.2

1.20

1.23

mmol/l

2.15

172

Use of biperiden

227

1328

1.79

14.12

3.7

3.9

1.23

mmol/l

0.52

193

1160

Cyst of kidney

320

2047

1.64

14.09

5.4

3.7

1.23

1.22

mmol/l

0.95

292

1789

Focal epilepsy, strict definition

790

5945

1.36

14.08

4.1

4.0

1.22

1.23

mmol/l

5.66

737

5180

Osteonecrosis due to drugs

353

2.70

14.02

14.9

3.8

1.23

mmol/l

0.44

311

Malignant cancer of tonsil and base of tongue, including Hilmo

107

487

2.36

13.97

5.1

3.3

1.24

1.22

mmol/l

1.08

101

407

Thoracic aortic aneurysm

597

4317

1.43

13.97

5.0

3.8

1.22

mmol/l

1.27

538

3787

Carpal tunnel syndrome

2617

19744

1.18

13.95

3.7

3.8

1.23

mmol/l

1.19

2298

17191

Wide developmental disorders

109

496

2.29

13.83

3.2

4.2

1.22

1.23

mmol/l

1.15

435

Scoliosis

345

2245

1.59

13.82

3.3

1.23

mmol/l

0.44

307

1914

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1336

10703

1.26

13.81

3.7

3.6

1.22

1.23

mmol/l

1.23

1160

9424

Malignant neoplasm of oropharynx, including Hilmo

414

2.48

13.78

5.0

3.4

1.25

1.22

mmol/l

1.46

356

Cardiomyopathy, other and unspecified

322

2069

1.62

13.74

5.8

3.5

1.21

1.23

mmol/l

6.48

301

1776

Other inflammatory liver diseases

280

1743

1.68

13.72

5.4

3.8

1.22

1.23

mmol/l

0.74

259

1505

Oxicams

1062

4687

1.31

13.72

3.1

4.7

1.22

mmol/l

0.46

930

4142

Malignant neoplasm of stomach

214

1241

1.80

13.67

4.4

3.1

1.22

mmol/l

0.68

197

1047

6-mercaptopurine

126

613

2.16

13.66

3.3

3.1

1.22

1.23

mmol/l

0.78

112

510

Unspecified/other endometriosis

328

2112

1.60

13.64

2.8

3.0

1.23

mmol/l

0.03

276

1849

Cardiac arrest

246

1256

1.73

13.59

6.3

2.9

1.21

1.23

mmol/l

7.72

221

1033

Presence of cardiac and vascular implants and grafts

1776

10929

1.22

13.58

4.8

3.7

1.22

1.23

mmol/l

8.24

1648

9538

Memory loss

155

2816

0.53

13.53

3.8

3.9

1.23

mmol/l

0.03

135

2471

Pyoderma gangrenosum

159

3.60

13.52

4.1

3.8

1.22

mmol/l

0.30

134

Orchitis and epididymitis

348

2279

1.58

13.51

5.1

4.4

1.22

mmol/l

0.73

307

2033

Malignant neoplasm of other connective and soft tissue, including Hilmo

177

976

1.91

13.50

7.4

2.9

1.23

mmol/l

0.60

159

815

Idiopathic thrombocytopenic purpura

143

738

2.07

13.46

4.8

3.3

1.22

1.23

mmol/l

0.86

128

635

Status epilepticus

164

884

1.96

13.44

5.7

3.5

1.21

1.23

mmol/l

4.22

155

763

Any event in hilmo or specialist outpatient

24.93

13.42

4.1

1.4

1.21

1.23

mmol/l

—

Systemic sclerosis (FG)

119

576

2.23

13.41

3.7

3.5

1.23

1.24

mmol/l

1.11

110

486

Gastroduodenal ulcer

1158

9200

1.28

13.39

6.1

3.8

1.22

1.23

mmol/l

2.77

1061

7873

Other disorders of conjunctiva

612

4479

1.41

13.33

4.1

4.0

1.23

mmol/l

0.14

547

3921

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

260

1597

1.69

13.33

3.7

3.5

1.23

mmol/l

0.06

228

1392

Temporal arteritis

189

1076

1.88

13.25

4.7

3.7

1.22

1.23

mmol/l

1.61

177

925

Polyneuropathies and other disorders of the peripheral nervous system

908

7037

1.32

13.24

6.7

4.0

1.22

mmol/l

2.30

816

6140

Oter anti-inflammatory and antirheumatic agents, non-steroids

1027

4405

1.31

13.23

3.5

4.7

1.22

mmol/l

0.01

904

3899

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

382

2568

1.54

13.20

4.6

3.1

1.22

mmol/l

1.31

341

2177

Other overlap syndromes

430

2.44

13.20

3.8

3.6

1.22

1.23

mmol/l

0.70

374

Noninflammatory disorders of female genital tract

1691

6965

1.23

13.20

3.5

3.3

1.23

mmol/l

0.38

1456

6002

Disorders of synovium and tendon

2184

16202

1.19

13.20

3.9

3.7

1.23

mmol/l

0.32

1894

14131

Carcinoma in situ of skin

398

2710

1.53

13.19

6.0

3.7

1.22

1.23

mmol/l

0.38

339

2353

Artificial opening status

226

1348

1.76

13.12

7.7

3.7

1.21

1.23

mmol/l

2.60

208

1179

Acute suppurative otitis media

851

6078

1.33

13.12

4.4

3.5

1.22

mmol/l

1.73

754

5296

Renal agenesis and other reduction defects of kidney

113

4.17

13.06

14.8

3.9

1.21

1.23

mmol/l

0.62

Pyogenic arthritis

278

1747

1.65

13.05

7.0

3.9

1.22

mmol/l

0.97

257

1526

Symptoms and signs involving the skin and subcutaneous tissue

2974

25301

1.16

13.03

4.5

3.7

1.23

mmol/l

0.68

2693

22015

Acetic acid derivatives and related substances

1219

5021

1.28

13.02

3.4

4.7

1.22

mmol/l

0.12

1044

4422

Hepatocellular carcinoma

450

2.37

13.01

5.2

3.1

1.21

1.22

mmol/l

0.89

378

Chorioretinal inflammation

132

670

2.10

13.01

4.1

3.6

1.23

mmol/l

0.14

116

583

Acne

310

1987

1.59

12.99

5.9

3.1

1.22

1.23

mmol/l

0.17

268

1707

Cholecystitis

590

4308

1.41

12.94

4.2

3.8

1.22

1.23

mmol/l

1.00

528

3717

Polycythaemia vera

151

804

1.99

12.94

3.0

2.9

1.21

1.23

mmol/l

2.12

125

667

Monoamine oxidase A inhibitors

465

3259

1.47

12.93

4.0

3.8

1.23

mmol/l

0.08

390

2894

Gestational diabetes (for exclusion)

1148

6330

1.28

12.92

2.6

3.1

1.22

1.23

mmol/l

5.70

970

5580

Malignant neoplasm of liver and intrahepatic bile ducts

126

630

2.13

12.91

5.6

3.1

1.21

1.22

mmol/l

1.23

116

533

Other and unspecified injuries of lower leg

297

1900

1.62

12.89

4.3

3.4

1.23

mmol/l

0.40

261

1640

Lymphoid leukaemia

247

1518

1.71

12.88

5.5

4.0

1.22

mmol/l

0.15

231

1322

Disorders of muscles

404

2759

1.51

12.87

4.2

3.8

1.22

1.23

mmol/l

0.15

352

2405

Type 1 diabetes, strict definition, subgroup 1

221

1307

1.73

12.77

3.7

3.2

1.22

1.23

mmol/l

0.42

180

1135

Myelodysplastic syndrome, including Hilmo

133

682

2.08

12.74

4.7

3.0

1.20

1.22

mmol/l

3.43

125

567

Focal brain injury

250

1537

1.68

12.73

3.5

4.0

1.21

1.22

mmol/l

3.13

217

1341

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

175

983

1.89

12.72

4.6

3.7

1.22

1.23

mmol/l

0.56

156

838

Malignant neoplasm, without specification of site, including Hilmo

193

1110

1.82

12.69

5.5

2.9

1.23

mmol/l

0.44

180

923

Malignant neoplasm of rectum

369

2487

1.53

12.62

4.6

3.1

1.22

mmol/l

1.56

328

2121

Symptoms and signs involving emotional state

131

669

2.07

12.61

4.2

3.5

1.22

1.23

mmol/l

0.21

124

578

Giant cell arteritis with polymyalgia rheumatica

189

1093

1.85

12.59

4.7

3.7

1.22

1.23

mmol/l

1.52

177

940

Dermatitis due to substances taken internally

231

1401

1.72

12.58

6.6

3.4

1.22

1.23

mmol/l

1.26

203

1214

Neuroendocrine tumor and carcinoma of small intestine

284

2.76

12.57

4.6

2.5

1.22

mmol/l

0.64

236

Inflammatory diseases of prostate (prostatitis)

467

3293

1.46

12.54

3.9

4.5

1.21

mmol/l

0.22

399

2921

Pre-eclampsia or poor fetal growth

1039

8196

1.28

12.53

3.5

3.1

1.23

mmol/l

0.14

910

7154

Psoriasis (vulgaris), strict definition

138

720

2.02

12.49

3.3

4.1

1.22

1.23

mmol/l

0.59

124

632

Other bacterial intestinal infections

755

5752

1.34

12.48

9.4

3.6

1.22

1.23

mmol/l

6.13

690

4969

Hypermetropia

272

1718

1.64

12.45

5.5

3.9

1.23

mmol/l

0.88

226

1483

Presence of other devices

559

7577

0.72

12.45

2.7

3.6

1.23

mmol/l

0.92

537

6580

Schizotypal disorder

458

2.30

12.39

2.6

4.1

1.22

1.23

mmol/l

0.35

403

Dronedarone medication

147

791

2.00

12.38

2.8

3.5

1.22

1.23

mmol/l

0.48

123

686

Benign intracranial hypertension

166

3.30

12.38

4.8

2.8

1.22

mmol/l

0.02

141

Hernia

4049

24079

1.14

12.37

4.3

3.7

1.22

1.23

mmol/l

3.55

3592

20999

Visual field defects

363

2454

1.53

12.35

4.4

3.9

1.22

1.23

mmol/l

1.19

325

2127

Thyrotoxicosis with toxic multinodular goitre

285

1835

1.63

12.33

4.0

3.6

1.23

mmol/l

0.42

255

1583

Acne vulgaris

247

1523

1.66

12.30

5.5

3.0

1.22

1.23

mmol/l

0.50

219

1308

Hidradenitis suppurativa

144

765

1.98

12.29

4.9

3.3

1.22

1.23

mmol/l

0.83

126

662

Mycoses

1067

8509

1.28

12.27

6.1

3.7

1.22

1.23

mmol/l

1.06

959

7427

Disorders of tooth development and eruption

586

3464

1.39

12.27

4.5

3.0

1.23

mmol/l

0.25

523

3047

Enterocolitis due to Clostridium difficile

460

3255

1.46

12.25

11.8

3.6

1.21

1.23

mmol/l

5.18

419

2810

Arthropod-borne viral fevers and viral haemorrhagic fevers

378

2578

1.52

12.25

4.1

1.22

mmol/l

0.09

343

2255

Autism

413

2.34

12.24

2.8

3.9

1.22

mmol/l

0.79

360

Acute lymphadenitis

227

1379

1.71

12.21

6.5

3.3

1.22

1.23

mmol/l

0.46

206

1187

Other enthesopathies

1185

9562

1.26

12.19

3.5

3.6

1.23

mmol/l

0.62

1059

8348

Visual disturbances and blindness

2166

18498

1.18

12.13

4.1

3.8

1.22

1.23

mmol/l

3.43

1936

16044

Melanocytic naevi, other sites/unspecified

315

2073

1.57

12.12

6.8

3.6

1.23

mmol/l

0.26

281

1812

Adenocarcinoma and papilloma adenocarcinoma of rectum

363

2460

1.52

12.10

4.7

3.2

1.22

mmol/l

1.54

327

2086

Type 1 diabetes, strict definition

235

1434

1.68

12.07

3.8

3.2

1.22

1.23

mmol/l

0.36

193

1247

Persistent mood disorders

738

5628

1.34

12.04

3.8

3.6

1.22

1.23

mmol/l

2.25

642

4946

Non-small cell lung cancer, adenocarcinoma

249

1558

1.67

12.02

5.7

3.1

1.22

1.23

mmol/l

0.09

237

1313

Malignant neoplasm of other connective and soft tissue

108

525

2.20

12.01

9.0

2.9

1.23

1.22

mmol/l

0.72

102

431

Juvenile arthritis (FINNGEN)

160

883

1.88

12.01

3.8

3.1

1.22

1.23

mmol/l

0.86

141

750

Mental retardation

141

744

1.97

11.99

4.5

4.6

1.24

1.23

mmol/l

0.35

128

658

Malignant neoplasm of pancreas

272

1738

1.63

11.98

6.0

3.1

1.22

1.23

mmol/l

0.94

256

1465

Malignant neoplasm of bronchus and lung

722

4547

1.35

11.98

5.5

3.1

1.23

1.22

mmol/l

2.61

684

3821

Other symptoms and signs involving general sensations and perceptions

186

1082

1.81

11.95

4.0

3.6

1.23

mmol/l

0.01

156

924

Disorders of pituitary gland, other and/or unspecified

125

3.81

11.94

5.5

3.1

1.21

1.23

mmol/l

0.77

110

Malignant neoplasm of tonsil, including Hilmo

333

2.53

11.91

5.3

3.4

1.25

1.22

mmol/l

1.13

287

Universal erythroderma, KELA reimbursement

316

2.60

11.89

5.3

4.6

1.21

1.22

mmol/l

0.50

283

COPD, hospital admission 2, with asthma infections

1377

9697

1.24

11.85

5.1

3.9

1.21

1.22

mmol/l

15.10

1266

8376

Other specified/unspecified soft tissue disorders

223

1365

1.71

11.80

3.5

3.6

1.23

mmol/l

0.30

190

1149

Chronic iridocyclitis

207

1243

1.74

11.77

4.1

3.6

1.23

mmol/l

0.01

186

1067

Other viral hepatitis

222

1353

1.70

11.76

4.5

3.8

1.21

1.23

mmol/l

2.95

200

1173

Other and unspecified mood [affective] disorders

238

1474

1.66

11.73

4.7

3.3

1.23

mmol/l

0.35

211

1290

Sleep disorders, other/unspecified

135

713

1.98

11.73

3.5

3.6

1.22

1.23

mmol/l

1.64

112

625

Mixed connective tissue disease

265

1694

1.63

11.72

4.2

3.6

1.23

mmol/l

0.66

245

1468

Use of other anti-dementia drugs

1242

8384

1.25

11.66

2.7

3.9

1.23

1.22

mmol/l

3.64

1002

7232

Use of memantine

1242

8384

1.25

11.66

2.7

3.9

1.23

1.22

mmol/l

3.64

1002

7232

Benign neoplasm of other and ill-defined parts of digestive system

754

5808

1.33

11.64

4.9

3.9

1.23

mmol/l

0.32

685

5061

Continuous positive airway pressure

312

3925

0.66

11.61

4.3

3.3

1.23

mmol/l

0.51

296

3329

Peritonsillar abscess

760

5845

1.32

11.60

3.9

3.8

1.23

1.22

mmol/l

0.37

668

5155

Crohn disease (strict definition, require KELA)

239

1492

1.66

11.55

3.7

3.6

1.23

mmol/l

0.01

209

1298

Malignant neoplasm of corpus uteri, including Hilmo

403

2820

1.48

11.55

3.3

2.9

1.24

mmol/l

0.23

349

2303

Crohn disease (strict definition, require KELA, min 2 HDR)

236

1470

1.66

11.51

3.7

3.6

1.23

mmol/l

0.00

207

1280

Chronic viral hepatitis

187

1096

1.77

11.50

4.7

3.7

1.20

1.23

mmol/l

4.82

167

959

Polyuria

916

7238

1.29

11.48

3.9

3.7

1.22

mmol/l

0.02

790

6312

Symptoms and signs involving speech and voice

1379

11388

1.23

11.47

4.2

3.7

1.22

1.23

mmol/l

4.98

1204

9897

Tobacco use

209

1266

1.72

11.47

4.2

3.8

1.22

mmol/l

0.68

189

1102

Abnormal blood-pressure reading, without diagnosis

185

1084

1.78

11.47

3.1

3.5

1.23

mmol/l

0.69

159

922

Alcoholic liver disease

395

2754

1.48

11.44

5.7

4.3

1.20

1.22

mmol/l

8.24

370

2452

Diseases of inner ear

2329

19445

1.17

11.41

3.7

3.8

1.23

mmol/l

0.01

2020

16930

Fracture of skull and facial bones

792

6143

1.31

11.39

3.7

3.9

1.22

1.23

mmol/l

1.21

706

5384

Pediculosis, acariasis and other infestations

566

4187

1.38

11.36

4.5

3.7

1.23

mmol/l

0.01

511

3668

Migraine without aura and triptan purchases

529

3870

1.39

11.33

3.0

3.5

1.23

mmol/l

0.88

474

3396

Malignant neoplasm of rectosigmoid junction, including Hilmo

122

633

2.04

11.32

4.5

2.9

1.22

mmol/l

0.16

114

523

Malignant cancer of tonsil and base of tongue

398

2.35

11.32

5.5

3.3

1.24

1.22

mmol/l

1.00

336

Malignant neoplasm of mesothelium and soft tissue

163

927

1.85

11.31

8.0

2.9

1.23

mmol/l

0.17

153

776

Alcohol withdrawal state with delirium

269

1739

1.61

11.30

4.6

4.5

1.20

1.22

mmol/l

4.53

243

1548

Disorders of phosphorus metabolism and phosphatases

105

4.05

11.28

12.6

3.3

1.23

mmol/l

0.05

Enteropathic arthropathies

100

483

2.20

11.28

2.9

3.3

1.24

1.23

mmol/l

0.28

405

Anisometropia and aniseikonia

140

762

1.95

11.27

4.7

3.8

1.23

mmol/l

0.03

107

662

Autism spe

402

2.29

11.26

2.5

3.4

1.22

1.23

mmol/l

0.94

354

Systemic lupus erythematosus

156

878

1.87

11.25

5.0

3.4

1.22

1.23

mmol/l

0.91

146

744

Unspecified misadventure during surgical and medical care

235

1477

1.66

11.24

6.4

3.7

1.22

1.23

mmol/l

0.71

227

1284

Drug-induced interstitial lung disorders, unspecified

6.54

11.21

5.8

3.8

1.22

1.23

mmol/l

0.20

Other and unspecified polyneuropathies, also in other diseases

788

6136

1.31

11.19

7.1

4.0

1.22

mmol/l

2.03

707

5360

Malignant neoplasm of tonsil

281

2.63

11.19

5.5

3.1

1.25

1.22

mmol/l

0.89

242

Calcific tendinitis of shoulder

236

1483

1.65

11.19

3.3

3.9

1.23

mmol/l

0.27

211

1289

Leiomyoma of uterus

2616

12857

1.17

11.19

3.6

3.3

1.24

mmol/l

0.78

2245

11223

Other bursopathies

545

4029

1.39

11.16

4.3

3.8

1.23

mmol/l

0.46

474

3505

Postviral fatigue syndrome

134

3.45

11.15

2.7

2.8

1.22

mmol/l

0.28

111

Other juvenile arthritis

138

745

1.92

11.15

3.6

3.1

1.22

1.23

mmol/l

0.76

120

633

Peripheral artery disease

1920

13004

1.19

11.14

7.3

3.7

1.21

1.23

mmol/l

19.01

1723

11205

Car occupant injured in other and unspecified transport accidents

680

5185

1.34

11.12

3.9

3.7

1.23

mmol/l

0.15

600

4531

Chronic tubulo-interstitial nephritis

168

969

1.82

11.11

12.4

3.0

1.22

1.23

mmol/l

1.25

156

817

Systemic sclerosis

119

619

2.06

11.10

3.7

3.5

1.23

mmol/l

0.61

110

534

Unspecified chronic bronchitis

159

902

1.85

11.09

4.5

3.9

1.22

mmol/l

0.33

140

771

Abnormal reflex

106

3.96

11.08

4.2

3.9

1.21

1.23

mmol/l

1.05

Psoriasis vulgaris

712

5472

1.33

11.08

4.1

4.0

1.23

mmol/l

0.14

636

4822

Non-seminoma of testis, including Hilmo

4.46

11.05

5.2

2.3

1.23

1.22

mmol/l

0.28

Other sexually transmitted chlamydial diseases

1261

0.38

11.05

2.4

2.8

1.23

1.22

mmol/l

0.16

1071

Hypermobility syndrome

194

1162

1.73

11.05

2.7

3.1

1.23

mmol/l

0.23

164

997

Disorders of continuity of bone

368

2547

1.49

11.04

5.8

3.4

1.23

mmol/l

0.24

336

2206

Chronic sinusitis

1729

14602

1.20

11.04

3.7

3.8

1.23

mmol/l

1.07

1509

12728

Chronic hepatitis, not elsewhere classified

150

841

1.88

10.98

4.2

3.4

1.22

1.23

mmol/l

0.95

140

719

Strabismus

987

7881

1.27

10.97

4.5

3.8

1.23

mmol/l

0.48

862

6900

Corneal ulcer

693

5313

1.33

10.95

4.7

3.8

1.22

1.23

mmol/l

0.85

618

4669

Disorders of optic nerve and visual pathways

355

2445

1.49

10.94

5.6

3.7

1.22

1.23

mmol/l

1.01

317

2123

Fracture of lower leg, including ankle

2279

19507

1.17

10.90

4.6

3.7

1.22

1.23

mmol/l

2.61

2004

16973

Mumps

112

573

2.07

10.84

3.6

3.7

1.23

mmol/l

0.07

102

504

Striae atrophicae

220

2.84

10.83

5.2

3.3

1.23

mmol/l

0.24

184

Other secondary gonarthrosis

233

1476

1.65

10.82

3.9

4.2

1.23

mmol/l

0.35

208

1288

Any dementia

1778

10461

1.20

10.78

3.4

4.0

1.23

mmol/l

0.81

1466

9049

Degenerative macular diseases

531

3939

1.39

10.78

4.3

3.8

1.22

1.23

mmol/l

1.74

453

3437

Superficial injury of forearm

356

2458

1.49

10.78

3.4

3.6

1.23

mmol/l

0.10

316

2139

Other fall from one level to another

811

6354

1.30

10.78

4.1

4.0

1.23

1.22

mmol/l

0.34

715

5570

Monoarthritis, not elsewhere classified

177

1044

1.77

10.78

5.8

3.6

1.23

mmol/l

0.01

154

899

Other intervertebral disc disorders

3456

18433

1.14

10.73

3.5

3.8

1.23

mmol/l

1.90

3028

16105

Pediculosis, acariasis and other infestations

222

1389

1.66

10.69

6.5

4.0

1.22

1.23

mmol/l

0.42

201

1221

Papilloedema, unspecified

102

508

2.14

10.68

7.4

3.3

1.22

1.23

mmol/l

1.45

438

Synovial cyst of popliteal space [Baker]

321

2184

1.52

10.66

3.8

1.24

1.23

mmol/l

1.05

287

1867

Kyphosis

340

2.45

10.63

5.4

3.2

1.23

mmol/l

0.06

295

Bacterial intestinal infections, IBD co-morbidities

750

5841

1.31

10.61

9.4

3.8

1.22

1.23

mmol/l

5.68

685

5070

Malignant neoplasm of oropharynx

313

2.48

10.60

5.4

3.1

1.25

1.22

mmol/l

1.01

267

Primary gonarthrosis, bilateral

2254

16711

1.17

10.59

3.7

4.0

1.23

mmol/l

0.04

1953

14521

Lichen simplex chronicus and prurigo

262

1713

1.59

10.54

6.6

3.5

1.21

1.23

mmol/l

3.05

234

1489

Laparoscopic right hemicolectomy

261

1711

1.60

10.54

3.8

4.0

1.23

mmol/l

0.00

235

1490

Enthesopathies of lower limb, excluding foot

851

6734

1.29

10.49

3.3

3.7

1.23

mmol/l

0.05

741

5881

L02BA Anti-estrogens

685

5289

1.33

10.43

5.2

3.4

1.24

mmol/l

0.16

645

4555

Viral hepatitis

253

1641

1.59

10.40

4.6

3.8

1.21

1.23

mmol/l

2.21

226

1437

Idiopathic gout

384

2719

1.46

10.35

7.0

4.0

1.21

1.22

mmol/l

1.05

355

2387

Lateral epicondylitis

493

3631

1.39

10.30

3.0

3.8

1.23

mmol/l

0.86

431

3195

Chronic Coagulation defects

103

522

2.09

10.26

5.8

3.3

1.22

1.23

mmol/l

0.39

444

Gastrointestinal stromal tumor and sarcoma

233

2.75

10.26

2.9

2.5

1.23

1.22

mmol/l

0.53

193

Suppurative and unspecified otitis media

1233

8997

1.23

10.25

4.2

3.5

1.22

1.23

mmol/l

2.24

1077

7868

Maternal care for cervical incompetence

169

1001

1.77

10.25

3.6

3.1

1.24

mmol/l

0.07

148

850

conjunctival haemorrhage

323

2222

1.51

10.21

4.2

3.9

1.23

mmol/l

0.09

290

1937

Open wound of lower leg

595

4518

1.35

10.18

5.3

3.7

1.22

1.23

mmol/l

1.24

544

3899

Hyperprolactinaemia

129

705

1.91

10.15

3.9

2.6

1.23

mmol/l

0.32

114

602

Female genital prolapse

1225

5677

1.24

10.13

3.2

3.5

1.24

mmol/l

0.35

1054

4933

Speech disturbances, not elsewhere classified

377

2671

1.46

10.12

4.3

3.7

1.22

1.23

mmol/l

1.24

339

2319

261

2.53

10.11

7.4

2.6

1.22

1.23

mmol/l

0.90

218

Astigmatism

222

1406

1.63

10.10

6.1

3.8

1.23

mmol/l

0.34

189

1201

Otitis externa, unspecified

417

3001

1.43

10.10

5.1

3.8

1.23

mmol/l

0.01

359

2620

Leiomyosarcoma, including Hilmo

188

2.95

10.08

6.7

2.6

1.24

1.22

mmol/l

1.23

156

Abnormal findings in cerebrospinal fluid

4.96

10.04

7.1

3.8

1.22

1.23

mmol/l

0.31

Systemic sclerosis, icd10

117

627

2.00

10.04

3.7

3.5

1.23

mmol/l

0.72

108

542

Hypertensive Heart Disease

892

5570

1.27

10.01

6.7

3.3

1.22

1.23

mmol/l

4.34

811

4682

SLE, strict definition

150

866

1.83

10.00

5.0

3.4

1.22

1.23

mmol/l

0.88

141

739

SLE, ICD10

150

866

1.83

10.00

5.0

3.4

1.22

1.23

mmol/l

0.88

141

739

Bronchiectasis

347

2432

1.48

9.96

5.0

3.8

1.22

1.23

mmol/l

2.13

314

2103

Biological medicines for asthma

393

2.25

9.94

2.9

3.4

1.23

mmol/l

0.07

352

Assault by unspecified means

366

2.28

9.89

3.9

1.20

1.23

mmol/l

1.95

325

Malignant melanoma of skin, including Hilmo

533

4001

1.36

9.88

4.8

3.1

1.23

mmol/l

0.48

473

3371

Adenocarcinoma and ductal carcinoma of pancreas

137

772

1.87

9.88

6.2

3.0

1.21

1.22

mmol/l

1.00

125

642

Congenital malformations of the musculoskeletal system, not elsewhere classified

335

2.35

9.87

2.4

3.4

1.22

mmol/l

0.06

287

Urethral stricture

232

1499

1.61

9.85

5.9

4.4

1.22

mmol/l

0.00

198

1330

Other strabismus

780

6134

1.29

9.83

4.3

3.7

1.23

mmol/l

0.45

681

5375

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

152

861

1.78

9.80

5.1

3.6

1.23

mmol/l

0.12

136

741

Mixed hyperlipidaemia

172

1038

1.74

9.73

8.1

3.3

1.21

1.23

mmol/l

1.68

153

896

Abnormal involuntary movements

508

3798

1.37

9.71

4.5

3.8

1.22

1.23

mmol/l

0.27

435

3311

Poisoning by narcotics and psychodysleptics [hallucinogens]

280

2.47

9.69

5.0

3.2

1.20

1.22

mmol/l

1.65

239

Other shoulder lesions

359

2537

1.45

9.67

4.3

3.7

1.23

mmol/l

0.49

320

2204

Acute laryngitis and tracheitis

363

2520

1.44

9.64

4.2

3.5

1.22

1.23

mmol/l

1.35

312

2181

Carcinoma in situ of breast, other/unspecified

396

2.28

9.64

4.1

3.5

1.24

mmol/l

0.37

339

Other maternal disorders predominantly related to pregnancy

2095

11351

1.17

9.56

3.2

3.3

1.23

mmol/l

2.02

1802

9890

Other/unspecified rheumatoid arthritis

526

3969

1.36

9.56

4.1

3.7

1.23

mmol/l

0.13

484

3420

Social phobias

247

1620

1.56

9.55

3.1

3.2

1.22

1.23

mmol/l

0.85

197

1413

Mental retardation, wide definition

144

824

1.81

9.52

4.5

4.6

1.24

1.23

mmol/l

0.56

131

727

Lumbar disc prolapse

2580

17393

1.15

9.50

3.5

3.8

1.23

mmol/l

0.83

2254

15233

Malignant neoplasm of corpus uteri

350

2480

1.46

9.49

3.2

2.9

1.24

mmol/l

0.35

298

2022

Use of anticholinesterases

1544

10324

1.20

9.49

2.8

4.0

1.23

mmol/l

3.90

1236

8914

N06DA Anticholinesterases

1544

10324

1.20

9.49

2.8

4.0

1.23

mmol/l

3.90

1236

8914

Other other unspecified disorders of the circulatory system

163

978

1.75

9.49

5.4

3.6

1.23

mmol/l

0.16

154

847

Hepatic failure, not elsewhere classified

158

940

1.76

9.46

6.0

3.8

1.20

1.23

mmol/l

5.33

150

818

Amputation of toe

297

2042

1.51

9.44

12.1

3.9

1.20

1.22

mmol/l

6.15

273

1786

Postprocedural disorders of digestive system, not elsewhere classified

142

821

1.82

9.43

7.1

3.5

1.22

1.23

mmol/l

0.33

135

705

Mental disorders, not otherwise specified

284

1929

1.51

9.41

3.4

3.5

1.23

mmol/l

1.05

256

1681

Diseases of spleen

424

2.18

9.38

7.1

3.7

1.22

1.23

mmol/l

0.77

373

143

2397

0.58

9.35

5.5

4.3

1.18

1.22

mmol/l

10.35

131

2122

Secondary parkinsonism, excluding more controls

101

525

2.02

9.34

4.8

3.6

1.24

1.23

mmol/l

1.24

463

Open wound of forearm

354

2513

1.45

9.32

4.3

3.7

1.22

mmol/l

0.89

309

2190

Endometriosis ASRM stages 1,2

629

4870

1.32

9.32

2.9

3.2

1.23

mmol/l

1.53

525

4272

Complications of cardiac and vascular prosthetic devices, implants and grafts

101

529

2.04

9.31

8.5

3.3

1.21

1.22

mmol/l

0.89

454

Herpesviral [herpes simplex] infections

902

7289

1.26

9.31

5.2

3.4

1.22

1.23

mmol/l

1.98

809

6351

Dislocation, sprain and strain of joints and ligaments of head

153

903

1.76

9.31

4.1

3.5

1.23

mmol/l

0.40

136

774

Vasomotor and allergic rhinitis

1406

11633

1.20

9.29

3.0

3.7

1.23

mmol/l

1.45

1262

10147

Viral haemorrhagic fevers, not elsewhere classified/unspecified

298

2054

1.50

9.28

3.9

4.1

1.22

mmol/l

0.38

268

1805

Impacted teeth

568

3843

1.33

9.28

3.6

3.3

1.22

mmol/l

0.24

489

3298

Disorders of psychological development

348

2274

1.44

9.27

4.1

3.6

1.22

1.23

mmol/l

0.69

309

1968

Other chondrocalcinosis

342

2.36

9.27

5.4

4.0

1.21

1.22

mmol/l

0.64

299

Diplopia

521

3941

1.35

9.26

3.9

1.22

1.23

mmol/l

2.47

475

3449

Mandibular retrognathia

218

1401

1.60

9.25

3.3

3.6

1.23

mmol/l

0.63

197

1229

Hyperhidrosis

115

625

1.92

9.24

3.6

2.5

1.23

mmol/l

0.06

103

523

Suppurative and necrotic conditions of lower respiratory tract

221

1435

1.60

9.23

6.8

4.3

1.21

1.22

mmol/l

1.61

212

1255

Gingival hyperplasia

143

833

1.80

9.23

13.3

3.9

1.21

1.23

mmol/l

1.66

135

731

Open wound of ankle and foot

383

2761

1.42

9.23

6.3

3.8

1.22

mmol/l

0.56

347

2413

Coxarthrosis, primary

2601

19447

1.14

9.17

3.5

4.0

1.23

mmol/l

1.58

2275

16875

Other disorders of eyelid

1941

16017

1.17

9.17

3.6

3.8

1.23

mmol/l

0.94

1687

13896

Other and unspecified psoriasis

264

1783

1.53

9.15

3.8

3.9

1.22

1.23

mmol/l

0.52

245

1553

Restless leg syndrome

530

4028

1.35

9.14

3.3

3.8

1.22

1.23

mmol/l

1.25

439

3511

Bell's palsy

456

3388

1.38

9.13

3.6

3.9

1.23

mmol/l

0.05

409

2958

Dilated cardiomyopathy

460

3431

1.38

9.04

4.8

4.3

1.21

1.22

mmol/l

4.22

430

3020

Coxarthrosis, primary, with hip surgery

2054

16750

1.16

9.02

3.5

4.0

1.23

mmol/l

0.83

1787

14496

Preterm labour and delivery

912

7406

1.25

9.01

3.7

3.3

1.23

mmol/l

0.69

786

6452

Other diseases of arteries and capillaries

356

2553

1.43

8.93

6.5

3.5

1.21

1.23

mmol/l

4.48

320

2214

Crohn disease (strict definition, all UC cases excluded)

183

1144

1.66

8.93

3.0

3.6

1.22

1.23

mmol/l

0.52

155

993

Diffuse brain injury

130

741

1.82

8.92

3.6

1.22

mmol/l

0.66

110

639

Ehlers-Danlos syndrome

217

2.62

8.91

1.9

3.3

1.22

mmol/l

0.10

184

Superficial injuries involving multiple body regions

109

592

1.94

8.88

5.0

3.6

1.20

1.23

mmol/l

1.35

513

Use of rasagiline

122

692

1.88

8.83

3.0

3.8

1.22

1.23

mmol/l

0.05

103

602

Appendectomy

2530

21378

1.14

8.81

3.8

3.7

1.23

mmol/l

0.02

2261

18686

CR(E)ST syndrome

409

2.17

8.78

3.9

3.5

1.23

mmol/l

0.70

357

Carcinoma in situ of skin, other sites/unspecified

397

2.21

8.78

8.3

3.8

1.23

1.22

mmol/l

0.09

344

Benign neoplasm: Endocrine pancreas

175

2.98

8.78

4.2

4.3

1.22

1.23

mmol/l

0.09

160

Endometriosis of rectovaginal septum and vagina

319

2254

1.46

8.74

2.9

3.4

1.24

mmol/l

0.13

269

1933

Malignant neoplasm of brain, including Hilmo

171

1057

1.67

8.72

5.9

2.9

1.22

1.23

mmol/l

1.30

160

890

Other bacterial intestinal infections

907

7393

1.25

8.72

8.4

3.5

1.22

1.23

mmol/l

5.44

824

6388

Follow-up examination after treatment for conditions other than malignant neoplasms

1446

11259

0.84

8.70

3.3

3.7

1.23

mmol/l

1.01

1286

9541

Cardiac murmurs and other cardiac sounds

320

2230

1.45

8.70

3.6

3.5

1.23

mmol/l

0.28

280

1905

Episcleritis

197

1263

1.62

8.69

4.0

3.6

1.23

mmol/l

0.03

180

1091

Infections of genitourinary tract in pregnancy

338

2411

1.44

8.68

3.7

3.2

1.23

mmol/l

0.88

303

2092

Cluster headache, wide

135

785

1.78

8.67

3.0

3.4

1.22

1.23

mmol/l

0.51

122

682

Cluster headache, strict

125

711

1.83

8.67

3.0

3.5

1.22

1.23

mmol/l

0.34

113

625

Other and unspecified coagulation defects

188

1194

1.63

8.64

4.8

3.2

1.22

1.23

mmol/l

0.78

174

1030

Other and unspecified diseases of blood and blood-forming organs

117

658

1.88

8.63

5.2

3.7

1.23

mmol/l

0.04

572

malignant neoplasm of female genital organs

590

4559

1.32

8.62

3.3

2.8

1.24

mmol/l

0.20

510

3774

Other diseases of lip and oral mucosa

1582

13574

1.18

8.61

3.8

3.7

1.23

mmol/l

0.70

1405

11832

Golimumab

128

736

1.81

8.61

2.5

3.8

1.24

1.23

mmol/l

2.05

121

640

Other local infections of skin and subcutaneous tissue

383

2797

1.40

8.59

7.2

3.6

1.22

1.23

mmol/l

0.05

347

2444

Unspecified dementia

458

3084

1.36

8.59

3.2

3.8

1.22

mmol/l

0.38

375

2668

Portal vein thrombosis

364

2.21

8.56

6.3

4.3

1.23

mmol/l

0.01

324

Cystic fibrosis

5.05

8.54

6.1

3.3

1.23

mmol/l

0.02

Bacterial, viral and other infectious agents

294

2052

1.47

8.53

5.4

4.0

1.22

1.23

mmol/l

2.02

268

1802

Open wound of wrist and hand

1637

13759

1.17

8.51

3.7

4.1

1.22

mmol/l

0.34

1408

12146

Other skin changes

757

6075

1.27

8.51

6.0

3.8

1.23

mmol/l

0.05

688

5284

Ankylosing spondylitis

318

2255

1.45

8.46

3.3

3.9

1.23

1.22

mmol/l

1.33

286

1985

Raynaud syndrome

323

2300

1.44

8.45

3.0

3.6

1.23

mmol/l

0.20

285

2013

D07AA Corticosteroids, weak (group I)

524

4006

1.33

8.44

3.8

3.7

1.22

1.23

mmol/l

2.09

453

3482

Acute generalized exanthematous pustulosis

179

1132

1.65

8.44

6.4

3.5

1.22

1.23

mmol/l

0.52

160

970

Spontaneous rupture of synovium and tendon

333

2386

1.44

8.44

4.3

3.9

1.23

mmol/l

0.47

304

2066

Demyelinating diseases of the central nervous system

295

2065

1.47

8.43

3.9

3.5

1.23

mmol/l

0.32

255

1794

Poor fetal growth

363

2630

1.41

8.41

3.0

2.9

1.22

1.23

mmol/l

0.75

300

2286

Mixed disorders of conduct and emotions

356

2.16

8.40

3.8

2.6

1.22

mmol/l

0.38

300

Other and unspecified local infections of skin and subcutaneous tissue

362

2633

1.41

8.35

7.4

3.6

1.22

1.23

mmol/l

0.25

327

2296

Postmenopausal atrophic vaginitis

1117

5115

1.22

8.31

3.2

3.6

1.24

mmol/l

0.70

982

4445

Ulcerative enterocolitis

123

708

1.82

8.29

5.3

3.7

1.22

1.23

mmol/l

0.30

117

615

Scabies

451

3391

1.35

8.27

4.4

3.6

1.22

1.23

mmol/l

0.49

401

2956

UC patients in KELA-register (code 208), prior to 1994

178

1131

1.64

8.27

4.5

3.8

1.22

1.23

mmol/l

0.68

154

998

Persistent delusional disorders

296

2086

1.46

8.25

3.1

3.8

1.23

mmol/l

0.72

251

1814

Adhesive capsulitis of shoulder

664

5266

1.29

8.24

4.3

3.7

1.23

mmol/l

0.64

593

4587

Disorders of conjunctiva

3376

24422

1.12

8.24

3.6

3.8

1.23

mmol/l

0.16

2954

21297

Calculus of lower urinary tract

217

1443

1.56

8.21

4.2

4.3

1.23

1.22

mmol/l

3.52

191

1267

Amputation

404

3000

1.38

8.20

11.7

3.8

1.20

1.22

mmol/l

7.67

370

2607

Cervicalgia

817

6632

1.25

8.20

3.3

3.7

1.23

mmol/l

0.28

711

5731

Other and unspecified injuries of ankle and foot

156

959

1.69

8.19

4.5

3.4

1.22

1.23

mmol/l

1.32

136

825

Other and unspecified hydrocephalus

454

2.05

8.15

5.5

3.8

1.22

mmol/l

0.55

394

Other specified/unspecified systemic involvement of connective tissue

224

1503

1.54

8.08

4.2

3.5

1.23

mmol/l

0.29

211

1300

Other disorders starting during childhood or adolescence

137

808

1.72

7.98

5.0

3.9

1.23

mmol/l

0.07

122

689

Other/unspecified mastoiditis and related conditions

108

3.37

7.97

4.4

3.5

1.22

mmol/l

0.34

Candidiasis

512

3948

1.32

7.97

7.2

3.5

1.22

1.23

mmol/l

1.37

454

3411

Bacterial, viral and other infectious agents

309

2205

1.43

7.95

5.3

4.0

1.22

1.23

mmol/l

1.08

280

1939

Other appendicitis

315

2258

1.43

7.95

4.0

1.23

mmol/l

0.09

281

1971

Carcinoma in situ of skin of scalp and neck

123

723

1.81

7.94

6.5

3.7

1.22

mmol/l

0.38

109

631

Adenocarcinoma and papillary adenocarcinoma of stomach

104

577

1.88

7.92

4.7

3.2

1.21

1.22

mmol/l

0.43

487

Pruritus

422

3173

1.36

7.88

5.8

3.5

1.23

mmol/l

0.83

368

2744

Diseases of salivary glands

1244

10553

1.19

7.85

3.7

1.23

mmol/l

0.48

1092

9206

Duodenal ulcer

444

3367

1.35

7.84

5.9

3.9

1.22

mmol/l

0.82

406

2904

Trigeminal neuralgia

233

1589

1.52

7.78

3.3

3.5

1.23

mmol/l

0.37

206

1363

Malignant neoplasm of eye, brain and central nervous system

146

895

1.69

7.76

5.6

2.8

1.22

1.23

mmol/l

0.08

137

750

Toxic effect of other and unspecified substances

238

2.42

7.76

3.7

1.21

1.23

mmol/l

0.93

211

Haemolytic anaemias

141

860

1.71

7.76

9.1

3.9

1.22

1.23

mmol/l

0.28

129

743

Right bundle-branch block

150

929

1.68

7.74

4.8

3.5

1.22

1.23

mmol/l

0.48

131

795

Primary angle-closure glaucoma

190

1246

1.59

7.74

4.5

3.9

1.23

mmol/l

0.03

166

1076

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

246

1692

1.49

7.74

3.5

3.0

1.23

mmol/l

1.26

213

1487

Varicella [chickenpox]

154

957

1.66

7.74

7.7

4.2

1.22

1.23

mmol/l

1.25

142

848

Peripheral retinal degeneration

132

793

1.75

7.72

3.4

3.8

1.23

mmol/l

0.14

115

692

Generalized skin eruption due to drugs and medicaments

156

977

1.66

7.71

6.9

3.4

1.22

1.23

mmol/l

0.60

140

840

Pregnancy hypertension

1440

11068

1.18

7.70

3.5

3.2

1.23

mmol/l

0.55

1268

9638

Other demyelinating diseases of the central nervous system

136

822

1.72

7.68

3.0

3.2

1.22

1.23

mmol/l

0.90

117

715

Other symptoms and signs involving cognitive functions and awareness

1925

15374

1.15

7.68

4.1

3.9

1.22

1.23

mmol/l

1.29

1701

13306

Intermittent heterotropia

192

1256

1.57

7.67

5.1

3.7

1.23

mmol/l

0.10

167

1086

Other and unspecified disorders of vitreous body

1735

14927

1.16

7.64

3.9

3.8

1.23

mmol/l

0.48

1506

13001

Congenital malformations and deformations of the musculoskeletal system

271

1891

1.46

7.63

3.9

3.6

1.23

mmol/l

0.27

240

1636

Speech and linguistic disorders, excluding more controls

204

1268

1.54

7.63

4.2

3.5

1.23

mmol/l

0.02

188

1105

Atypical facial pain

203

1353

1.55

7.61

4.0

3.6

1.23

mmol/l

0.22

183

1159

Systemic lupus erythematosus, unspecified

126

752

1.76

7.57

4.8

3.5

1.22

1.23

mmol/l

1.04

118

641

Triptan medication for migraine, min. 3 purchases

2005

13443

1.15

7.52

2.7

3.6

1.23

mmol/l

0.18

1743

11792

Cluster headache, strict, including avohilmo

174

1122

1.60

7.52

2.9

3.7

1.22

1.23

mmol/l

0.94

159

982

Other conditions related to polyarteritis nodosa

4.86

7.52

5.6

5.1

1.23

1.22

mmol/l

0.48

Other and unspecified urticaria

703

5673

1.26

7.48

4.0

3.6

1.23

mmol/l

1.16

601

4961

Lesion of ulnar nerve

511

3973

1.31

7.48

4.5

4.1

1.22

mmol/l

0.57

466

3498

Cluster headache, wide,, including avohilmo

184

1203

1.58

7.48

2.9

3.7

1.22

1.23

mmol/l

1.02

168

1051

Postmenopausal bleeding

1142

5118

1.21

7.48

3.6

1.24

mmol/l

0.49

981

4433

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

377

2814

1.37

7.47

6.4

3.8

1.22

1.23

mmol/l

1.38

346

2456

Rash and other nonspecific skin eruption

370

2753

1.38

7.47

5.3

3.7

1.23

mmol/l

0.16

338

2400

Scleritis and episcleritis

219

1488

1.52

7.43

4.2

3.5

1.23

mmol/l

0.27

199

1286

Cerebral palsy and other paralytic syndromes

404

3046

1.35

7.41

4.5

3.9

1.22

1.23

mmol/l

0.86

371

2654

Vitamin B12 deficiency anaemia

421

3199

1.35

7.36

4.4

3.6

1.21

1.23

mmol/l

3.90

367

2746

Gluteal tendinitis

159

1013

1.63

7.34

3.8

3.3

1.24

1.23

mmol/l

0.65

142

866

Myositis

109

631

1.81

7.31

6.2

3.8

1.22

mmol/l

0.17

542

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

340

2.16

7.30

5.3

4.0

1.23

1.22

mmol/l

0.09

301

Type1 diabetes, definitions combined, early onset

181

1177

1.57

7.29

4.0

3.4

1.22

1.23

mmol/l

0.37

147

1021

Behavioural disorders, excluding more controls

255

2.27

7.26

3.8

4.1

1.23

1.22

mmol/l

0.13

221

Contact with nonpowered hand tool

151

951

1.65

7.26

3.7

4.5

1.22

mmol/l

0.53

125

846

Cystic fibrosis with pulmonary manifestations

9.31

7.21

7.3

2.3

1.22

mmol/l

0.08

Dislocation of lens

368

2.09

7.19

5.8

3.3

1.23

1.22

mmol/l

0.16

312

Pre-eclampsia

674

5442

1.26

7.15

3.8

3.2

1.23

mmol/l

0.47

601

4763

Injuries involving multiple body regions

141

878

1.67

7.12

4.7

3.8

1.21

1.23

mmol/l

1.10

123

760

Gastric ulcer

745

6090

1.24

7.12

6.1

3.8

1.22

1.23

mmol/l

3.26

683

5222

Other extrapyramidal and movement disorders in other diseases

938

7843

1.21

7.10

3.7

3.9

1.23

mmol/l

0.63

790

6824

Myopia

407

3088

1.34

7.10

4.7

3.5

1.23

mmol/l

0.40

337

2689

Amputation of ankle bones

534

1.88

7.09

17.2

3.5

1.20

1.22

mmol/l

2.35

464

Malignant neoplasm of bladder

242

1690

1.47

7.07

4.7

3.0

1.22

mmol/l

0.76

222

1435

Other diseases of intestine

565

4486

1.28

7.05

6.3

3.7

1.22

1.23

mmol/l

1.27

506

3870

Atopic conjunctivitis

167

1085

1.59

7.04

2.8

3.3

1.23

mmol/l

0.12

150

943

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

115

680

1.75

7.02

6.5

3.5

1.22

1.23

mmol/l

2.05

106

580

Conjunctivitis (acute, non atopic)

1005

8422

1.20

7.02

4.5

3.7

1.23

mmol/l

0.59

879

7384

Ocular pain

303

2207

1.41

7.02

3.6

3.5

1.23

mmol/l

0.12

270

1914

Assault by bodily force

244

1709

1.46

7.00

4.3

3.7

1.22

1.23

mmol/l

0.13

215

1498

Adrenomedullary hyperfunction

4.16

6.99

7.2

3.4

1.23

1.22

mmol/l

0.30

Osteomyelitis of vertebra

3.90

6.98

5.0

3.3

1.19

1.23

mmol/l

2.68

Anankastic personality disorder

131

804

1.69

6.98

3.0

3.4

1.23

mmol/l

0.13

104

698

Special screening examination for neoplasms

104

1744

0.58

6.97

3.8

1.23

1.22

mmol/l

0.70

1483

Somnolence, stupor and coma

169

1105

1.58

6.95

6.0

3.9

1.21

1.22

mmol/l

1.88

155

953

Pyothorax

167

1092

1.59

6.91

6.7

4.2

1.20

1.22

mmol/l

1.78

162

946

Adenocarcinoma of pancreas

103

597

1.81

6.88

6.2

2.8

1.21

1.22

mmol/l

0.84

493

Mycoses

3484

27632

1.10

6.85

4.1

3.8

1.23

mmol/l

0.91

3066

24120

Other infective otitis externa

1548

0.56

6.85

5.6

3.6

1.23

mmol/l

0.00

1334

Localized skin eruption due to drugs and medicaments

280

2.24

6.84

5.0

3.8

1.21

1.23

mmol/l

1.01

250

COPD, hospital admissions 3, with asthma pneumonia sepsis

1125

8178

1.19

6.83

5.4

3.9

1.21

1.22

mmol/l

12.21

1038

7056

Maternal care for other known or suspected fetal problems

677

3455

1.25

6.78

2.6

3.2

1.22

1.23

mmol/l

1.90

567

3030

Other injuries of spine and trunk, level unspecified

190

2.52

6.76

5.4

3.9

1.21

1.22

mmol/l

0.72

166

Drug-induced hypoglycaemia without coma

355

2.06

6.76

8.4

3.8

1.20

1.23

mmol/l

3.12

307

Other disorders of amniotic fluid and membranes

399

2966

1.33

6.75

2.8

3.3

1.23

mmol/l

0.49

340

2599

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

3.44

6.73

14.7

2.8

1.25

1.22

mmol/l

1.61

Chronic lymphocytic leukaemia, helper endpoint

108

639

1.77

6.72

6.6

2.7

1.22

mmol/l

0.69

103

531

Chronic lymphocytic leukaemia

108

639

1.77

6.72

6.6

2.7

1.22

mmol/l

0.69

103

531

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

108

639

1.77

6.72

6.6

2.7

1.22

mmol/l

0.69

103

531

Intestinal adhesions without obstruction

341

2552

1.37

6.71

5.4

3.8

1.21

1.23

mmol/l

3.53

305

2191

Other noninfective disorders of lymphatic vessels and lymph nodes

142

901

1.64

6.70

5.0

3.6

1.23

mmol/l

0.34

136

774

Persons encountering health services for examination and investigation

2941

13304

1.12

6.68

3.9

3.7

1.23

1.22

mmol/l

0.59

2631

11316

Melanoma in situ

185

1249

1.54

6.67

6.0

3.7

1.23

1.22

mmol/l

0.22

161

1082

Pre-eclampsia or eclampsia

729

5982

1.24

6.67

3.8

3.2

1.23

mmol/l

0.51

654

5222

Non-invasive ventilation

440

5056

0.77

6.66

6.1

3.1

1.21

1.24

mmol/l

12.72

414

4314

Migraine, single triptan purchase ok & required. ICD-code if available is included

2925

17912

1.11

6.65

2.9

3.8

1.23

mmol/l

1.51

2555

15678

Triptan medication for migraine, single purchase ok

2925

17912

1.11

6.65

2.9

3.8

1.23

mmol/l

1.51

2555

15678

Inflammatory diseases of female pelvic organs

2394

15762

1.13

6.64

3.4

3.3

1.23

mmol/l

2.02

2058

13629

Neuralgia and neuritis, unspecified

190

1286

1.52

6.64

5.0

3.6

1.22

1.23

mmol/l

1.37

179

1107

Rotator cuff syndrome

2542

16386

1.12

6.63

3.7

3.8

1.23

mmol/l

0.11

2285

14309

Other disorders of optic [2nd] nerve and visual pathways

231

1624

1.46

6.63

6.6

3.7

1.22

1.23

mmol/l

0.79

205

1398

Erosion of teeth , including avohilmo

836

6955

1.22

6.62

5.0

3.7

1.23

mmol/l

0.15

731

6131

Other misadventures during surgical and medical care

568

1.82

6.61

7.1

4.0

1.21

1.23

mmol/l

1.61

499

Agoraphobia

557

1.80

6.58

2.9

2.8

1.22

1.23

mmol/l

0.50

486

Amiodarone users

391

2999

1.34

6.52

3.9

4.2

1.21

1.22

mmol/l

3.25

366

2638

Malignant neoplasm of cervix uteri, including Hilmo

532

1.83

6.51

3.9

2.4

1.23

mmol/l

0.14

428

Gestational [pregnancy-induced] hypertension

818

6786

1.22

6.50

3.1

1.23

mmol/l

0.00

710

5925

Ovarian dysfunction

219

1525

1.47

6.50

3.7

2.3

1.22

1.23

mmol/l

0.37

199

1288

Injury of other and unspecified intrathoracic organs

236

1672

1.45

6.49

4.5

4.0

1.22

mmol/l

0.36

219

1467

Other aneurysm

215

1500

1.48

6.48

7.1

3.6

1.22

mmol/l

0.23

193

1307

Malignant neoplasm of oesophagus, including Hilmo

132

830

1.65

6.47

5.7

3.3

1.21

1.22

mmol/l

0.42

125

704

Decubitus ulcer and pressure area

246

1763

1.44

6.39

10.0

3.6

1.21

1.22

mmol/l

2.38

234

1516

Superficial injury of shoulder and upper arm

406

3133

1.32

6.38

3.8

3.7

1.23

mmol/l

0.18

345

2725

Other/unspecified enthesopathies of lower limb, excluding foot

250

1793

1.43

6.37

2.9

3.6

1.23

mmol/l

0.12

219

1555

Malignant melanoma of skin

381

2916

1.33

6.37

4.6

3.0

1.23

mmol/l

0.36

336

2458

Cervical disc disorders

1408

12270

1.16

6.35

3.5

3.9

1.23

mmol/l

0.07

1231

10712

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

974

8246

1.19

6.35

3.2

3.8

1.22

1.23

mmol/l

0.92

847

7263

Other and unspecified abdominal hernia

174

1172

1.54

6.34

6.0

3.9

1.23

mmol/l

0.16

156

1009

therapeutic use

869

0.44

6.34

7.0

3.3

1.23

mmol/l

0.03

736

Acquired haemolytic anaemia

102

606

1.77

6.32

10.6

3.4

1.22

1.23

mmol/l

0.94

517

Arthropathy in Crohn disease

189

2.44

6.31

2.9

3.7

1.25

1.22

mmol/l

0.97

164

Other and unspecified intracranial injuries

114

696

1.70

6.30

3.9

3.5

1.22

mmol/l

0.37

101

603

Nail disorders

293

2163

1.39

6.29

6.2

3.6

1.23

mmol/l

0.34

268

1880

Nonspecific lymphadenitis

204

1416

1.48

6.25

5.4

3.6

1.23

mmol/l

0.03

185

1230

Thyroiditis

260

1887

1.41

6.23

3.2

3.5

1.23

mmol/l

0.21

213

1639

Malignant neoplasm of vulva, including Hilmo

332

2.07

6.23

5.2

2.7

1.22

1.23

mmol/l

0.59

272

Otitis media, unspecified

349

2429

1.34

6.23

5.2

3.3

1.23

mmol/l

0.04

303

2085

Peripheral arterial reconstruction

688

5665

1.24

6.22

9.3

3.8

1.21

1.22

mmol/l

9.37

615

4887

Congenital malformations and deformations of the musculoskeletal system

335

2508

1.35

6.22

3.9

3.6

1.23

mmol/l

0.08

299

2175

Undefined dementia

463

3356

1.29

6.21

3.2

3.6

1.22

mmol/l

0.23

379

2856

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1616

12359

1.15

6.21

3.5

3.3

1.23

mmol/l

0.47

1420

10732

Dependent personality disorder

482

1.86

6.21

4.4

3.6

1.23

mmol/l

0.56

421

Antenatal screening

482

3429

0.78

6.20

2.3

3.3

1.23

mmol/l

0.16

420

2989

Habit and impulse disorders

268

2.15

6.19

2.8

3.6

1.21

1.22

mmol/l

0.94

241

Contusion of other and unspecified parts of foot

167

1116

1.54

6.19

3.4

3.3

1.22

1.23

mmol/l

0.94

145

953

Use of antiglaucoma preparations and miotics

328

2474

1.36

6.18

5.8

3.6

1.23

mmol/l

0.43

287

2119

Iridocyclitis in diseases classified elsewhere

446

1.89

6.18

3.4

3.7

1.23

mmol/l

0.63

388

Heartburn

391

3015

1.32

6.18

4.0

3.5

1.23

mmol/l

0.80

348

2610

Other and unspecified disorders of skin and subcutaneous tissue

112

1787

0.61

6.17

4.9

3.4

1.23

mmol/l

0.05

104

1552

Abdominal aortic aneurysm (AAA)

395

3027

1.32

6.16

6.1

3.8

1.21

1.22

mmol/l

1.70

357

2622

Congenital malformations of the musculoskeletal system, not elsewhere classified

283

2.13

6.16

2.6

3.7

1.22

mmol/l

0.11

244

Varicella [chickenpox]

164

1092

1.54

6.15

7.3

4.3

1.22

1.23

mmol/l

1.13

150

960

Atopic dermatitis, strict definition with reimbursement

957

7826

1.19

6.14

4.1

3.4

1.23

mmol/l

0.10

848

6858

Spondylolisthesis/Spondylolysis

701

5786

1.23

6.14

3.4

3.7

1.23

mmol/l

0.33

620

5022

Macular pucker

625

5111

1.25

6.12

4.2

3.9

1.22

1.23

mmol/l

0.69

538

4486

Microscopic polyangiitis

163

2.63

6.10

11.3

4.0

1.22

1.23

mmol/l

0.63

144

Dystonia

205

1435

1.47

6.08

3.0

3.7

1.23

mmol/l

0.57

178

1247

Nummular dermatitis

305

2281

1.37

6.07

4.3

3.8

1.23

1.22

mmol/l

0.34

268

1999

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

204

1399

1.47

6.06

5.1

3.2

1.22

1.23

mmol/l

1.48

182

1197

Other specified/unspecified hearing loss

168

2455

0.67

6.05

5.4

3.6

1.22

1.23

mmol/l

0.12

146

2136

Pleural plaque without asbestos

156

1039

1.57

6.05

3.6

3.7

1.21

1.22

mmol/l

0.58

138

899

Impetigo

143

929

1.58

6.05

4.4

3.2

1.23

mmol/l

0.18

130

806

Burns and corrosions

454

3578

1.29

6.03

4.3

4.0

1.22

mmol/l

0.53

396

3145

Vascular disorders of the intestines

282

2088

1.39

6.01

6.4

3.6

1.22

1.23

mmol/l

0.56

256

1794

Aggressive periodontitis

517

1.81

6.01

4.4

3.8

1.22

1.23

mmol/l

0.60

450

Atherosclerosis, excluding cerebral and coronary sclerosis

1748

12265

1.14

6.01

7.3

3.7

1.21

1.23

mmol/l

17.41

1569

10552

Asthma and allergy, excluding more controls

362

2731

1.32

5.98

2.9

2.7

1.23

mmol/l

0.74

323

2330

False labour

888

4648

1.20

5.97

2.6

3.3

1.22

1.23

mmol/l

3.00

759

4087

Left bundle-branch block

282

2090

1.38

5.96

4.2

3.4

1.22

1.23

mmol/l

2.14

258

1781

Sequelae of other and unspecified infectious and parasitic diseases

182

1249

1.50

5.95

4.2

3.8

1.22

1.23

mmol/l

0.73

159

1101

Mild mental retardation

494

1.81

5.94

3.9

3.8

1.24

1.23

mmol/l

0.98

443

Dermatophytosis

477

3795

1.28

5.94

4.7

4.0

1.22

mmol/l

0.22

433

3338

Postprocedural musculoskeletal disorders, not elsewhere classified

284

2114

1.38

5.90

4.2

4.0

1.23

mmol/l

0.11

256

1850

Ankylosing spondylitis, ICD10

301

2254

1.36

5.90

3.3

3.9

1.23

mmol/l

0.77

272

1973

Juvenile rheumatoid arthirtis

414

1.88

5.89

4.1

3.0

1.22

1.23

mmol/l

1.02

349

Perineal laceration during delivery

301

3347

0.74

5.89

2.8

3.0

1.23

mmol/l

0.06

264

2866

Other mental disorders due to brain damage and dysfunction and to physical disease

449

3554

1.29

5.87

4.3

4.0

1.23

mmol/l

0.09

379

3116

Other disorders of bone

675

5573

1.23

5.87

4.8

3.4

1.22

1.23

mmol/l

0.92

615

4867

Superficial injury of ankle and foot

381

2947

1.31

5.87

4.1

3.8

1.22

1.23

mmol/l

0.79

337

2554

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

169

2.43

5.86

5.6

2.9

1.24

1.22

mmol/l

0.80

143

Injury of eye and orbit

464

3679

1.28

5.86

4.3

3.9

1.22

mmol/l

0.68

422

3233

Atrophic disorders of skin

569

4625

1.25

5.86

3.6

3.4

1.23

mmol/l

0.45

490

3990

Burns and corrosions of external body surface, specified by site

360

2767

1.33

5.85

4.5

3.9

1.22

mmol/l

0.65

310

2426

Diseases of appendix

2923

24034

1.10

5.83

3.8

1.23

mmol/l

0.04

2608

21027

Ehlers-Danlos syndrome

170

2.44

5.83

2.0

3.5

1.22

mmol/l

0.43

146

Intercostal neuropathy

191

2.41

5.83

4.4

3.5

1.22

mmol/l

0.07

171

Prurigo nodularis

107

660

1.70

5.81

6.9

3.7

1.21

1.23

mmol/l

1.88

574

Cervicocranial syndrome

400

3123

1.31

5.80

3.5

3.7

1.23

mmol/l

0.01

352

2722

Malignant neoplasm, without specification of site

116

727

1.65

5.79

5.6

2.6

1.23

1.22

mmol/l

0.31

107

605

Benign neoplasm: Skin, unspecified

153

1023

1.55

5.79

5.0

3.6

1.22

1.23

mmol/l

0.27

135

884

Chronic gastritis

848

10003

0.84

5.78

3.8

3.7

1.22

1.23

mmol/l

2.37

747

8561

Injuries to unspecified part of trunk, limb or body region

373

2889

1.32

5.77

5.3

3.8

1.22

1.23

mmol/l

1.01

336

2514

Appendicitis, broad definition

2895

23890

1.10

5.77

3.8

1.23

mmol/l

0.08

2582

20902

Open wound of shoulder and upper arm

433

1.86

5.76

5.2

4.0

1.23

mmol/l

0.16

379

Oligomenorrhoea

123

782

1.62

5.76

2.5

2.9

1.22

1.23

mmol/l

1.37

112

672

Injury of nerves and spinal cord at neck level

508

1.80

5.76

3.7

4.0

1.22

mmol/l

0.14

452

Glucosamine medication

2090

14980

1.12

5.75

3.5

3.9

1.23

mmol/l

1.28

1778

12971

Membranous nephropathy

3.11

5.73

19.1

4.0

1.21

1.22

mmol/l

0.19

Disorders of iron metabolism

341

1.98

5.72

3.8

3.2

1.23

mmol/l

0.08

299

Oesophagitis

209

1486

1.45

5.72

4.7

3.8

1.21

1.22

mmol/l

2.24

191

1283

Sequelae of injuries of neck and trunk

109

676

1.68

5.71

3.3

3.7

1.22

1.23

mmol/l

0.18

101

588

Maternal care for known or suspected fetal abnormality and damage

260

3022

0.73

5.71

2.4

3.2

1.22

1.23

mmol/l

2.48

221

2646

Other renal tubulo-interstitial diseases

577

1.74

5.70

11.2

3.0

1.22

1.23

mmol/l

1.01

487

Paralytic ileus

149

995

1.55

5.66

4.8

3.6

1.21

1.22

mmol/l

1.45

131

846

Glaucoma secondary to other eye disorders

156

1052

1.53

5.65

8.5

3.9

1.22

mmol/l

0.37

142

906

Polyarthritis, unspecified

138

907

1.58

5.64

3.8

3.6

1.23

mmol/l

0.03

128

773

Abnormality of white blood cells, not elsewhere classified

180

2.40

5.64

8.7

3.9

1.21

1.22

mmol/l

0.48

160

Malignant neoplasm of oral cavity

118

748

1.64

5.64

5.6

3.1

1.25

1.22

mmol/l

1.20

110

626

Malignant neoplasm of oral cavity, including Hilmo

155

1044

1.53

5.62

5.0

3.0

1.24

1.23

mmol/l

1.09

146

876

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

229

1664

1.42

5.59

3.5

3.8

1.23

mmol/l

0.75

200

1443

Benign neoplasm: Sigmoid colon

512

6305

0.80

5.59

4.9

4.0

1.23

mmol/l

0.05

455

5496

Viral pneumonia (known virus, not influenza)

106

659

1.68

5.56

9.7

3.7

1.22

1.23

mmol/l

0.91

101

570

Open wound of abdomen, lower back and pelvis

105

649

1.67

5.55

5.4

3.8

1.21

1.22

mmol/l

1.74

565

Pedal cyclist injured in other and unspecified transport accidents

386

3018

1.30

5.55

3.3

3.9

1.22

1.23

mmol/l

0.46

349

2626

Abnormality of red blood cells

120

2.78

5.54

5.9

4.1

1.20

1.22

mmol/l

0.70

102

Infectious mononucleosis

231

1673

1.40

5.54

3.3

3.1

1.22

1.23

mmol/l

2.20

196

1447

Family history of certain disabilities and chronic diseases leading to disablement

152

1021

1.53

5.53

2.5

3.0

1.23

mmol/l

0.35

131

869

Rosacea

419

3313

1.29

5.53

4.1

3.6

1.23

mmol/l

0.60

357

2894

Disorders of oesophagus in diseases classified elsewhere

569

1.74

5.52

8.2

3.7

1.21

1.23

mmol/l

2.32

495

Asthma and allergy

362

2763

1.31

5.52

2.9

2.8

1.23

mmol/l

0.59

323

2363

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1045

9013

1.17

5.50

4.0

3.8

1.22

1.23

mmol/l

0.65

918

7912

Reactive arthropathies

306

2323

1.34

5.49

5.0

3.8

1.22

1.23

mmol/l

0.58

273

2037

Paralytic strabismus

263

1958

1.38

5.46

5.1

3.9

1.23

1.22

mmol/l

0.16

235

1694

Hereditary factor VIII deficiency

3.98

5.45

2.1

3.2

1.23

mmol/l

0.01

Superficial injury of wrist and hand

669

5561

1.22

5.44

3.6

3.9

1.23

mmol/l

0.09

584

4870

Contact with sharp glass

125

809

1.59

5.43

3.8

3.6

1.23

mmol/l

0.02

106

697

Soft tissue disorders related to use, overuse and pressure

1041

8989

1.17

5.43

3.3

3.7

1.23

mmol/l

0.05

934

7829

Pustular psoriasis

175

1218

1.48

5.42

3.8

3.7

1.23

mmol/l

0.19

152

1058

Arthropathy in ulcerative colitis

270

2.08

5.41

2.6

3.7

1.23

mmol/l

0.01

238

Alcohol-induced acute pancreatitis

127

828

1.59

5.40

6.1

4.6

1.20

1.22

mmol/l

3.02

112

732

Other disorders of the musculoskeletal system and connective tissue

553

4524

1.24

5.40

3.7

3.9

1.23

mmol/l

0.08

485

3950

Other and unspecified trigeminal disorders

385

1.89

5.39

4.2

3.5

1.22

1.23

mmol/l

0.78

338

Malignant neoplasm of oesophagus

563

1.72

5.38

6.0

3.2

1.22

mmol/l

0.21

472

Other specified and unspecified disorders of eye and adnexa

965

0.51

5.38

3.3

3.6

1.23

mmol/l

0.06

827

Dementia due to Parkinsons disease, excluding more controls

565

1.72

5.35

2.9

3.9

1.22

mmol/l

0.20

494

Bullous disorders

220

1599

1.42

5.34

4.9

3.7

1.23

mmol/l

0.89

199

1369

Pneumonia derived septicemia

129

847

1.58

5.33

6.0

3.9

1.22

mmol/l

0.14

115

725

Injuries to the wrist and hand

4133

26577

1.08

5.30

3.6

3.8

1.23

mmol/l

0.66

3587

23233

Hypersomnia

293

2.02

5.30

2.9

4.1

1.23

mmol/l

0.01

259

Acute nephritic syndrome

483

1.78

5.29

12.9

3.3

1.22

1.23

mmol/l

0.55

424

Other abnormal findings in urine

395

1.88

5.29

6.5

4.0

1.23

1.22

mmol/l

0.07

345

Non-small cell lung cancer, adenocarcinoma, helper endpoint

249

1851

1.38

5.28

5.7

3.9

1.22

mmol/l

0.14

237

1607

Localized swelling, mass and lump of skin and subcutaneous tissue

911

10609

0.85

5.28

4.3

3.7

1.23

mmol/l

0.06

832

9234

Hypertension, Pulmonary Arterial

179

2.34

5.25

4.6

3.6

1.22

1.23

mmol/l

0.58

157

Striking against or struck by other objects

1111

9648

1.16

5.25

3.9

1.22

mmol/l

0.24

969

8498

Retinal detachments and breaks

1399

12364

1.14

5.24

4.4

3.8

1.23

mmol/l

0.16

1197

10816

Neovascular glaucoma

156

1070

1.51

5.23

8.5

3.7

1.22

mmol/l

0.64

142

919

Allergic asthma (mode), excluding more controls

707

5796

1.20

5.22

3.1

2.8

1.23

mmol/l

0.60

628

4912

Polycystic ovarian syndrome

152

1033

1.50

5.21

2.5

2.2

1.22

1.23

mmol/l

0.56

136

864

Other disorders of veins

1585

14036

1.13

5.20

3.9

3.5

1.23

mmol/l

3.08

1353

12212

Other peripheral vascular diseases

296

2258

1.34

5.19

4.0

3.4

1.23

mmol/l

0.17

271

1959

Autoimmune thyroiditis

403

1.84

5.19

3.7

3.1

1.23

mmol/l

0.10

349

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

148

2.48

5.18

3.4

2.7

1.23

mmol/l

0.00

121

Mental and behavioural disorders associated with the puerperium

179

2.29

5.18

5.6

3.7

1.24

1.23

mmol/l

0.54

153

Pain associated with micturition

429

3431

1.27

5.17

3.5

1.23

mmol/l

0.97

385

2971

Alzheimer’s disease, strict definition

802

7758

0.84

5.17

3.1

3.9

1.23

mmol/l

0.84

634

6697

Carcinoma in situ of skin of upper limb, including shoulder

113

730

1.63

5.17

7.2

3.7

1.23

1.22

mmol/l

0.32

631

Bulimia nervosa (incl. atypical)

582

1.67

5.16

2.7

1.22

1.23

mmol/l

0.37

500

Ingrowing nail

185

1312

1.45

5.15

7.1

3.7

1.22

1.23

mmol/l

0.58

171

1149

Acute appendicitis, no complications

2013

18082

1.12

5.14

3.7

3.8

1.23

mmol/l

0.14

1787

15857

Carcinoma in situ of other and unspecified sites

145

987

1.53

5.13

4.1

4.4

1.22

mmol/l

0.18

122

864

Personal history of other diseases and conditions

318

2437

1.32

5.11

4.4

3.1

1.22

1.23

mmol/l

3.83

271

2102

Other keratitis

382

3016

1.29

5.11

4.7

3.8

1.22

1.23

mmol/l

0.72

337

2623

Use of rotigotine

292

2.03

5.10

2.9

3.8

1.22

1.23

mmol/l

1.31

252

Other diseases of stomach and duodenum

253

1894

1.37

5.10

7.2

3.7

1.21

1.23

mmol/l

3.94

233

1641

Endometriosis of ovary

601

4859

1.22

5.10

3.2

3.5

1.23

1.24

mmol/l

0.16

527

4225

Disorders of breast

1886

15403

1.12

5.10

3.3

3.4

1.24

1.23

mmol/l

2.11

1676

13293

Viral meningitis

124

815

1.57

5.09

4.9

3.3

1.23

mmol/l

0.39

108

698

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

223

2.19

5.08

3.8

4.2

1.22

mmol/l

0.12

197

Voice disturbances

1016

8813

1.17

5.05

4.2

3.7

1.22

1.23

mmol/l

2.73

878

7666

Pneumococcal septicemia

124

818

1.57

5.04

6.1

3.9

1.22

mmol/l

0.07

110

705

Benign neoplasm of middle ear and respiratory system

289

2208

1.34

5.04

3.7

4.0

1.22

mmol/l

0.18

262

1934

Henoch-Schönlein purpura nephritis (HSPN)

3.21

5.02

16.2

3.6

1.21

1.22

mmol/l

0.34

Umbilical hernia

987

8547

1.17

4.99

4.8

4.0

1.22

mmol/l

4.12

869

7516

Fenamates

584

3268

1.23

4.97

3.3

4.6

1.23

mmol/l

1.45

513

2876

Pure hyperglyceridaemia

538

1.71

4.96

5.0

3.0

1.20

1.22

mmol/l

2.73

466

Viral infections of the central nervous system

247

1848

1.37

4.96

6.3

3.6

1.22

1.23

mmol/l

0.82

217

1596

Glaucoma, exfoliation

445

3597

1.26

4.94

3.4

3.7

1.23

mmol/l

1.16

383

3065

Allergic rhinitis

1002

8587

1.16

4.93

2.9

3.7

1.23

mmol/l

0.16

910

7552

Other or unspecified common variable immunodeficiency

3.39

4.92

5.6

3.6

1.21

1.23

mmol/l

0.68

Anti-inflammatory and antirheumatic products, non-steroids

1184

5187

1.16

4.91

3.6

4.8

1.22

mmol/l

0.39

1028

4572

Chronic ulcer of skin, not elsewhere classified

261

1975

1.35

4.90

7.9

3.6

1.22

1.23

mmol/l

1.07

244

1706

Other disorders of breast

296

3819

0.76

4.88

2.8

3.3

1.23

1.24

mmol/l

0.87

271

3306

Fissure and fistula of anal and rectal regions

894

7704

1.17

4.84

3.7

3.6

1.23

mmol/l

0.78

789

6689

Prolonged pregnancy

263

3024

0.75

4.84

2.6

3.3

1.23

mmol/l

0.12

224

2645

Other and unspecified rosacea

306

2370

1.32

4.83

4.4

3.7

1.23

mmol/l

0.32

259

2075

Polyhydramnios

136

921

1.51

4.81

3.6

3.0

1.22

1.23

mmol/l

1.75

114

804

Carcinoma in situ of colon

522

1.72

4.80

5.0

3.8

1.22

1.23

mmol/l

0.10

460

Carcinoma in situ of skin of trunk

136

929

1.53

4.78

6.3

3.7

1.23

1.22

mmol/l

1.71

115

801

Sequelae of injuries of head

175

1247

1.44

4.77

3.4

4.3

1.22

mmol/l

0.86

145

1101

Vascular dementia (undefined)

151

1036

1.48

4.77

3.6

3.8

1.23

1.22

mmol/l

1.28

128

887

Exclusion endpoint for clefts

324

1.88

4.75

6.3

4.9

1.22

1.23

mmol/l

0.28

286

Obstructed labour due to malposition and malpresentation of fetus

457

5226

0.81

4.72

3.1

3.2

1.23

mmol/l

0.06

408

4581

Reactive arthropathies, FINNGEN

235

1759

1.36

4.72

4.5

3.9

1.23

mmol/l

0.25

212

1514

Volvulus

108

703

1.60

4.71

5.9

3.4

1.20

1.23

mmol/l

2.73

590

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

282

2170

1.33

4.71

7.2

3.6

1.22

1.23

mmol/l

1.03

263

1866

Arterial embolism and thrombosis

220

1633

1.38

4.69

10.1

3.6

1.21

1.22

mmol/l

1.32

207

1412

Other congenital malformations

262

1991

1.34

4.69

4.7

3.7

1.22

1.23

mmol/l

0.39

237

1728

Optic neuritis

140

961

1.50

4.68

4.3

3.2

1.22

1.23

mmol/l

0.83

127

826

Pustulosis palmaris et plantaris

156

1095

1.47

4.68

3.7

3.8

1.23

mmol/l

0.34

136

952

Other specified congenital malformation syndromes affecting multiple systems

255

2.00

4.67

7.0

5.1

1.22

1.23

mmol/l

0.22

229

Other/unspecified enthesopathies, not elsewhere classified

314

2452

1.31

4.66

3.6

3.9

1.23

mmol/l

0.29

289

2120

Malignant neoplasm of brain

105

679

1.59

4.65

5.7

2.9

1.22

1.23

mmol/l

0.70

563

Sequelae of injuries, of poisoning and of other consequences of external causes

810

6951

1.18

4.65

3.7

3.9

1.22

1.23

mmol/l

1.87

711

6128

Embedded and impacted teeth

749

5254

1.19

4.64

3.8

3.5

1.23

1.22

mmol/l

0.50

641

4573

Injury of blood vessels at lower leg level

100

2.76

4.63

12.4

4.0

1.21

1.22

mmol/l

0.71

Spasmodic torticollis

121

811

1.55

4.62

3.1

3.4

1.22

1.23

mmol/l

1.13

106

703

Deep endometriosis

350

2775

1.29

4.62

2.9

3.3

1.23

mmol/l

0.02

294

2390

Erythema nodosum

115

763

1.56

4.61

4.2

3.5

1.23

mmol/l

0.50

101

648

Otalgia

271

2079

1.33

4.61

3.9

3.4

1.23

mmol/l

0.32

240

1812

Brain meningioma, including Hilmo

173

1240

1.43

4.60

3.8

3.0

1.23

mmol/l

0.06

157

1033

Herpesviral keratitis and keratoconjunctivitis

160

1134

1.45

4.56

4.8

3.6

1.22

1.23

mmol/l

0.30

145

963

Acute myeloid leukaemia and myelodysplastic syndromes

427

1.76

4.56

6.2

2.6

1.20

1.22

mmol/l

1.53

351

MS-disease / Multiple Sclerosis

230

1725

1.36

4.56

3.9

3.4

1.23

mmol/l

0.36

194

1492

Parkinson's disease

594

4985

1.21

4.55

3.1

4.0

1.23

1.22

mmol/l

1.30

507

4335

Fracture of neck

221

1653

1.37

4.54

3.9

4.2

1.22

mmol/l

0.61

196

1439

Other menopausal disorders

1062

5222

1.16

4.52

2.8

3.5

1.24

mmol/l

0.20

877

4562

Carcinoma in situ, bladder

132

907

1.51

4.51

4.0

4.4

1.22

mmol/l

0.58

111

798

Male infertility

117

778

1.53

4.51

6.7

4.1

1.23

1.22

mmol/l

0.80

112

718

Allergic contact dermatitis

468

3839

1.24

4.49

3.3

3.5

1.23

mmol/l

0.83

410

3366

Benign neoplasm: Transverse colon

256

3320

0.76

4.48

4.6

4.2

1.22

1.23

mmol/l

0.54

231

2914

Other neurotic disorders

176

1272

1.42

4.48

3.9

3.8

1.22

1.23

mmol/l

1.48

150

1101

Panniculitis affecting regions of neck and back

131

897

1.50

4.47

3.6

3.2

1.23

mmol/l

0.05

122

760

Other peripheral vertigo

349

2780

1.28

4.46

3.7

3.8

1.23

mmol/l

0.04

312

2406

Hypotension due to drugs

387

1.81

4.46

6.4

4.0

1.20

1.22

mmol/l

2.05

339

Polycystic ovarian syndrome, broad definition

294

2288

1.30

4.41

2.4

2.8

1.22

1.23

mmol/l

1.39

257

1962

Abscess of anal and rectal regions

275

2127

1.32

4.38

5.0

3.9

1.22

mmol/l

0.45

249

1853

Malignant neoplasm of palate

3.84

4.38

3.5

3.3

1.34

1.21

mmol/l

1.08

Haemorrhoids and perianal venous thrombosis

1298

11530

1.13

4.38

3.7

3.6

1.23

mmol/l

0.44

1131

9921

Congenital malformations of the respiratory system

402

1.76

4.37

4.0

3.9

1.24

1.23

mmol/l

0.27

352

Maternal care for known or suspected abnormality of pelvic organs

742

4307

1.18

4.37

2.9

3.3

1.22

1.23

mmol/l

3.94

648

3779

Assault by blunt object

262

1.95

4.37

4.2

4.1

1.22

1.23

mmol/l

0.20

236

Congenital malformations of great arteries

320

1.84

4.36

3.2

4.9

1.22

1.23

mmol/l

0.30

282

Diseases of middle ear and mastoid

2053

15287

1.10

4.36

4.2

3.6

1.22

1.23

mmol/l

2.15

1809

13332

Burn and corrosion of shoulder and upper limb, except wrist and hand

448

1.72

4.36

3.4

3.9

1.22

1.23

mmol/l

0.23

385

Other bullous disorders

106

701

1.57

4.35

4.3

3.7

1.24

1.23

mmol/l

0.78

595

Allergic asthma (mode)

707

5900

1.18

4.34

3.1

2.9

1.23

mmol/l

0.38

628

5031

Viral infections of the central nervous system

260

2001

1.32

4.34

6.1

3.6

1.22

1.23

mmol/l

0.62

229

1729

Other and unspecified injuries of wrist and hand

129

886

1.50

4.34

4.4

3.6

1.23

mmol/l

0.06

109

758

Malignant neoplasm of eye and adnexa, including Hilmo

344

1.83

4.32

6.3

2.5

1.24

1.23

mmol/l

1.04

287

Noise effects on inner ear

964

0.57

4.32

3.7

4.7

1.21

1.22

mmol/l

0.23

858

Ulcer of vagina/vulva

101

662

1.58

4.32

3.9

3.0

1.23

mmol/l

0.00

552

Toxic liver disease

360

1.81

4.29

5.3

3.5

1.21

1.23

mmol/l

1.00

312

Von Willebrand disease

279

1.92

4.29

4.0

3.6

1.23

mmol/l

0.11

236

Malignant neoplasm of cervix uteri

315

1.86

4.29

3.4

2.2

1.21

1.23

mmol/l

1.37

259

Benign neoplasm: salivary glands, exclude unknown (D119)

318

2519

1.29

4.27

4.6

3.9

1.21

1.23

mmol/l

3.70

279

2193

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

2.66

4.25

3.5

1.21

1.23

mmol/l

1.02

Allergic colitis

321

1.82

4.24

3.3

3.7

1.23

mmol/l

0.07

279

Female infertility, associated with anovulation

202

1500

1.37

4.24

2.4

2.7

1.22

1.23

mmol/l

1.57

179

1315

Other/unspecified synovitis and tenosynovitis

406

3309

1.25

4.19

3.8

3.7

1.23

mmol/l

0.49

346

2879

Lesion of radial nerve

134

935

1.48

4.19

5.0

3.7

1.22

mmol/l

0.53

123

794

Retinal vascular occlusion

461

3811

1.23

4.19

5.0

4.0

1.23

mmol/l

0.82

400

3334

Aphakia

302

1.86

4.18

4.6

3.7

1.23

1.22

mmol/l

0.16

257

Subacute thyroiditis

128

887

1.49

4.15

3.0

3.1

1.23

mmol/l

0.12

107

777

Other conjunctival vascular disorders and cysts

623

1.59

4.10

3.4

4.0

1.24

1.23

mmol/l

0.94

546

Intracerebral haemorrhage

482

4008

1.22

4.09

5.0

4.0

1.22

mmol/l

1.57

428

3421

Sacroiliitis, not elsewhere classified

142

1004

1.44

4.07

2.7

3.2

1.23

mmol/l

0.18

128

863

Disorders of endocrine glands in diseases classified elsewhere

5.01

4.07

20.4

3.4

1.23

1.24

mmol/l

0.30

Peripheral artery operations in Hilmo

475

3945

1.22

4.07

10.9

3.7

1.21

1.22

mmol/l

7.88

425

3414

Major anomalies of jaw size

574

1.60

4.06

2.8

3.6

1.23

mmol/l

0.10

499

Renal cell carcinoma of kidney

112

760

1.52

4.05

7.3

2.8

1.23

1.22

mmol/l

0.37

104

631

Blepharochalasis

1205

10749

1.13

4.03

3.3

3.8

1.23

mmol/l

0.57

1025

9322

Malignant neoplasm of anus and anal canal, including Hilmo

256

1.93

4.03

6.4

2.4

1.23

1.22

mmol/l

0.26

212

Carcinoma in situ of cervix uteri

282

2214

1.29

4.03

3.1

2.9

1.23

mmol/l

0.44

237

1895

Alzheimer’s disease (Late onset)

743

7224

0.86

4.02

3.1

3.8

1.23

mmol/l

0.82

584

6230

Disorders of orbit

157

1136

1.42

4.02

3.6

1.23

mmol/l

0.24

143

983

Status post-ami

774

6806

0.86

4.01

5.4

3.6

1.22

1.23

mmol/l

3.59

709

5821

Anosmia

303

1.81

4.01

3.1

1.8

1.23

1.24

mmol/l

0.34

232

Childhood allergy (age < 16)

337

2217

1.26

4.01

3.4

3.2

1.22

mmol/l

0.30

291

1855

Other salmonella infections

134

944

1.46

4.00

4.2

3.5

1.22

1.23

mmol/l

0.48

111

806

Parkinson's disease, including avohilmo

613

5223

1.19

3.99

3.1

4.0

1.23

1.22

mmol/l

1.42

525

4535

Left ventricular outflow tract obstruction, narrow definition

149

1068

1.43

3.99

4.4

4.5

1.22

mmol/l

0.03

134

934

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

108

2.54

3.98

7.8

3.6

1.22

mmol/l

0.03

Procreative management

1077

7939

1.14

3.98

4.3

3.9

1.23

mmol/l

0.61

961

7004

Paranoid personality disorder

375

1.74

3.98

3.3

3.7

1.23

1.22

mmol/l

0.26

327

Polyp of the female genital tract

1171

5964

1.14

3.97

3.4

3.5

1.24

1.23

mmol/l

1.00

1016

5188

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

2.96

3.97

7.2

4.5

1.23

1.22

mmol/l

0.25

Other and unspecified injuries of shoulder and upper arm

108

731

1.52

3.97

5.3

3.6

1.22

1.23

mmol/l

1.02

626

Unspecified privation

233

3010

0.76

3.96

5.2

3.9

1.22

1.23

mmol/l

0.19

210

2630

Retinal vascular disorders

466

3880

1.22

3.95

5.1

4.0

1.23

mmol/l

0.68

404

3391

Asthma and opportunity respiratory infection

181

1347

1.38

3.94

3.8

3.6

1.22

1.23

mmol/l

1.33

167

1148

Ventricular septal defect, a heart condition

374

1.73

3.93

4.5

4.4

1.22

1.23

mmol/l

0.43

322

Motorcycle rider injured in other and unspecified transport accidents

165

1205

1.39

3.93

3.5

4.1

1.22

mmol/l

0.31

154

1064

Malignant neoplasm of vulva

231

1.99

3.92

6.1

2.7

1.23

mmol/l

0.36

192

Toxic effects of substances chiefly nonmedicinal as to source

361

2928

1.25

3.92

3.5

3.9

1.22

1.23

mmol/l

1.52

319

2565

Injury of nerves at wrist and hand level

121

839

1.48

3.91

2.9

4.4

1.22

1.23

mmol/l

0.34

103

725

Use of levodopa decarboxylase inhibitor

532

4489

1.20

3.91

3.2

4.0

1.23

1.22

mmol/l

0.74

451

3905

Hallux valgus (acquired)

1311

8439

1.13

3.91

3.3

3.6

1.23

mmol/l

0.27

1118

7274

Benign neoplasm of major salivary glands

351

2844

1.26

3.90

4.5

3.9

1.21

1.23

mmol/l

4.08

311

2482

Tic and related disorders

166

2.12

3.90

3.7

5.4

1.22

1.23

mmol/l

0.19

151

Other and unspecified nerve root and plexus disorders, also in other diseases

689

5933

1.17

3.88

3.5

3.9

1.23

mmol/l

0.68

599

5201

Cutaneous lupus erythematosus

631

1.56

3.88

5.1

3.5

1.24

1.23

mmol/l

0.18

541

Prolapse and hernia of ovary and fallopian tube

1222

0.64

3.84

3.4

3.5

1.24

1.23

mmol/l

0.44

1004

Alopecia areata

599

1.57

3.83

4.1

3.2

1.23

mmol/l

0.48

514

Viral encephalitis, not elsewhere classified/unspecified

473

1.65

3.83

9.2

3.8

1.22

1.23

mmol/l

0.22

412

Erectile dysfunction

277

2191

1.29

3.82

4.4

4.5

1.21

mmol/l

0.05

245

1941

Acute appendicitis

2638

22857

1.08

3.80

3.8

3.9

1.23

mmol/l

0.06

2357

20016

Impacted maxillary molar

152

1101

1.40

3.79

2.8

3.0

1.23

1.22

mmol/l

0.42

140

931

Suppurative otitis media, unspecified

568

1.58

3.78

4.6

3.3

1.22

1.23

mmol/l

0.52

483

Seronegative juvenile rheumatoid arthritis

312

1.79

3.77

2.9

3.1

1.21

1.22

mmol/l

0.97

272

Oral lichen planus and hypothyroidism or thyroxine medication

485

1.64

3.76

3.2

3.7

1.24

1.23

mmol/l

0.38

413

Other specified/unspecified spondylopathies

100

676

1.53

3.76

4.9

3.1

1.22

1.23

mmol/l

0.58

570

Chronic hepatitis NAS

315

1.80

3.75

4.3

3.3

1.22

1.23

mmol/l

0.46

273

Tonsillectomy and adenotomy

1550

11906

0.90

3.74

3.6

1.22

1.23

mmol/l

0.35

1345

10530

Trigger finger

508

4282

1.20

3.74

4.4

3.7

1.23

mmol/l

0.35

437

3737

Other disorders of bone density and structure

570

1.57

3.74

4.6

3.1

1.23

mmol/l

0.08

485

Other and unspecified vascular occlusions

357

2914

1.25

3.74

4.0

3.9

1.23

mmol/l

1.16

304

2560

Acute gastritis

275

2179

1.29

3.73

5.9

3.7

1.23

mmol/l

0.07

248

1878

Allergic bronchopulmonary aspergillosis (ABPA)

2.96

3.73

4.4

3.1

1.24

1.23

mmol/l

0.21

Benign neoplasm: Cerebral meninges

353

2881

1.25

3.71

4.2

3.7

1.24

1.23

mmol/l

0.47

312

2481

Hydrocele

381

3128

1.23

3.70

6.0

4.4

1.21

mmol/l

0.58

340

2763

Other symptoms and signs involving the circulatory and respiratory systems

216

1660

1.32

3.69

3.8

3.5

1.23

mmol/l

0.51

183

1426

Perioral dermatitis

493

1.62

3.69

2.9

3.1

1.23

mmol/l

0.09

423

Congenital malformations of aortic and mitral valves

126

892

1.45

3.66

4.4

4.3

1.23

1.22

mmol/l

0.14

112

781

Blood alcohol or alcohol intoxication level

493

1.61

3.66

3.8

3.9

1.20

1.23

mmol/l

2.41

422

Amblyopia ex anopsia

128

909

1.44

3.65

5.5

3.8

1.23

mmol/l

0.06

111

793

Pilonidal cyst

240

1871

1.30

3.65

3.5

3.3

1.22

mmol/l

0.10

210

1636

Achalasia of cardia

464

1.64

3.65

4.5

4.0

1.21

1.23

mmol/l

0.86

400

Primary coxarthrosis, bilateral

1158

10374

1.13

3.64

3.3

4.0

1.23

mmol/l

0.15

1014

8965

Carcinoma in situ of other and unspecified digestive organs

131

939

1.44

3.64

5.0

3.9

1.22

1.23

mmol/l

0.18

117

820

Acute bronchiolitis

149

974

1.40

3.63

6.2

3.2

1.22

1.23

mmol/l

0.46

136

830

Arterial embolism and thrombosis of lower extremity artery

132

946

1.43

3.62

9.9

3.5

1.21

1.22

mmol/l

1.39

122

819

Nystagmus and other irregular eye movements

295

1.81

3.61

4.9

3.8

1.23

mmol/l

0.25

260

Congenital malformations of the nervous system

416

1.66

3.61

6.4

3.4

1.22

1.23

mmol/l

0.33

357

Other congenital malformations of urinary system

2.64

3.59

16.4

4.6

1.25

1.22

mmol/l

2.61

Thrombotic microangiopathy

126

2.30

3.59

11.9

3.9

1.22

mmol/l

0.02

108

Fracture at wrist and hand level

1178

10538

1.12

3.58

3.7

3.9

1.22

1.23

mmol/l

0.91

1035

9264

Benign neoplasm of meninges

388

3210

1.23

3.58

4.1

3.7

1.23

mmol/l

0.38

346

2764

Dementia in other diseases classified elsewhere

166

1239

1.37

3.56

4.3

3.8

1.23

1.22

mmol/l

0.67

136

1084

Abscess of tendon sheath

140

2.22

3.55

5.9

3.9

1.22

1.23

mmol/l

0.45

124

Personal history of malignant neoplasm

125

1735

0.71

3.54

3.7

3.3

1.24

mmol/l

0.08

120

1503

Congenital iodine-deficiency syndrome/hypothyroidism

107

742

1.49

3.54

4.9

3.5

1.22

1.23

mmol/l

0.86

101

642

Sequelae of injuries of upper limb

318

2578

1.25

3.53

3.6

4.0

1.22

1.23

mmol/l

1.11

282

2261

Mental and behavioural disorders of puerperium, not classified elsewhere

209

1.95

3.53

5.6

3.3

1.24

1.23

mmol/l

0.61

176

Disorders of optic nerve, not elsewhere classified

540

1.58

3.53

4.8

3.7

1.22

1.23

mmol/l

0.32

472

Excessive earwax

2182

19674

1.09

3.52

4.2

3.9

1.23

mmol/l

0.13

1859

17168

Retinoschisis and retinal cysts

638

1.53

3.51

4.6

3.6

1.23

mmol/l

0.02

559

Congenital malformations of the respiratory system

366

1.70

3.51

4.2

4.0

1.24

1.23

mmol/l

0.49

320

Abrasion of teeth

1225

11026

1.12

3.51

3.5

3.7

1.23

mmol/l

0.09

1032

9672

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

320

1.75

3.50

5.2

5.1

1.23

mmol/l

0.03

279

Cramp and spasm

157

1164

1.38

3.50

3.9

3.5

1.22

1.23

mmol/l

1.75

139

1008

Inflammation of lacrimal passages (acute and unspecified)

453

1.63

3.50

3.8

3.4

1.23

mmol/l

0.17

381

Dislocation, sprain and strain of joints and ligaments of thorax

112

784

1.47

3.50

4.7

3.7

1.23

mmol/l

0.04

102

682

Endometriosis ASRM stages 3,4

809

7107

1.15

3.49

3.1

3.3

1.23

mmol/l

0.03

699

6138

Brain meningioma

161

1199

1.37

3.49

3.7

2.9

1.24

1.23

mmol/l

0.34

145

998

Malignant neoplasm of gallbladder, including Hilmo

141

2.19

3.48

4.7

2.6

1.22

1.23

mmol/l

0.03

114

Problems related to social environment

670

1.50

3.46

4.3

3.3

1.22

1.23

mmol/l

0.16

574

!Aliquae complicationes praecoces traumatis

142

1038

1.40

3.46

5.7

4.0

1.22

1.23

mmol/l

0.44

128

908

Early complications of trauma

142

1038

1.40

3.46

5.7

4.0

1.22

1.23

mmol/l

0.44

128

908

Viral warts

687

5971

1.16

3.44

6.6

3.6

1.22

1.23

mmol/l

2.07

615

5215

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

583

1.55

3.44

5.8

3.8

1.22

1.23

mmol/l

0.38

510

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

538

4592

1.18

3.43

3.5

3.1

1.23

mmol/l

0.94

456

3983

Postzoster neuralgia

409

1.66

3.42

6.8

3.6

1.22

mmol/l

0.01

357

Other and unspecified nail disorders

535

1.57

3.42

4.7

3.4

1.23

mmol/l

0.30

469

Other or ill-defined heart diseases

170

1278

1.35

3.42

6.8

3.5

1.22

1.23

mmol/l

1.37

157

1093

Melanoma in situ of trunk

386

1.69

3.42

4.9

4.1

1.22

mmol/l

0.15

341

Disorders of purine and pyrimidine metabolism

136

2.23

3.42

7.4

3.4

1.22

mmol/l

0.31

121

Benign neoplasm: Parotid gland

282

2269

1.27

3.41

4.5

3.9

1.21

1.23

mmol/l

3.35

247

1970

Ankylosing spondylitis, strict definition

130

938

1.42

3.41

3.2

3.9

1.22

1.23

mmol/l

0.69

121

810

Salpingitis and oophoritis

641

5555

1.17

3.40

3.5

3.3

1.23

1.24

mmol/l

2.27

546

4818

Hypersensitivity angiitis

123

2.30

3.40

9.7

4.1

1.24

1.22

mmol/l

0.81

106

Malignant neoplasm of larynx, including Hilmo

424

1.63

3.39

5.4

3.4

1.21

1.22

mmol/l

0.67

360

Cerebral atherosclerosis

339

1.73

3.39

4.8

3.8

1.23

1.22

mmol/l

0.55

285

Diabetic neuropathy

449

3771

1.21

3.37

7.8

4.5

1.21

1.22

mmol/l

2.81

405

3356

Recurrent aphthous stomatitis , including avohilmo

495

4206

1.19

3.37

4.4

3.7

1.23

mmol/l

0.89

441

3650

Granulomatous disorders of skin and subcutaneous tissue

634

1.51

3.37

6.5

3.3

1.23

mmol/l

0.53

543

Early lumbar disc prolapse, operated

251

1989

1.28

3.36

3.5

1.22

1.23

mmol/l

0.81

229

1767

Inflammatory disease of uterus

451

3802

1.20

3.35

2.9

3.2

1.23

mmol/l

2.17

386

3305

Pneumothorax

231

1818

1.29

3.35

5.4

3.5

1.22

mmol/l

0.87

218

1581

Other disorders affecting eyelid function

234

0.33

3.34

1.5

3.6

1.25

1.23

mmol/l

—

207

Palindromic rheumatism

251

1.85

3.33

3.6

3.5

1.22

1.23

mmol/l

0.77

210

Chondrocostal junction syndrome [Tietze]

131

953

1.41

3.32

3.4

3.5

1.23

mmol/l

0.01

113

812

Autonomic disorders

563

1.54

3.32

3.3

3.6

1.22

1.23

mmol/l

0.80

481

Conduct disorder

347

1.68

3.32

3.8

3.9

1.23

mmol/l

0.11

306

Generalized epilepsy

124

892

1.42

3.32

4.1

3.6

1.21

1.23

mmol/l

2.48

113

759

Contact with heat and hot substances

167

1260

1.35

3.31

5.2

3.9

1.22

1.23

mmol/l

0.70

137

1103

Inflammatory diseases of the central nervous system

272

2185

1.27

3.31

5.8

3.7

1.21

1.23

mmol/l

3.30

248

1906

Malignant neoplasm of ureter, including Hilmo

179

2.02

3.31

8.0

2.9

1.21

1.22

mmol/l

0.22

147

Bicuspidal aortic valve syndrome

112

793

1.45

3.30

3.6

4.3

1.23

1.22

mmol/l

0.04

100

698

Other disorders of pigmentation

158

1186

1.37

3.29

4.2

3.3

1.23

mmol/l

0.24

137

1015

Fall involving bed

126

914

1.42

3.29

5.5

3.7

1.22

mmol/l

0.27

116

783

Common variable immunodeficiency

124

2.24

3.29

4.7

3.4

1.22

1.23

mmol/l

0.03

106

Alzheimer’s disease (Late onset), excluding more controls

584

3289

1.18

3.29

3.2

3.8

1.23

mmol/l

0.27

467

2794

167

1256

1.35

3.28

3.6

3.4

1.22

mmol/l

0.16

143

1035

Disorders of eyelid in diseases classified elsewhere

116

830

1.44

3.26

4.8

3.4

1.23

mmol/l

0.27

104

708

Other congenital malformations of circulatory system

598

1.52

3.25

3.7

4.0

1.22

1.23

mmol/l

0.78

522

Secondary parkinsonism

101

708

1.47

3.20

4.8

3.7

1.24

1.22

mmol/l

1.60

606

Tularaemia

423

1.62

3.20

5.3

4.0

1.22

1.23

mmol/l

0.17

379

Retinal detachment with retinal break

463

3935

1.19

3.19

4.6

4.0

1.22

1.23

mmol/l

0.26

402

3486

COPD-related respiratory insufficiency

428

3614

1.20

3.19

7.2

4.1

1.20

1.22

mmol/l

10.08

398

3131

Vulvovaginal ulceration/inflammation in other diseases

182

1398

1.32

3.19

4.3

2.9

1.23

mmol/l

0.38

156

1203

Other epidermal thickening

153

1149

1.36

3.19

8.4

3.4

1.22

1.23

mmol/l

1.19

136

985

Paraplegia, diplegia of upper limbs

512

1.56

3.17

4.4

3.6

1.21

1.22

mmol/l

0.90

444

Non-small cell lung cancer, squamous

145

1079

1.37

3.17

4.3

3.0

1.24

1.22

mmol/l

3.04

136

905

Disorder of the sleep-wake schedule

345

1.68

3.17

5.9

3.9

1.23

mmol/l

0.29

311

Dermatopolymyositis, unspecified

120

2.25

3.15

4.0

4.4

1.22

mmol/l

0.23

108

hereditary angioödema type 3

5.17

3.15

2.3

6.1

1.21

mmol/l

—

Other adrenocortical overactivity

2.39

3.14

11.9

2.6

1.22

1.23

mmol/l

1.06

Vestibular neuronitis

316

2599

1.24

3.14

3.0

4.0

1.23

mmol/l

0.13

275

2269

Contact with other hot fluids

651

1.48

3.14

4.1

3.8

1.22

1.23

mmol/l

1.05

567

Melanocytic naevi of trunk

392

3288

1.21

3.13

6.2

3.7

1.23

mmol/l

0.14

347

2876

Infection of intervertebral disc (pyogenic)

317

1.72

3.13

7.9

3.3

1.23

mmol/l

0.17

270

Complications of genitourinary prosthetic devices, implants and grafts

620

1.50

3.12

5.2

3.2

1.22

1.23

mmol/l

0.78

525

Secondary parkinsonism+Parkinsonism in other disease

104

737

1.46

3.12

4.9

3.7

1.24

1.22

mmol/l

1.62

636

Benign neoplasm of bone and articular cartilage

268

2166

1.26

3.12

3.9

3.7

1.22

1.23

mmol/l

0.36

231

1893

Venous complications and haemorrhoids in the puerperium

264

1.79

3.11

2.4

2.9

1.23

1.24

mmol/l

0.22

231

Other/unspecified postprocedural disorders of ear and mastoid process

0.00

3.10

0.0

3.7

—

1.23

—

Ovarian dysfunction, other/unspecified

107

2.28

3.09

4.4

3.5

1.23

mmol/l

0.01

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

141

1052

1.37

3.09

3.4

3.8

1.23

mmol/l

0.54

127

913

Inflammatory disorders of male genital organs, not elsewhere classified

226

1.83

3.09

6.3

3.5

1.22

mmol/l

0.01

203

Conjunctivitis

2878

22532

1.07

3.07

3.6

3.7

1.23

mmol/l

0.75

2507

19651

Acute posthaemorrhagic anaemia

122

890

1.41

3.07

6.6

3.2

1.21

1.22

mmol/l

1.25

112

756

Parkinson's disease, strict definition

537

4637

1.17

3.06

2.9

4.0

1.23

1.22

mmol/l

0.84

458

4036

Other contact dermatitis

263

2126

1.26

3.05

4.3

3.5

1.23

mmol/l

0.64

231

1841

Arnold-Chiari syndrome

148

2.05

3.05

3.5

3.6

1.23

1.22

mmol/l

0.24

127

Benign neoplasm of mouth and pharynx

376

3153

1.21

3.05

4.4

3.9

1.22

1.23

mmol/l

0.32

336

2771

Other localized connective tissue disorders

494

1.55

3.03

6.4

3.5

1.24

1.23

mmol/l

0.36

429

Ectopic pregnancy

570

4943

1.16

3.02

3.3

1.23

mmol/l

0.73

493

4318

Adenomyosis (Endometriosis of uterus)

485

4157

1.18

3.02

3.1

3.5

1.23

1.24

mmol/l

2.92

406

3595

Haemorrhagic and haematological disorders of fetus and newborn

195

1.86

3.02

8.2

6.2

1.23

mmol/l

0.15

177

Delivery

1521

7334

1.10

3.01

3.3

3.6

1.23

mmol/l

0.05

1285

6283

Cardiomyopathy, Hypertrophic obstructive

422

1.59

3.00

6.2

4.0

1.21

1.23

mmol/l

1.72

364

Atypical virus infections of central nervous system

230

1.84

2.99

4.2

3.6

1.24

1.23

mmol/l

0.35

203

Disorders of lacrimal system and orbit in diseases classified elsewhere

627

1.48

2.97

3.2

3.3

1.22

1.23

mmol/l

1.34

530

Hypertrichosis

422

1.58

2.97

3.7

2.7

1.23

mmol/l

0.32

357

Anxious personality disorder

335

1.66

2.97

2.6

3.2

1.22

1.23

mmol/l

0.16

294

Stomatitis and related lesions

669

5875

1.15

2.97

4.6

3.7

1.22

1.23

mmol/l

1.01

594

5129

Plantar fascial fibromatosis

326

2704

1.22

2.96

3.2

3.8

1.23

mmol/l

0.05

293

2351

Other congenital malformations of nervous system

164

1.97

2.95

3.5

4.2

1.23

1.22

mmol/l

0.49

141

Other vitreous opacities

141

1061

1.36

2.94

4.2

3.6

1.23

mmol/l

0.00

125

912

Hypertrophic cardiomyopathy

147

1113

1.35

2.94

6.3

4.1

1.22

mmol/l

0.28

137

971

Other encephalitis

636

1.47

2.94

5.9

3.7

1.22

1.23

mmol/l

1.27

558

Right hemicolectomy

213

1693

1.28

2.94

5.0

3.8

1.22

1.23

mmol/l

0.21

196

1467

Dermatitis herpetiformis

441

1.58

2.94

4.3

3.8

1.24

1.23

mmol/l

1.11

378

Obstructed labour due to maternal pelvic abnormality

372

4411

0.83

2.93

3.3

3.4

1.24

mmol/l

0.17

330

3839

Carcinoma in situ of skin of lower limb, including hip

623

1.49

2.93

7.0

3.7

1.23

mmol/l

0.44

542

Effects of heat and light

180

1.94

2.93

3.6

4.0

1.23

1.22

mmol/l

0.74

160

Malignant neoplasm of accessory sinuses

3.42

2.92

8.2

3.7

1.23

1.21

mmol/l

0.65

Overexertion and strenuous or repetitive movements

207

2601

0.79

2.91

3.7

3.8

1.22

1.23

mmol/l

0.33

182

2280

Other and unspecified epidermal thickening

638

1.47

2.90

10.1

3.4

1.21

1.23

mmol/l

1.20

539

Congenital malformation of biliary tract

3.36

2.89

16.7

4.4

1.24

1.23

mmol/l

0.21

Burn and corrosion of hip and lower limb, except ankle and foot

515

1.52

2.88

3.5

3.7

1.22

1.23

mmol/l

0.63

443

Use of donepezil

823

7031

1.13

2.86

2.7

3.8

1.23

mmol/l

1.86

664

6044

Allergic purpura

681

1.44

2.86

6.2

3.3

1.22

1.23

mmol/l

0.72

586

Disorders of myoneural junction and muscle in diseases classified elsewhere

189

1.91

2.85

7.1

3.4

1.22

1.23

mmol/l

0.50

169

Disorders of tyrosine metabolism

4.92

2.84

8.0

3.4

1.23

1.22

mmol/l

—

Other and specified injuries of hip and thigh

559

1.49

2.83

4.4

3.7

1.22

1.23

mmol/l

0.58

484

Exposure to other and unspecified animate mechanical forces

624

1.46

2.82

4.2

3.4

1.23

mmol/l

0.20

542

Poisoning by medicine, drug-induced

264

1.73

2.80

5.4

3.8

1.21

1.23

mmol/l

1.05

236

Posteruptive colour changes of dental hard tissues

2.68

2.80

4.8

3.0

1.24

1.23

mmol/l

0.62

Combined immunodeficiencies

242

1.77

2.80

4.5

3.8

1.25

1.23

mmol/l

0.88

216

Vascular dementia

331

2667

1.21

2.80

3.8

1.23

1.22

mmol/l

1.46

288

2293

Other obstructed labour

239

1935

1.25

2.78

3.1

3.2

1.23

mmol/l

0.31

213

1673

Haemangioma and lymphangioma, any site

299

2479

1.22

2.77

3.6

3.9

1.23

mmol/l

0.40

272

2160

Sequelae of infectious and parasitic diseases

241

1954

1.25

2.77

4.5

3.8

1.22

mmol/l

0.21

211

1699

Muscle strain

101

728

1.42

2.75

4.2

3.6

1.23

mmol/l

0.11

615

Fall on and from stairs and steps

932

8400

1.12

2.71

4.2

3.8

1.22

1.23

mmol/l

1.90

812

7326

Acute nasopharyngitis (common cold)

330

2744

1.21

2.71

4.7

3.9

1.22

mmol/l

1.02

300

2425

Other specified disorders of muscle

680

1.43

2.71

3.7

4.1

1.22

1.23

mmol/l

0.51

578

Burns and corrosions of multiple and unspecified body regions

481

1.52

2.71

2.9

4.0

1.23

1.22

mmol/l

0.39

420

Colonic or urogenital fistula

957

8640

1.12

2.70

3.9

1.23

mmol/l

0.30

848

7571

Tooth agenesis EXCLUDE clefts and syndromes

645

1.43

2.69

4.3

3.8

1.23

mmol/l

0.02

553

Other surgical follow-up care

102

740

1.41

2.68

4.2

2.6

1.23

mmol/l

0.22

619

Pemphigoid

104

760

1.41

2.68

5.0

3.6

1.23

1.22

mmol/l

0.57

651

Other and unspecified acne

252

1.72

2.67

11.1

2.9

1.22

mmol/l

0.22

217

Acute lymphocytic leukaemia, helper endpoint

2.35

2.67

6.3

3.0

1.24

1.23

mmol/l

0.27

Acute lymphocytic leukaemia

2.35

2.67

6.3

3.0

1.24

1.23

mmol/l

0.27

Acute lymphocytic leukaemia, including Hilmo

2.35

2.67

6.3

3.0

1.24

1.23

mmol/l

0.27

Postprocedural disorders of ear and mastoid process, not elsewhere classified

209

0.37

2.67

2.5

3.2

1.21

1.22

mmol/l

—

184

Other diseases of upper respiratory tract

4758

23646

1.05

2.66

3.7

3.8

1.23

mmol/l

0.91

4179

20576

Other and unspecified disorders of pigmentation

135

2.02

2.66

6.6

3.7

1.22

mmol/l

0.14

124

Retinal haemorrhage

677

1.43

2.64

10.5

3.9

1.23

mmol/l

0.00

590

Artificial joint re-operation

263

2170

1.24

2.63

4.5

3.9

1.22

1.23

mmol/l

1.76

246

1893

Other sexually transmitted chlamydial diseases

151

1948

0.77

2.63

2.6

3.0

1.22

mmol/l

0.29

122

1663

Behavioural disorders

362

1.58

2.63

3.8

3.7

1.23

mmol/l

0.00

313

Maternal care for known or suspected disproportion

883

0.66

2.62

3.2

1.23

mmol/l

0.24

788

Encephalitis

685

1.42

2.62

5.8

3.6

1.21

1.23

mmol/l

1.59

597

Dislocation, sprain and strain of joint and ligaments of hip

129

977

1.35

2.62

3.4

3.7

1.24

1.22

mmol/l

1.34

118

838

Personality and behavioural disorders due to brain disease, damage and dysfunction

316

1.64

2.62

3.6

4.0

1.22

mmol/l

0.05

286

Viral haemorrhagic fevers, not elsewhere classified/unspecified

403

4693

0.85

2.61

4.0

4.1

1.22

1.23

mmol/l

0.49

359

4113

Benign neoplasm: Skin of trunk

139

1064

1.33

2.60

6.1

3.7

1.23

mmol/l

0.13

130

915

Flatulence and related conditions

217

1.78

2.59

3.4

3.6

1.21

1.23

mmol/l

0.84

190

Subjective visual disturbances

912

8236

1.12

2.58

3.9

3.7

1.22

1.23

mmol/l

1.65

817

7140

Residual foreign body in soft tissue

156

1213

1.31

2.57

3.3

3.8

1.22

mmol/l

0.03

144

1056

Sexual assault by bodily force

2.80

2.57

2.2

3.4

1.22

mmol/l

0.03

Benign neoplasm: Rectum

521

5948

0.87

2.56

4.1

4.0

1.23

mmol/l

1.01

465

5194

Other bursitis of hip

538

1.48

2.56

2.9

3.1

1.23

mmol/l

0.10

458

Injury of intra-abdominal organs

538

1.47

2.53

4.9

3.7

1.21

1.23

mmol/l

1.34

465

Combined immunodeficiency, unspecified

4.32

2.53

7.0

5.2

1.24

1.21

mmol/l

—

Seborrhoeic keratosis

863

7787

1.12

2.52

6.5

3.6

1.23

mmol/l

0.53

779

6722

Haemangioma, any site

279

2324

1.22

2.50

3.7

3.8

1.23

mmol/l

0.67

252

2024

Abnormal serum enzyme levels

902

9709

0.90

2.50

5.0

4.2

1.22

mmol/l

1.68

841

8475

Injury of unspecified body region

256

2116

1.23

2.49

5.5

3.8

1.22

1.23

mmol/l

0.89

231

1829

Other melanin hyperpigmentation

627

1.43

2.47

3.1

3.5

1.24

1.23

mmol/l

0.36

546

Desensitization to allergens

1084

0.70

2.47

2.3

3.3

1.23

mmol/l

0.13

931

Corns and callosities

229

1875

1.24

2.47

7.6

3.5

1.22

1.23

mmol/l

0.78

209

1629

Hirsutism in women

361

1.56

2.45

3.1

2.6

1.22

1.23

mmol/l

0.82

300

Exposure to other specified electric current

465

0.55

2.45

4.4

3.4

1.24

1.23

mmol/l

0.37

399

Graves ophthalmopathy

628

1.42

2.43

3.2

3.5

1.22

1.23

mmol/l

1.44

531

Guttate psoriasis

308

1.61

2.40

3.6

1.21

1.23

mmol/l

0.62

265

Vascular diseases of the intestine

141

1096

1.31

2.39

6.4

3.4

1.22

1.23

mmol/l

0.44

127

937

Spermatocele

239

1971

1.23

2.39

4.4

4.6

1.21

1.22

mmol/l

0.53

216

1751

Other noninflammatory disorders of vulva and perineum

303

2554

1.20

2.39

3.6

3.3

1.23

1.24

mmol/l

1.42

259

2207

Mucinous and mucinous cystic tumor of rectum

2.21

2.38

2.7

2.9

1.23

1.22

mmol/l

0.13

Other and unspecified iridocyclitis

144

1123

1.31

2.37

3.6

3.8

1.23

mmol/l

0.15

134

963

Hemiplegia

161

1273

1.29

2.37

4.8

3.7

1.22

1.23

mmol/l

0.49

147

1095

Event of undetermined intent

183

1468

1.26

2.36

5.1

3.8

1.21

1.23

mmol/l

3.80

167

1283

Malignant neoplasm of floor of mouth

2.14

2.36

5.2

2.8

1.25

1.22

mmol/l

0.45

Arteriovenous malformation of cerebral vessels

247

1.69

2.36

4.5

4.2

1.22

1.23

mmol/l

0.14

219

Carcinoma in situ of skin of ear and external auricular canal

375

1.55

2.35

6.6

3.9

1.21

mmol/l

0.24

321

Brain astrocytoma

2.68

2.33

3.5

2.7

1.22

mmol/l

0.26

Brain astrocytoma, including Hilmo

2.68

2.33

3.5

2.7

1.22

mmol/l

0.26

Third [oculomotor] nerve palsy

466

1.49

2.32

6.7

3.7

1.23

mmol/l

0.03

405

Hypothermia

441

1.50

2.31

5.7

3.9

1.19

1.22

mmol/l

1.97

392

Other secondary coxarthrosis

117

892

1.34

2.31

4.0

3.6

1.24

1.23

mmol/l

1.20

108

760

Congenital dyserythropoietic anaemia

5.22

2.30

2.0

4.0

1.22

1.21

mmol/l

—

Propionic acid derivatives

1129

5186

1.10

2.29

3.6

4.8

1.22

mmol/l

0.28

978

4571

Sequelae of intentional self-harm, assault and events of undetermined intent

107

2.05

2.28

3.1

3.5

1.24

1.22

mmol/l

0.72

Occupant of special vehicle mainly used on industrial premises injured in transport accident

2.19

2.26

6.2

4.1

1.25

1.21

mmol/l

0.94

Other abnormal immunological findings in serum

451

1.48

2.26

5.4

3.5

1.23

mmol/l

0.10

384

Other disorders of eye and adnexa

462

4044

1.15

2.26

3.5

3.7

1.23

mmol/l

0.11

404

3513

Use of rivastigmine

593

5265

1.14

2.26

2.8

3.8

1.23

mmol/l

1.23

462

4495

Ulcerative proctitis

184

1487

1.26

2.25

3.5

3.4

1.23

mmol/l

0.25

172

1290

Tic disorders

195

1.74

2.25

3.8

4.6

1.22

1.23

mmol/l

0.76

174

Stenosis and insufficiency of lacrimal passages

335

2868

1.18

2.24

3.4

3.6

1.23

mmol/l

0.00

291

2477

Bacterial pneumonia, not elsewhere classified

1231

11745

0.92

2.24

5.9

3.2

1.22

1.23

mmol/l

7.93

1123

10037

Hair colour and hair shaft abnormalities

102

2.12

2.24

2.8

4.4

1.22

mmol/l

0.07

Pterygium

105

793

1.36

2.24

4.8

4.2

1.22

mmol/l

0.16

684

Myocardial infarction, unclassifiable

698

6927

0.89

2.24

5.5

3.9

1.21

1.22

mmol/l

8.03

621

5972

Other disorders of penis

271

2276

1.20

2.23

4.0

4.4

1.22

mmol/l

0.54

230

2038

Melanocytic naevi

1003

9174

1.10

2.23

5.7

3.7

1.23

mmol/l

0.08

876

8035

656

1.40

2.23

5.1

3.8

1.21

1.22

mmol/l

1.33

563

Other enthesopathy of foot (+metatarsalgia)

337

2888

1.18

2.21

3.9

3.6

1.23

mmol/l

1.26

305

2501

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

639

1.39

2.19

2.9

3.7

1.22

1.23

mmol/l

0.41

559

Intrahepatic Cholestasis of Pregnancy (ICP)

186

1509

1.25

2.19

3.1

3.0

1.22

1.23

mmol/l

2.00

170

1305

Scar conditions and fibrosis of skin

128

995

1.31

2.19

4.5

3.1

1.22

1.23

mmol/l

1.07

115

858

Fistulae involving female genital tract

422

1.49

2.19

5.7

3.1

1.23

1.24

mmol/l

0.34

351

Lesion of lateral popliteal nerve

159

1270

1.27

2.19

6.1

4.0

1.22

mmol/l

0.77

143

1099

Other and unspecified disorders of adult personality and behaviour

102

2.06

2.18

2.3

2.7

1.23

mmol/l

0.09

Single spontaneous delivery

1490

7321

1.08

2.18

3.3

3.7

1.24

1.23

mmol/l

0.39

1261

6272

Adult respiratory distress syndrome

292

1.60

2.18

10.0

3.9

1.20

1.23

mmol/l

2.14

258

Progressive external ophthalmoplegia

5.78

2.16

3.2

7.1

1.23

1.21

mmol/l

—

Burn and corrosion of trunk

684

1.37

2.16

5.0

3.9

1.22

1.23

mmol/l

0.69

595

Fourth [trochlear] nerve palsy

566

1.42

2.15

4.3

3.8

1.23

1.22

mmol/l

0.38

493

Disorder of lipoprotein metabolism, unspecified

474

4175

1.15

2.15

5.2

3.2

1.22

1.23

mmol/l

2.28

414

3540

Vertical strabismus

109

832

1.34

2.15

3.4

3.6

1.23

mmol/l

0.07

722

Small fibre neuropathy

100

755

1.36

2.15

6.4

3.8

1.22

1.23

mmol/l

0.25

659

Alzheimer’s disease (Early onset)

1247

0.74

2.14

2.3

3.7

1.23

1.22

mmol/l

0.30

1075

Exposure to other and unspecified inanimate mechanical forces

143

1799

0.79

2.14

5.8

3.8

1.22

mmol/l

0.27

124

1569

Diseases of tongue

207

1706

1.23

2.13

4.1

3.2

1.23

mmol/l

0.34

181

1472

Infarction of spleen

170

1.81

2.13

3.8

3.6

1.22

mmol/l

0.01

152

Trichomoniasis

247

1.66

2.13

3.8

3.5

1.24

1.23

mmol/l

0.47

211

Campylobacter enteritis

609

1.39

2.12

4.2

3.6

1.22

1.23

mmol/l

0.34

530

Benign leiomyoma with endometriosis

585

5228

1.13

2.11

3.7

3.5

1.24

mmol/l

0.08

496

4493

Radial styloid tenosynovitis [de Quervain]

164

1319

1.26

2.11

3.2

3.6

1.23

mmol/l

0.68

144

1137

Nonsuppurative otitis media

672

5222

1.12

2.11

5.0

3.5

1.22

1.23

mmol/l

0.29

599

4494

Olecranon bursitis

199

1636

1.23

2.11

4.2

1.21

1.22

mmol/l

1.73

181

1449

Syphilis

559

1.41

2.10

11.2

4.0

1.21

1.23

mmol/l

1.99

494

Syphilis

559

1.41

2.10

11.2

4.0

1.21

1.23

mmol/l

1.99

494

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

186

1517

1.24

2.10

3.1

3.0

1.22

1.23

mmol/l

1.80

170

1318

Open wound of hip and thigh

730

1.35

2.10

2.9

3.7

1.21

1.23

mmol/l

1.49

633

Rare circulating lymphoid malignancy

111

1.99

2.10

11.5

2.9

1.24

1.22

mmol/l

0.46

Hallux rigidus

386

4426

0.86

2.09

3.8

3.7

1.23

mmol/l

0.01

331

3797

Benign neoplasm: Scapula and long bones of upper limb

208

1.70

2.09

3.5

3.9

1.21

1.22

mmol/l

0.53

184

Motor neuron disease (with DMD)

417

1.47

2.09

2.3

4.2

1.22

1.23

mmol/l

0.86

369

Abnormal findings in nipple discharge synovial fluid wound secretions

352

1.53

2.09

5.2

3.5

1.22

1.23

mmol/l

0.86

311

Benign neoplasm: Duodenum

699

1.37

2.08

4.1

3.8

1.22

1.23

mmol/l

0.25

611

Abnormalities of forces of labour

202

2443

0.82

2.08

2.8

3.1

1.24

1.23

mmol/l

0.36

181

2136

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

2.82

2.08

3.8

3.3

1.26

1.21

mmol/l

—

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

2.05

2.08

2.7

3.7

1.22

mmol/l

0.17

Other and unspecified disease of Bartholin gland

777

0.68

2.08

3.1

3.3

1.22

1.23

mmol/l

0.98

659

Chronic suppurative otitis media

138

1734

0.79

2.07

4.6

3.6

1.22

1.23

mmol/l

0.64

118

1483

Benign neoplasm: Rectum, anus and anal canal

608

6772

0.89

2.07

4.5

3.9

1.23

mmol/l

0.85

540

5909

Benign neoplasm: Descending colon

168

2062

0.80

2.06

4.6

4.0

1.23

1.22

mmol/l

0.03

154

1814

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

567

1.40

2.05

5.8

3.9

1.22

1.23

mmol/l

0.65

498

Crushed, pushed or stepped on by crowd or human stampede

127

1612

0.78

2.05

3.3

3.5

1.23

mmol/l

0.01

118

1404

Localized scleroderma [morphea]

362

1.51

2.05

3.2

3.3

1.24

1.23

mmol/l

0.43

315

Use of levodopa decarbox-comt-inhibitor

114

884

1.32

2.05

3.1

4.0

1.22

mmol/l

0.01

765

Pyogenic granuloma

378

1.49

2.04

4.6

3.4

1.23

mmol/l

0.14

329

Organ-limited amyloidosis

120

1.95

2.04

7.7

3.5

1.20

1.22

mmol/l

0.51

102

Acne conglobata

2.17

2.02

8.0

3.1

1.22

mmol/l

0.21

Atopic dermatitis, strict definition

854

7629

1.10

2.02

4.1

3.5

1.23

mmol/l

0.02

761

6680

Other specified/unspecified deforming dorsopathies

412

1.47

2.02

3.7

3.4

1.22

1.23

mmol/l

0.62

352

Other erythematous conditions

114

885

1.31

2.01

8.2

3.7

1.23

mmol/l

0.29

106

754

Struck by thrown, projected or falling objec

147

1176

1.27

2.01

4.6

4.0

1.22

mmol/l

0.19

129

1022

Other symptoms and signs involving the urinary system

338

2924

1.17

2.01

4.6

3.8

1.22

mmol/l

0.34

294

2550

Sulfonylureas

1356

10039

1.08

2.01

5.5

3.9

1.22

1.23

mmol/l

6.15

1179

8630

Hypertrophic disorders of skin

170

1383

1.25

2.00

2.9

3.1

1.22

1.23

mmol/l

0.61

155

1194

Other puerperal infections

200

1653

1.22

1.99

2.4

2.6

1.22

1.23

mmol/l

2.99

166

1416

Nontraumatic intracranial haemmorrhage

748

6793

1.11

1.99

4.8

3.8

1.22

1.23

mmol/l

2.89

660

5784

Other articular cartilage disorders

574

1.39

1.99

3.0

3.7

1.23

mmol/l

0.10

487

Complications predominantly related to the puerperium

793

7220

1.10

1.98

3.0

3.2

1.23

mmol/l

1.04

685

6299

Other disorders of male genital organs

745

1.34

1.98

4.4

4.7

1.21

1.22

mmol/l

0.71

669

Malignant neoplasm of gallbladder

2.07

1.98

4.4

3.1

1.22

mmol/l

0.01

Other acquired deformities of musculoskeletal system and connective tissue

144

1153

1.27

1.98

3.3

3.9

1.23

mmol/l

0.16

128

1011

Bullous pemphigoid

602

1.39

1.97

5.2

3.6

1.22

mmol/l

0.18

514

Evidence of alcohol involvement determined by blood alcohol level

307

1.54

1.97

4.3

3.7

1.21

1.23

mmol/l

1.10

270

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

135

1072

1.28

1.97

4.5

3.4

1.23

mmol/l

0.15

118

923

Delivery, wide proxy

1268

6238

1.09

1.97

3.0

3.6

1.23

mmol/l

0.45

1072

5300

Other diseases of gallbladder

150

1208

1.26

1.96

4.7

3.4

1.23

mmol/l

0.12

132

1021

Dementia due to Parkinson's disease

707

1.35

1.95

2.9

3.8

1.22

mmol/l

0.05

604

Anomalies of dental arch relationship, including avohilmo

576

4651

1.12

1.95

3.9

3.5

1.23

mmol/l

0.22

505

4056

Disorders of synovium and tendon in diseases classified elsewhere

508

1.41

1.95

4.7

4.0

1.21

1.23

mmol/l

0.85

435

Other disorders of central nervous system

268

1.58

1.95

2.9

3.5

1.23

mmol/l

0.10

233

Pregnancy, childbirth and the puerperium

1139

5491

1.09

1.94

3.2

3.5

1.23

mmol/l

0.06

960

4674

Trichomoniasis

230

1.65

1.93

4.1

3.5

1.24

1.23

mmol/l

0.32

196

Injury of muscle and tendon at wrist and hand level

419

3689

1.15

1.93

3.1

4.2

1.23

1.22

mmol/l

0.82

373

3267

Oesophageal obstruction

125

989

1.29

1.92

5.4

3.9

1.22

mmol/l

0.14

117

853

Bullous keratopathy

222

1.65

1.92

5.6

3.6

1.23

mmol/l

0.10

196

Trochanteric bursitis

513

4578

1.13

1.92

3.1

3.6

1.24

mmol/l

0.49

458

3920

Motor neuron disease

408

1.46

1.92

2.3

3.5

1.22

1.23

mmol/l

0.76

360

Lichen simplex chronicus

115

901

1.30

1.91

5.6

3.5

1.22

1.23

mmol/l

0.82

104

781

Benign neoplasm: Choroid

212

1776

1.21

1.90

4.6

3.7

1.23

mmol/l

0.26

178

1549

Use of amantadine

410

1.46

1.89

3.3

3.7

1.22

1.23

mmol/l

0.38

358

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS